Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7

Yasunobu Okada; Tomohiro Numata; Ravshan Z Sabirov; Makiko Kashio; Peter G Merzlyak; Kaori Sato-Numata

doi:10.3389/fcell.2023.1246955

. 2023 Sep 29;11:1246955. doi: 10.3389/fcell.2023.1246955

Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7

Yasunobu Okada ^1,^2,^3,^4,^5,^*, Tomohiro Numata ², Ravshan Z Sabirov ⁶, Makiko Kashio ^1,³, Peter G Merzlyak ⁶, Kaori Sato-Numata ²

PMCID: PMC10576435 PMID: 37842082

Abstract

Cell volume regulation (CVR) is a prerequisite for animal cells to survive and fulfill their functions. CVR dysfunction is essentially involved in the induction of cell death. In fact, sustained normotonic cell swelling and shrinkage are associated with necrosis and apoptosis, and thus called the necrotic volume increase (NVI) and the apoptotic volume decrease (AVD), respectively. Since a number of ubiquitously expressed ion channels are involved in the CVR processes, these volume-regulatory ion channels are also implicated in the NVI and AVD events. In Part 1 and Part 2 of this series of review articles, we described the roles of swelling-activated anion channels called VSOR or VRAC and acid-activated anion channels called ASOR or PAC in CVR and cell death processes. Here, Part 3 focuses on therein roles of Ca²⁺-permeable non-selective TRPM2 and TRPM7 cation channels activated by stress. First, we summarize their phenotypic properties and molecular structure. Second, we describe their roles in CVR. Since cell death induction is tightly coupled to dysfunction of CVR, third, we focus on their participation in the induction of or protection against cell death under oxidative, acidotoxic, excitotoxic, and ischemic conditions. In this regard, we pay attention to the sensitivity of TRPM2 and TRPM7 to a variety of stress as well as to their capability to physicall and functionally interact with other volume-related channels and membrane enzymes. Also, we summarize a large number of reports hitherto published in which TRPM2 and TRPM7 channels are shown to be involved in cell death associated with a variety of diseases or disorders, in some cases as double-edged swords. Lastly, we attempt to describe how TRPM2 and TRPM7 are organized in the ionic mechanisms leading to cell death induction and protection.

Keywords: cell volume regulation, apoptosis, necrosis, pyroptosis, oxidative cell death, acidotoxic cell death, TRPM2, TRPM7

Introduction

Animal cells must regulate their cell volume even under physiological conditions with constant extracellular osmolarity. First, it is because the fluctuation of intracellular osmolarity is inevitably induced by cell activity per se which constantly requires osmolyte transport across the cell membrane and cell metabolism (anabolism and catabolism). Second, it is because cell volume changes are coupled to cell migration and cell proliferation connoting mitosis. After cell swelling and shrinkage, animal cells can shortly regulate their volume. The mechanisms of cell volume regulation are called the regulatory volume decrease (RVD) and the regulatory volume increase (RVI) that are attained by water movements driven by KCl efflux and NaCl influx, respectively (Hoffmann et al., 2009; Lang et al., 1998; Okada, 2004). In most types of mammalian cells, such volume-regulatory KCl and NaCl transports are principally accomplished by the activities of ubiquitously expressed anion and cation channels.

When the CVR mechanisms are persistently impaired, cells cannot survive. Sustained cell shrinkage and swelling are major hallmarks of the early, presumably earliest, events of necrotic and apoptotic cell death, and thus called the apoptotic volume decrease (AVD) (Maeno et al., 2000) and the necrotic volume increase (NVI) (Barros et al., 2001; Okada et al., 2001), respectively. Thus, these cell death processes are associated with dysregulation of a variety of ion transport mechanisms especially ion channels (Ritter et al., 2021). In the previous Part 1 article (Okada et al., 2021a) and Part 2 article (Okada et al., 2021b), we summarized the roles of the volume-sensitive outwardly rectifying anion channel (VSOR) (Okada, 1997), also called the volume-regulated anion channel (VRAC) (Nilius et al., 1997a), and those of the acid-sensitive outwardly rectifying anion channel (ASOR) (Wang et al., 2007), also called the proton-activated anion channel (PAC) (Yang et al., 2019), respectively, in CVR and cell death induction. To attain net KCl and NaCl transports, these anion channels should operate in parallel with K⁺ channels and Na⁺-permeable cation channels due to the electroneutrality constraint. In fact, altered activities of TRPM2 and TRPM7 cation channels are known to be implicated in CVR function/dysfunction and cell death induction. Here, we review the roles of TRPM2 and TRPM7 channels in the processes of CVR and cell death induction in this Part 3 article.

Phenotypic properties and molecular structures of TRPM2 and TRPM7

Chanzymes TRPM2 and TRPM7 as the members of sensor TRP channels

The Transient Receptor Potential (TRP) ion channel family consists of a large number (28 for human) of members, and is subdivided into 6 subfamilies in mammals: TRPC (“Canonical” or “Classical”), TRPM (“Melastatin”), TRPV (“Vanilloid”), TRPA (“Ankyrin”), TRPML (“MucoLipin”), and TRPP (PKD or “Polycystin”). TRP channels have a tetrameric subunit stoichiometry, with each subunit containing the cytoplasmic N- and C-terminal regions, six transmembrane domains (S1∼S6), and a pore-forming region between S5 and S6. TRP channels are non-selective cation-conductive membrane proteins and play a central role in physiological processes involving ionic signals. TRP channels are polymodal ion channels that have the role of integrating and transmitting a variety of environmental stimuli, including physical stimuli such as mechanical and thermal, and/or chemical stimuli such as pH and plant-derived compounds. These features serve as sensors to monitor the body’s extrinsic and intrinsic abnormalities while providing the basis for maintaining homeostasis that controls adaptive signals. Therefore, these are closely linked to health and disease and are attractive targets for drug discovery.

TRPM, the largest TRP subfamily, contains four melastatin domains, that are TRPM homology regions (MHR1-4), at the N-terminus and functions in a wide variety of cells throughout our body, including homeostasis-related cell proliferation, metabolism, cell death, and cancer (Dhakal and Lee, 2019; Fliniaux et al., 2018; Hantute-Ghesquier et al., 2018; Wong et al., 2019). As a main example, TRPM1: ON bipolar function of the retina (Koike et al., 2010), TRPM2: oxidative stress sensor function of cells and tissues (Naziroğlu, 2007), TRPM3: thermal sensor function (Vriens and Voets, 2019), TRPM4: regulator of cardiac conduction (Wang C. et al., 2018), TRPM5: taste sensor and blood glucose control capability (Vennekens et al., 2018), TRPM6: regulation of magnesium homeostasis (de Baaij et al., 2015), TRPM7: mechano-sensor function in cells (Numata et al., 2017a; Numata et al., 2017b) as well as synaptic and cognitive functions in the nervous system (Abumaria et al., 2019), and TRPM8: cold sensor function (Liu et al., 2020). Among these sensor TRPM channels, TRPM2, TRPM3, TRPM6, TRPM7, and TRPM8 are Ca²⁺-permeable cation channels activated by stress. In particular, TRPM2 and TRPM7 are unique ion channels possessing both ion channel and enzyme structures/activities and are called chanzymes

Physiological roles of TRPM2 and TRPM7

The activities of TRPM2 and TRPM7 are involved in a variety of physiological functions, as shortly summarized below.

TRPM2

The TRPM2 channel was first cloned by Nagamine et al. (Nagamine et al., 1998) and is a homo-tetrameric, non-voltage-activated, and non-selective cation channel expressed in a variety of cell types including neurons, pancreatic β cells, cardiomyocytes, and immune cells including monocytes/macrophages and neutrophils. The unique characteristic feature of TRPM2 is its temperature sensitivity (Togashi et al., 2006), and the temperature threshold decreases from around 47°C in the absence of oxidative stress to around 35.5°C in the presence of 100 μM H₂O₂ (Kashio et al., 2012). Thus, TRPM2 contributes to body temperature regulation (Song et al., 2016; Tan and McNaughton, 2016). TRPM2 is also involved in a variety of physiological functions including immunological cell responses, insulin secretion, and oxytocin release (Kashio and Tominaga, 2017; Szollosi, 2021).

TRPM7

TRPM7 is first cloned by three separate groups (Nadler et al., 2001; Runnels et al., 2001; Yamaguchi et al., 2001) and is a constitutively active, homo-tetrameric, non-selective cation channel with protein serine/threonine kinase activity (Nadler et al., 2001; Runnels et al., 2001; Schmitz et al., 2003). The TRPM7 channel is expressed in almost all tissues, including brain, heart, liver, kidney, lung, and spleen (Nadler et al., 2001; Runnels et al., 2001). Accumulating evidence has shown that TRPM7 is essentially involved in a variety of fundamental physiological cell functions, as listed below: cell viability and growth (Nadler et al., 2001; Hanano et al., 2004; Elizondo et al., 2005; Che et al., 2014), cell adhesion (Clark et al., 2006; Su et al., 2006), cytoskeletal regulation (Nadler et al., 2001; Clark et al., 2006), cell migration (Wei et al., 2009; Kuras et al., 2012), cellular and systemic Mg²⁺ homeostasis (Schmitz et al., 2003; He et al., 2005; Ryazanova et al., 2010; Mittermeier et al., 2019), permeation of trace metal ions into cells (Nadler et al., 2001; Monteilh-Zoller et al., 2003; Schmitz et al., 2003), neurotransmitter release (Krapivinsky et al., 2006; Brauchi et al., 2008), axonal growth (Turlova et al., 2016), and the activation and differentiation of immune cells (see Review: Nadolni and Zierler, 2018).

Biophysical properties of TRPM2 and TRPM7

The monomers of chanzymes TRPM2 and TRPM7 have largely common domain structures, these tetramers both operate as Ca²⁺-permeable cation channels with different biophysical properties, as summarized below.

TRPM2

TRPM2 has MHR1-4 with the IQ-motif at the large N-terminus, conserved six transmembrane segment (S1-S6) regions, and a pore-forming loop domain between S5 and S6 as well as the C-terminus composed of the TRP helix containing TRP box1 and TRP box2, a coiled-coil domain (CCD), and a unique enzymatic NUDT9 homology (NUDT9-H) domain (Figure 1). The IQ-like motif, located at amino acids (AA) 406–416 of MHR1-4 in human TRPM2 (hTRPM2), is important for Ca-CaM binding (Tong et al., 2006). An additional Ca-CaM-binding motif, W1355-I1368, was found in the NUDT9-H domain of hTRPM2 (Gattkowski et al., 2019). In the pore region, the FGQI motif (AA 979–982) was recently identified as the selectivity filter of hTRPM2 channel (Yu et al., 2021). The CCD is critical for the heteromeric assembly formation of TRPM2 (Mei et al., 2006). In addition, TRPM2 contains a structure of ADP-ribose (ADPR) pyrophosphatase enzyme, although this domain of hTRPM2 is catalytically inactive (Iordanov et al., 2016), and is activated by cytosolic ADPR (cADPR) and reactive oxygen species (ROS) (Hara et al., 2002). Recently, it became clear that ADPR binds not only to the C-terminal NUDT9-H domain (AA 1197–1503 for hTRPM2) but also to MHR1-2 located at amino acids 1–422, and it was revealed that the channel activity is greatly affected by the latter binding (Huang et al., 2018b; Huang et al., 2019).

Human TRPM2 exhibits a rapid inactivation time course after activation even in the persistent presence of activators (Csanády and Törocsik, 2009), whereas sea anemone Nematostella vectensis TRPM2 (nvTRPM2) does not show such inactivation kinetics (Zhang et al., 2018). The existence of electroneutral residues of G984 and Y985 in the putative selectivity filter of hTRPM2 is judged to be responsible for the inactivation time course, based on the following observations: First, hTRPM2 currents became non-inactivating, when these residues were replaced with acidic residues (G984D and Y985E) (Tóth and Csanády, 2012). Second, the corresponding residues (D1041 and E1042) for an ancient type of nvTRPM2 are acidic or negatively charged (Iordanov et al., 2019).

The TRPM2 single-channel current exhibits a unitary conductance of about 50–80 pS and a linear current-voltage (I-V) relationship. The whole-cell current also shows a linear I-V relationship. This channel has permeabilities not only to monovalent cations such as Na⁺, K⁺ and Cs⁺ but also to divalent cations such as Ca²⁺ and Mg²⁺ with the permeability ratios to a monovalent cation Na⁺ of 0.67–0.9 and 0.47–0.5, respectively (Kraft et al., 2004; Sano et al., 2001; Xia et al., 2008). Such prominent divalent cation permeabilities are attained by interaction with glutamate, glutamine, and aspartate residues (E960, Q981, D987, and E1022 for hTRPM2) (Belrose and Jackson, 2018; Sumoza-Toledo and Penner, 2011; Turlova et al., 2018; Xia et al., 2008), the residues of which are forming the selectivity filter in the vestibule of the TRPM2 channel pore region (AA 952-1022 for hTRPM2; AA 949-1019 for mouse TRPM2).

TRPM7

TRPM7 has MHR1-4 at the large N-terminus followed by the conserved six transmembrane segment (S1-S6) regions containing the pore-forming loop domain between S5 and S6 and the C-terminus (Figure 2). The C-terminus contains the TRP helix, CCD, and a unique α-kinase domain with an Mg²⁺‧ATP-binding site (Simon et al., 2013; Yee et al., 2014). TRPM7’s characteristic α-kinase activity and its channel function are shown to be independent of each other by site-directed mutagenesis analyses combined with biochemical and electrophysiological studies (Schmitz et al., 2003; Demeuse et al., 2006). On the other hand, the role of α-kinase activity is, in a manner independent of ion channel activity, involved in phosphorylation of downstream signaling molecules such as annexin A1 (Dorovkov and Ryazanov, 2004), myosin II (Clark et al., 2006; Clark et al., 2008a; Clark et al., 2008b), SMAD2 (Romagnani et al., 2017), and PLCγ2 (Deason-Towne et al., 2012) as well as some store-operated Ca²⁺ entry (SOCE) components related to STIM or Orai, thereby regulating SOCE (Faouzi et al., 2017).

The single-channel current of TRPM7 has a unitary conductance of around 40 pS at negative voltages (of around −70 mV) in the absence of extracellular Mg²⁺ (Kozak et al., 2005; Li et al., 2006). The whole-cell currents show a nearly linear I-V relationship with weak inward rectification in the absence of extracellular divalent cations, but a non-linear I-V relationship with strong outward rectification in the presence of extracellular divalent cations (Nadler et al., 2001; Runnels et al., 2001; Aarts et al., 2003; Monteilh-Zoller et al., 2003; Schmitz et al., 2003) and especially in the presence of extracellular Mg²⁺ due to its open channel blocking action (Kerschbaum et al., 2003). The residues of D1054 and E1052 within the pore-forming region of human TRPM7 provide the binding sites and the selective filter for Mg²⁺ and Ca²⁺ (Numata and Okada, 2008a). On the other hand, in the case of mouse TRPM7, E1047 and E1052 were shown to represent the selectivity filter for Mg²⁺ and Ca²⁺ (Li et al., 2007). Thus, TRPM7 exhibits permeabilities both to monovalent cations such as Na⁺ and Cs⁺ and to divalent metal cations such as Mg²⁺, Ca²⁺, Ba²⁺, Sr²⁺, Cd²⁺, and Zn²⁺. TRPM7 localized in intracellular vesicles mediates Zn²⁺ release from the vesicles upon ROS-induced TRPM7 activation (Abiria et al., 2017). TRPM7 is characteristic in its permeability to protons (Jiang et al., 2005; Numata and Okada, 2008b). The channel permeability to cations including divalent cations is initiated by attraction to the glutamate and aspartate residues, which are negative charges in the pore vestibule of the TRPM7 channel (Li et al., 2007; Numata and Okada, 2008a; Schlingmann et al., 2007; Yee et al., 2014). The TRPM7 channel exhibits inward proton conductance (Jiang et al., 2005) in a manner sensitive to the presence of extracellular Mg²⁺ and Ca²⁺ (Numata and Okada, 2008b). It appears that the proton conductivity of TRPM7 is mediated by the pore per se, because the charge-neutralizing mutation of Asp-1054 (D1054A) of human TRPM7 abolished its proton conductance (Numata and Okada, 2008b).

Activation and inactivation signals for TRPM2 and TRPM7

TRPM2 and TRPM7 channel activities are stimulated or inhibited by numbers of intracellular signaling molecules that are generated or mobilized in response to various environmental stresses, as detailed below.

TRPM2

Adenosine diphosphate ribose (ADPR) is a key gating molecule of the TRPM2 channel (Perraud et al., 2001) with an EC₅₀ of 10–15 μM (Kolisek et al., 2005; Beck et al., 2006) and exerts the action through the binding not only to the C-terminal NUDT9-H domain of TRPM2 (Wehage et al., 2002; Heiner et al., 2003; Perraud et al., 2003; Kraft et al., 2004; Kolisek et al., 2005; Fliegert et al., 2017b) but also to the N-terminal MHR1/2 (Huang et al., 2018b; Huang et al., 2019) (Figure 1). A site-directed mutagenesis study showed that hydrogen bonding of R1433 and Y1349 in the C-terminus is required for hTRPM2 activation induced by the C-terminal binding of ADPR (Fliegert et al., 2017b). For the N-terminal ADPR-binding site, M215, Y295, and R302 were identified as the key residues (Huang et al., 2019). In response to stimulation by extracellular signals, especially oxidative stress (reactive oxygen species: ROS) and nitrosative stress (reactive nitrogen species: RNS), ADPR is generated from NAD⁺ in the cytosol via a special type of CD38 (see below), mitochondria via mitochondrial NUDT9 (Perraud et al., 2003; Perraud et al., 2005), and nuclei through the sequential actions of nuclear enzyme poly-ADPR polymerase (PARP) and poly-ADPR glycohydrolase (PARG) in response to DNA damage and PARP stimulation (Caiafa et al., 2009; Esposito and Cuzzocrea, 2009; Fauzee et al., 2010) (Figure 1). TRPM2 is also activated by ADPR upon stimulation with other extracellular stimuli including TNFα in mouse cardiac ventricular myocytes (Roberge et al., 2014), amyloid β-peptide (Aβ) in rat striatal cells (Fonfria et al., 2005), and Zn²⁺ in mouse microglial cells (Mortadza et al., 2017). ADPR-induced TRPM2 activation depends on the presence of phosphatidylinositol 4,5-bisphosphate (PIP₂) in the inner leaflet of cell membrane (Tóth and Csanády, 2012; Zhang et al., 2018) and cytosolic Ca²⁺ (Du et al., 2009a; McHugh et al., 2003; Starkus et al., 2007; Tong et al., 2006). ADPR cannot activate TRPM2 in the absence of Ca²⁺ (McHugh et al., 2003; Starkus et al., 2007) and of calmodulin (CaM) (Tong et al., 2006). CaM directly interacts with the IQ-like motif (AA406-416) in the N-terminus of TRPM2 (Tong et al., 2006) as well as with the Trp-1355∼Ile-1368 motif in the NUDT9-H domain of hTRPM2 with a Kd of 110 nM (Gattkowski et al., 2019) (Figure 1). Intracellular Ca²⁺ alone was also reported to activate TRPM2 in a manner independent of ADPR and the ADPR-binding site of the C-terminus of TRPM2 by Du et al. (Du et al., 2009a), although such was not observed by other groups (Csanády and Törocsik, 2009; McHugh et al., 2003; Starkus et al., 2007). In any case, not only ADPR binding but also Ca²⁺ binding are prerequisite for TRPM2 channel gating (Csanády and Törocsik, 2009). By making site-directed mutagenesis combining with patch-clamp functional assay, it was suggested that the D267-D268 motif in the N-terminus as a Ca²⁺-binding EF-loop is also critical for hTRPM2 channel activation induced by an unrealistically high concentration (50 mM) of Ca²⁺ (Luo et al., 2018). In addition, cryo-EM study recently revealed that the Ca²⁺-binding site is located at the intracellular border of the channel in between S2, S3, and the TRP helix coordinated by E843 and Q846 of S2, N809 of S3, and E1073 of the TRP helix of hTRPM2 (Wang L. et al., 2018). ROS and RNS were shown to stimulate the TRPM2 channel in intact cells (Hara et al., 2002; Wehage et al., 2002) in an indirect manner through promotion of ADPR generation (Fonfria et al., 2004; Perraud et al., 2005; Buelow et al., 2008; Blenn et al., 2011) (Figure 1). However, it is noteworthy that a splice variant of TRPM2 with deletion of the C-terminus can still be activated by H₂O₂ (though not by ADPR), suggesting that there exists some ADPR-independent activation mechanism. Of note, H₂O₂ reduces temperature thresholds for TRPM2 activation, thereby inducing TRPM2 activation at body temperature (37°C), in a manner independent of ADPR (Kashio et al., 2012). In connection with this, exposure to H₂O₂ was shown to induce tyrosine phosphorylation of TRPM2 with activation of TRPM2 channels (Zhang et al., 2007), though the detailed mechanism is not clarified as yet. TRPM2 is also known to be activated by nicotinamide dinucleotide (NAD⁺) (Sano et al., 2001; Hara et al., 2002; Wehage et al., 2002) and by its metabolite, nicotinic acid adenine dinucleotide phosphate (NAADP) (Beck et al., 2006) as well as by cADPR (Fleig and Penner, 2004; Mei et al., 2006; Perraud et al., 2001; Xia et al., 2008). However, NAD⁺-induced TRPM2 activation observed previously (Sano et al., 2001; Hara et al., 2002; Naziroğlu and Lückhoff, 2008) is now considered to be due to contamination with ADPR or metabolism of NAD⁺ (Beck et al., 2006; Grubisha et al., 2006), because after affinity-purification, NAD⁺ and NAADP were found to be incapable of stimulating TRPM2 even at concentrations considerably higher than their cytosolic concentrations (Tóth et al., 2015). In contrast, cADPR can directly gate the TRPM2 channel at high concentrations (Kolisek et al., 2005) with an EC₅₀ of 60–120 μM (Beck et al., 2006) and therefore seems to exert as a non-physiological low affinity agonist (Yu et al., 2019). O-acetyl-ADP ribose (OAADPR), which is generated in response to ROS/RNS by protein deacetylase sirtuins in the cytosol (via SIRT2), mitochondria (via SIRT1), and nuclei (via SIRT3/5), can also directly activate TRPM2 by binding to the NUDT9-H domain (Grubisha et al., 2006; Tong and Denu, 2010) (Figure 1). TRPM2 activity involves a multifunctional single-pass transmembrane glycoprotein enzyme, CD38, which converts NAD⁺ and NAAD into cADPR and then hydrolyzes cADPR to ADPR (Kim et al., 1993; Takasawa et al., 1993; Zocchi et al., 1993). Also, it is noted that CD38 is not only a generator of cADPR and ADPR but also a transmembrane transporter of cADPR and ADPR (Franco et al., 1998; Guida et al., 2004), thereby mediating the intracellular actions of cADPR and ADPR generated extracellularly (Figure 1). The most widely known type of CD38 (Type II) is ectoenzyme with the catalytic domain facing outside. In recent years, it was shown that there exists another type of CD38 (Type III) with an opposite orientation of which the catalytic domain is facing the cytosol, thereby catalyzing the synthesis of intracellular cADPR (Liu et al., 2017; Zhao et al., 2012). We showed, for the first time, that TRPM2 physically interacts to CD38, and activity of the ∆C-variant of TRPM2 (TRPM2-∆C) functioning as a hypertonicity-induced cation channel (HICC) is regulated by this direct interaction between TRPM2 and CD38 (Numata et al., 2012). Indeed, the CD38-TRPM2 interaction was shown to play important roles in oxytocin secretion (Higashida et al., 2018), natural killer cell activity (Rah et al., 2015), and chronic inflammation (García-Rodríguez et al., 2018; Balinas et al., 2019). Also, it is noted that hypertonic stimulation induces ROS production in kidney cells (Ikari et al., 2013; Yang et al., 2005) as well as HeLa cells (Numata et al., 2012) and a marked increase in the intracellular cADPR concentration (Numata et al., 2012). Moreover, both cationic currents activated by hypertonicity and by cADPR were inhibited not only by TRPM2-siRNA but also by CD38-siRNA (Numata et al., 2012). Thus, it is concluded that hypertonic stress induces increases in intracellular cADPR, presumably via activation of CD38, thereby activating the TRPM2 channel as HICC (Figure 1). 2′-Deoxy-ADPR, which is an endogenous nucleotide synthesized from nicotinamide mononucleotide (NMN) and deoxy-ATP by consecutive action of an NMN adenylyl transferase and CD38, was identified as an additional agonist of TRPM2 (Fliegert et al., 2017a), although its binding site is not identified as yet. One type of growth factors, vascular endothelial growth factor (VEGF), was shown to activate TRPM2 thereby inducing Ca²⁺ influx in vascular endothelial cells leading to cadherin phosphorylation (Mittal et al., 2015) and angiogenesis (Negri et al., 2019). Most recently, bilirubin and its derivatives were found to activate TRPM2 channels from the extracellular side by directly interacting with K928 and D1069 existing in the S5 and TRP helix regions of TRPM2, respectively (Figure 1), presumably after getting into an intramembrane deep cavity surrounded by the S3, S5 and TRP helix (Liu et al., 2023).

TRPM2 channel activity is sensitive to extracellular and intracellular acidification. Du et al. (Du et al., 2009b) found that extracellular protons inhibit TRPM2 with an IC₅₀ of pH 5.3 by interacting at H958, D964, and E994 existing in the outer vestibule of the TRPM2 pore, whereas Yang et al. (Yang et al., 2010) found that extracellular proton-induced TRPM2 inhibition (with IC₅₀ of pH 4.7) is mediated by binding to several residues in the outer vestibule of the pore especially K953 and D1002. In contrast, Starkus et al. (Starkus et al., 2010) reported that extracellular acidification inhibits TRPM2 with an IC₅₀ of pH 6.5 after permeating the TRPM2 pore and interacting with an intracellular site. Intracellular protons were observed to completely suppress TRPM2 activity at pH 6 by competitively antagonizing intracellular Ca²⁺ binding by the latter group (Starkus et al., 2010) and with an IC₅₀ of pH 6.7 by interacting at D933 in the S4-S5 linker region thereby decreasing sensitivity to intracellular Ca²⁺ and/or intracellular ADPR by the former group (Du et al., 2009b) (Figure 1). AMP, which is a breakdown product of ADPR, is known to specifically antagonize ADPR-induced activation of TRPM2 with an IC₅₀ of 10–70 μM (Kolisek et al., 2005; Beck et al., 2006; Lange et al., 2008) through a competition for the Nudix domain (Figure 1). A most abundant trace metal, Zn²⁺, inactivates the channel activity of TRPM2 overexpressed in HEK293 cells, in a manner dependent on membrane potentials, by the extracellular application (Yang et al., 2011). Zn²⁺-induced suppression was found to be full for the inward currents but only partial for the outward currents, suggesting an open-channel blocking action. Positively charged Lys⁹⁵² and negatively-charged Asp¹⁰⁰² in the outer pore region may provide the blocking site of Zn²⁺, because charge-neutralizing mutations of these residues (K952A and D1002A) were observed to strongly attenuate the Zn²⁺-induced suppression (Yang et al., 2011). On the other hand, another trace metal, Cu²⁺, inhibited, in a manner independent of voltages, hTRPM2 currents with an IC₅₀ of 2.6 μM, when applied extracellularly but not intracellularly (Zeng et al., 2012). However, Cu²⁺ was found to fail to affect the activity of mouse TRPM2 (mTRPM2), in which the residue corresponding to H995 of hTRPM2 is Q992, though the inhibitory effect of Cu²⁺ on hTRPM2 was bolstered (Yu et al., 2014). In fact, H995 was found to be critical for Cu²⁺-induced hTRPM2 inactivation, because charge-neutralizing mutation of His⁹⁹⁵ (H995A or H995Q) in the pore-forming region abolished the Cu²⁺-induced suppression (Yu et al., 2014).

TRPM7

The constitutive activity of TRPM7 channel is maintained by PIP₂ (Runnels et al., 2002; Kozak et al., 2005; Gwanyanya et al., 2006). Thus, TRPM7 currents are inactivated by PIP₂ depletion caused by PLC-coupled GPCR stimulation (Runnels et al., 2002; Langeslag et al., 2007) and by expression of voltage-sensitive phosphatase (VSP) (Xie et al., 2011). PIP₂ is known to bind to cationic residues of some TRPs, including TRPV1, TRPM8, and TRPM4 (Rohács et al., 2005; Bousova et al., 2015; Poblete et al., 2015). Similarly, K1112 and R1115 existing in the TRP domain were suggested to be required for PIP₂ dependence of mouse TRPM7 (Figure 2), because TRPM7 currents were found to be ablated by the K1112Q/R1115Q double mutation (Xie et al., 2011). In contrast to the inhibitory effect of PIP₂ depletion, transient PIP₂ hydrolysis was rather found to augment TRPM7 currents (Langeslag et al., 2007).

Intracellular free Mg²⁺ and Mg‧ATP suppress, in a manner independent of voltages, TRPM7 channel activity (Nadler et al., 2001; Runnels et al., 2001; Hermosura et al., 2002; Kozak and Cahalan, 2003; Schmitz et al., 2003). Depletion of intracellular Mg²⁺ or Mg‧ATP augments TRPM7 currents (Nadler et al., 2001; Kozak and Cahalan, 2003; Demeuse et al., 2006; Langeslag et al., 2007). Intracellular free Mg²⁺ completely inhibits TRPM7 currents at millimolar concentrations (Nadler et al., 2001) and suppresses the currents in a dually concentration-dependent manner with two independent sites. Such dual Mg²⁺-induced inhibitory effects were thus described by two IC₅₀ values of 10–25 and 90–165 μM in Jurkat T lymphocytes (Chokshi et al., 2012b; Chokshi et al., 2012c) or of 5.6–6.5 and 467–558 μM in TRPM7-overexpressing HEK293 cells (Inoue et al., 2021; Inoue et al., 2014). Extracellular Mg²⁺ also inhibits TRPM7 currents (Nadler et al., 2001) in a manner dependent on voltages with IC₅₀ values of 3.2 μM at −40 mV and 0.11 mM at +80 mV (Numata et al., 2007b), indicating voltage-dependent Mg²⁺ block of the TRPM7 channel pore. Intracellular Mg‧ATP inhibits TRPM7 activity with an IC₅₀ of 2 mM (Demeuse et al., 2006). Sensitivity to intracellular Mg²⁺ and Mg‧ATP may be mediated by C-terminal sites (Figure 2), one within and another outside the kinase domain (Schmitz et al., 2003; Demeuse et al., 2006; Yu H. et al., 2013). The kinase activity is not essential for the TRPM7 channel activity, because mutation of two autophosphorylation sites or of a key catalytic site that abolished kinase activity never affected the channel activity (Matsushita et al., 2005). However, the interaction between the kinase domain and channel domain is involved in the modulation of channel activity by altering the sensitivity to Mg²⁺ and Mg‧ATP (Demeuse et al., 2006; Yu H. et al., 2013). In fact, recently, it was clarified that the channel domain-kinase domain interaction increases TRPM7 currents by decreasing Mg²⁺-induced inhibition (Inoue et al., 2021). In this study, after cleaving the kinase domain, the channel domain (AA 1-1509) per se was found to be sensitive to intracellular Mg²⁺ with an IC₅₀ of 3.0 μM, and the interaction of the channel domain with the kinase domain was shown to rather decrease intracellular Mg²⁺ sensitivity (Inoue et al., 2021). Based on the truncation studies, the CCD of zebrafish TRPM7 (drTRPM7) was suggested to be involved in the channel’s regulation by Mg²⁺ and Mg‧ATP (Jansen et al., 2016). An involvement of the inter-subunit region between S6 and the TRP domain in the intracellular Mg²⁺ sensitivity of TRPM7 gating was also suggested, because the S1107E mutant of mouse TRPM7 (mTRPM7) exhibited constitutively active channels in a manner insensitive to intracellular Mg²⁺ (Hofmann et al., 2014). Indeed, the Mg²⁺-insensitive S1107E mutant of mTRPM7 was shown to become less sensitive to PIP₂ depletion (Zhelay et al., 2018). Recently, N1097 of mTRPM7 was also indicated to form the intracellular Mg²⁺ regulatory site, because the N1097Q mutation abrogated the inhibition of TRPM7 channel by physiological intracellular Mg²⁺ concentration (Schmidt et al., 2022). In addition, intracellular Mg²⁺ was reported to inhibit TRPM7 channel activity by screening the negatively charged PIP₂ (Kozak et al., 2005) and thereby disrupting the PIP₂-TRPM7 interaction (Zhelay et al., 2018) (Figure 2). Recently, cAMP/PKA was shown to downregulate the TRPM7 activity and expression by phosphorylating TRPM7 at S1269 existing near the CCD region (Tian et al., 2018; Broertjes et al., 2019) (Figure 2). Furthermore, TRPM7 channel activity was demonstrated to be inhibited by ADP-ribosylation factor-like GTPase 15 (ARL15) through forming a macromolecular complex together with TRPM7 and cystathione-β-synthase (CBS)-pair domain divalent metal cation transport mediator (CNNM) (Kollewe et al., 2021; Mahbub et al., 2023).

TRPM7 currents are activated by cytosolic alkalinization and inactivated by intracellular acidification (Kozak et al., 2005). Cytosolic protons inhibit TRPM7 channel with an IC₅₀ of pH 6.3 (Chokshi et al., 2012c) by a charge screening of PIP₂, thereby disrupting the PIP₂-TRPM7 interaction (Kozak et al., 2005; Zhelay et al., 2018). In contrast, extracellular acidification potentiates TRPM7 presumably by proton-induced unbinding of Ca²⁺ and Mg²⁺, thereby removing the blocking effects of Ca²⁺ and Mg²⁺ (J. Jiang et al., 2005), at the divalent cation binding sites, the negatively charged E1047 and E1052 for mTRPM7 (Li et al., 2007), and E1052 and D1054 for human TRPM7 (hTRPM7) (Numata and Okada, 2008a) in the pore region (Figure 2). In fact, hTRPM7 activation by extracellular protons was abolished by electro-neutralizing D1054 mutation, but not charge-preserving D1054E mutation (Numata et al., 2019).

TRPM7 was shown to be activated by ROS under anoxic conditions (Aarts et al., 2003). Such an enhancing effect of ROS may be caused by increased expression of TRPM7 mRNA and protein in cells exposed to oxidant agents (Wuensch et al., 2010; Nuñez-Villena et al., 2011). In contrast, recently, increased extracellular H₂O₂ concentrations were found to inhibit TRPM7 currents in a manner dependent on Mg²⁺ (with an IC₅₀ of 16 μM) but not on ATP (Inoue et al., 2014). The Mg²⁺-insensitive S1107E mutant of mTRPM7 is not affected by H₂O₂ (Inoue et al., 2021). Therefore, it is likely that the inhibitory effect of H₂O₂ is based on the enhancement of intracellular Mg²⁺ sensitivity. Supportively, C1809 and C1813 locating in the kinase domain of mTRPM7, which are essential not only for the Mg²⁺ sensitivity but also for kinase activity (Runnels et al., 2001), were shown to exert as the oxidative stress sensor in the presence of intracellular Mg²⁺ (H. Inoue et al., 2021).

Mechano-stress is an additional activating factor for TRPM7. Under the whole-cell recordings, osmotic cell swelling and shear stress induced by perfusion of bath solution were found to augment Mg²⁺-sensitive cation currents in hTRPM7-transfected, but not mock-transfected, HEK293 cells (Numata et al., 2007a). The shear stress-induced augmentation of whole-cell TRPM7 current was not affected by an exocytosis-blocking reagent brefeldin A under the experimental conditions employed in this study, although laminar flow-induced shear stress was reported to cause exocytotic translocation of TRPM7 to the plasma membrane in some cell types (Oancea et al., 2006). It is noteworthy that even under the cell-free inside-out configuration, membrane stretch was found to directly activate single-channel activity of TRPM7 by increasing the open probability (P _o) (Numata et al., 2007a). Moreover, similar Mg²⁺-sensitive single-channel and whole-cell cation currents were also observed upon application of membrane stretch and hypotonic stress, respectively, in human epithelial HeLa cells, in which TRPM7 is endogenously expressed, in a manner sensitive to siRNA-mediated knockdown of TRPM7 (Numata et al., 2007b). In contrast, it was suggested that TRPM7 senses the osmotic gradient rather than membrane stretch in HEK293 cells transfected with hTRPM7, on the basis of observations that whole-cell currents were only slightly increased by cell ballooning induced by intracellular pressure application during observation of TRPM7 activity under the whole-cell configuration (Bessac and Fleig, 2007). In this study, however, there remains a possibility that whole-cell TRPM7 currents were largely pre-activated by cell swelling caused by oncotic pressure due to the cytosolic presence of considerable amount of non-diffusible large organic (colloidal) osmolytes under the experimental conditions where the intracellular pipette solution and the extracellular bath solution had the identical osmolarity. Also, swelling-activated and shrinkage-inhibited Cl⁻ currents might have been, at least in part, contaminated in the whole-cell currents recorded under Cl⁻-rich conditions. The fact that TRPM7 directly senses mechanical stimulation was, in fact, confirmed in human bone marrow mesenchymal stem cells by measuring suction-induced and hydrostatic pressure-induced membrane currents (Xiao et al., 2015) and in HEK293 cells transfected with mTRPM7 by observing pressure-induced cytosolic Ca²⁺ increases (R. Zhao et al., 2019). Mechano-sensitivity of TRPM7 was also shown by Ca²⁺ imaging in mouse mesenchymal stroma cells in response to fluid shear stress (Liu et al., 2015), in rat odontoblasts in response to hypotonic stimulation (Won et al., 2018), and in human MDA-MB-231 adenocarcinoma cells in response to a hydrostatic pressure increase (Zhao et al., 2019). The mechano-sensitivity of TRPM7 might be implicated in hypertension, since molecular TRPM7 expression in vascular smooth muscle cells was found to be decreased in spontaneously hypertensive rats (Touyz et al., 2006).

Pharmacological properties of TRPM2 and TRPM7

For TRPM2 and TRPM7, a large number of potent antagonists have been identified, but only several agonists were found, as listed below. However, most of them are not so specific to TRPM2 or TRPM7. Most of the binding sites for antagonists and agonists of TRPM2 and TRPM7 await future identification.

TRPM2

Since ADPR and cADPR are endogenous activators of TRPM2 channels, it is quite natural that TRPM2 activity is inhibited by ADPR analogs, 8-bromo-ADP-ribose (8-Br-ADPR), at 900 μM (Partida-Sanchez et al., 2007), 8-phenyl-2′-deoxy-ADPR with an IC₅₀ of 3 μM (Moreau et al., 2013), and Compound 7i and 8a at 5–6 μM (Luo et al., 2018) as well as by a cADPR analog, 8-bromo-cyclic ADP-ribose (8-Br-cADPR), at ≥100 μM (Kolisek et al., 2005; Beck et al., 2006) by antagonizing the binding of ADPR and cADPR. Recently, 8-Br-cADPR was shown to exert an inhibitory action by binding not to the C-terminal binding site, the NUDT9-H domain, but to the N-terminal binding site, the U-shaped MHR1/2 domain (Huang et al., 2019). PARP inhibitors, SB750139-13, PJ34, and DPQ, are also effective to suppress TRPM2 activity with IC₅₀ values of 25.1 nM, 2.0 μM, and 15.8 μM, respectively (Fonfria et al., 2004). TRPM2 inhibition was observed to be abolished by exposure to a cell-permeable peptide targeting the Nudix motif of TRPM2, tat-M2NX, at 100 μM (Shimizu et al., 2016). Hydroxyl radical scavengers, dimethylthiourea (DMTU) and N-2-mercaptopropyonyl glycine (MPG), were shown to inhibit TRPM2 activity (Smith et al., 2003; Ishii et al., 2006). However, it must be noted that these chemicals exert inhibitory actions not directly to TRPM2 but indirectly via scavenging hydroxyl radicals. A Janus kinase 2 (JAK2) inhibitor tyrphostin, AG490, was also found to indirectly antagonize, in a manner independent of JAK2, TRPM2 channel activity by scavenging hydroxyl radicals (Shimizu et al., 2014). AG490-related compounds, AG555 and AG556, blocked H₂O₂-induced activation of TRPM2 channels more strongly than AG490 (Toda et al., 2016). A known phospholipase A2 (PLA2) inhibitor, N-(p-amylcinnamoyl) anthranilic acid (ACA), also blocks TRPM2 currents, in a manner independent of inhibition of PLA2, when applied extracellularly (but not intracellularly), with an IC₅₀ of 1.7 μM (Kraft et al., 2006). However, it must be noted that ACA is not specific for TRPM2 but is also known to inhibit activities of TRPM8 and TRPC6 (Kraft et al., 2006). Recently, one of the derivatives of ACA, called compound A23, was found to be a more effective and selective blocker for TRPM2 with an IC₅₀ of 788 nM (Zhang et al., 2021).

TRPM2 currents are blocked by an antipyretic acid-derivative nonsteroidal anti-inflammatory drug (NSAID), flufenamic acid (FFA), at 50–1000 μM with an IC₅₀ of 70 μM (Hill et al., 2004a). FFA also inhibits HICC/TRPM2-∆C activity (Wehner et al., 2003b) with an IC₅₀ of 117 μM (Numata et al., 2007c). However, it must be noted that FFA affects not only TRPM2 but also other ion channels including some chloride, sodium, potassium and calcium channels (Guinamard et al., 2013). FFA analogs, mefenamic acid (MFA) and niflumic acid (NFA), are also effective to inhibit TRPM2 channels with IC₅₀ values of 76 and ∼120 μM, respectively (Chen et al., 2012). Another fenamate analog, 2-aminoethoxydiphenyl borate (2-APB), suppresses TRPM2 activity with an IC₅₀ of 1.2 μM (Togashi et al., 2008) and HICC activity with an IC₅₀ of 525 μM (Numata et al., 2007c). 2-APB is not specific for TRPM2, because it also inhibits other TRPM members (Togashi et al., 2008) including TRPM7 (Li et al., 2006) and multiple TRPC channels (Xu et al., 2005) but activates several TRPV channels (Hu et al., 2004). In addition, a natural plant-derived polyphenol, curcumin, was more recently found to inhibit TRPM2 channels with an IC₅₀ of around 50 nM (Kheradpezhouh et al., 2016). However, curcumin has been shown to inhibit a variety of ion channels such as K⁺ channels, Ca²⁺ channels, CFTR, and VSOR/VRAC Cl⁻ channels (Zhang et al., 2014). Furthermore, TRPM2 activity is sensitive to antifungal agents, clotrimazole and econazole, with IC₅₀ values of 3–30 μM (Hill et al., 2004b) as well as miconazole with IC₅₀ of <3 μM (Togashi et al., 2008). However, these antifungal agents are not specific TRPM2 blockers but are known to block TRPV5 (Nilius et al., 2001), Ca²⁺-activated IK channels (Jensen et al., 1998), ATP-sensitive K⁺ channel (Jäger et al., 2004), and L-type Ca²⁺ channels (Thomas et al., 1999).

In contrast to these TRPM2 inhibitors, an analgesic and antipyretic drug, acetaminophen, was found to activate TRPM2 in rat hepatocytes at high concentrations (10–15 μM) (Kheradpezhouh et al., 2014).

TRPM7

TRPM7 inhibitors are divided into five categories: 1. In vivo metabolites such as sphingosine and spermine. 2. Natural products such as waixenicin A, carvacrol, and ginsenoside-Rd (GS-Rd) as well as quinine. 3. Non-specific channel blockers including NS8593, SKF-9635, and 2-APB. 4. Enzyme antagonists such as nafamostat, CCT128930, 5-ligoxygenase (5-LOX) inhibitors, and TG100-115. 5. Anesthesia-related drugs including lidocaine and midazolam.

Sphingosine is an amino alcohol forming a cell membrane phospholipid and potently inhibits TRPM7 currents with an IC₅₀ of 590 nM (Qin et al., 2013). Sphingosine also blocks TRPM6 (IC₅₀ of 460 nM) but neither TRPM2 nor TRPM4. Its structural analog fingolimod FTY720, which is an immunosuppressant and the first oral drug for treatment of multiple sclerosis, blocks TRPM7 with an IC₅₀ of 720 nM (Qin et al., 2013). These facts may suggest their inhibiting actions are mediated by interacting with membrane phospholipids. Spermine is a tetravalent cationic polyamine and can block, in a voltage-dependent manner, TRPM7 channel activity with an IC₅₀ of 2.3 μM from the extracellular side (Kozak et al., 2002) but not by the intracellular application (Kerschbaum et al., 2003). Single substitution of Ser-1107, which is known to be the site for sensitivity to intracellular Mg²⁺ (Hofmann et al., 2014), of TRPM7 by Glu (S1107E) was found to reduce the sensitivity not only to Mg²⁺ but also to spermine (Zhelay et al., 2018). Thus, it is conceivable that spermine-induced inhibition of TRPM7 activity is, in a manner similar to intracellular Mg²⁺, mediated by electrostatic screening and resultant disruption of interaction between PIP₂ and TRPM7 (Zhelay et al., 2018).

Several natural products have been shown to block TRPM7 channels. Among them, the most potent and specific blocker is waixenicin A which is a xenicane diterpenoide derived from marine soft coral (Zierler et al., 2011). Waixenicin A inhibits, in a manner dependent on the intracellular Mg²⁺ concentration ([Mg²⁺]_i), TRPM7 with IC₅₀ values of 16 nM and 7 μM in the presence and absence of 0.7 mM [Mg²⁺]_i, respectively. Since K1648R mutation of Mg²⁺-binding site on the kinase domain increased the IC₅₀ value to 2.5 μM in the absence of [Mg²⁺]_i, it is suggested that intracellular Mg²⁺ facilitates the binding of waixenicin A to TRPM7 (Zierler et al., 2011). Waixenicin A is exceptionally selective to TRPM7 against other TRP channels including TRPM6 (Zierler et al., 2011; Beesetty et al., 2018) and even against zebrafish TRPM7 (Jansen et al., 2016). TRPM7 is inhibited by carvacrol, which is a monoterpene phenolic compound derived from plant volatile oils, with an IC₅₀ of 306 μM (Parnas et al., 2009). GS-Rd isolated from kampo herbal medicine ginseng was shown to inhibit TRPM7 with an IC₅₀ of 170–178 μM (Kim, 2013). A plant alkaloid quinine, which is isolated from the bark of a cinchona, is used to treat malaria and a known blocker for Ca²⁺-activated K⁺ channels, can effectively inhibit TRPM7 channels at 30 μM (Chubanov et al., 2012).

A non-selective cation channel blocker NS8593, an aminobenzimidazole derivative, inhibits TRPM7 currents, in a manner sensitive to intracellular Mg²⁺, with IC₅₀ values of 1.6 and 5.9 μM in the absence and presence of 0.3 mM [Mg²⁺]_i, respectively (Chubanov et al., 2012). Since the mutation of Tyr-1049 on the pore-forming loop (Y1049P) resulted in reduction of IC₅₀ values to 0.47 and 1.9 μM in the absence and presence of 0.3 mM [Mg²⁺]_i, respectively, the TRPM7 pore loop is likely to be involved in the interaction between NS8593 and TRPM7 (Chubanov et al., 2012). NS8593 was shown to be selective at 10 μM to TRPM7 against other TRPs including TRPM2, TRPM3, TRPM5, TRPM8, TRPC6, TRPV1, and TRPA1 (Chubanov et al., 2012). Another non-selective cation channel blocker, 2-APB, inhibits TRPM7 channels with an IC₅₀ of 178 μM but enhances TRPM6 channels with an EC₅₀ of 205 μM (Li et al., 2006). Its inhibiting action is not direct to TRPM7 but indirect through an intracellular acidification (Chokshi et al., 2012a). 2-APB also inhibits the other multiple TRP members especially TRPM2, as mentioned in the above section. A classical non-selective cation channel blocker SKF-96365 exhibits irreversible full inhibition of TRPM7 at 20 μM (Kozak et al., 2002). However, it is noted that SKF-96365 can block voltage-dependent T-type Ca²⁺ channels as well (Singh et al., 2010).

Some blockers for a variety of enzymes have been shown to block TRPM7. A synthetic broad-spectrum serine protease inhibitor, nafamostat, inhibits TRPM7 currents in a manner dependent on voltages and on extracellular divalent cations (Chen X. et al., 2010). In this study, the IC₅₀ values were found to be 15 μM at −100 mV and 121 μM at +100 mV in Ca²⁺- and Mg²⁺-free bathing solution, whereas those values increased to 514 μM at −100 mV and 617 μM at +100 mV in the presence of extracellular 1 mM Ca²⁺ and Mg²⁺ in TRPM7-transfected HEK293 cells. Nafamostat-induced inhibition was largely depressed by the charge-neutralizing mutation of Glu-1052 (E1052A) (Chen X. et al., 2010). Thus, it is concluded that Glu-1052 is one of negatively charged residues important for inhibition of TRPM7 channels not only by divalent cations (Numata and Okada, 2008a) but also by nafamostat. Endogenous TRPM7 expressed in mouse hippocampal neurons was inhibited by nafamostat with an IC₅₀ of 27 μM in the presence of a low concentration (0.1 mM) of Ca²⁺ and Mg²⁺ in a bath solution, whereas the channels were unexpectedly found to be augmented by pre-application of nafamostat (Chen X. et al., 2010). A potent AKT inhibitor CCT128930 preferentially blocks, in an Mg²⁺-independent manner, TRPM7 with an IC₅₀ of 0.63–0.86 μM, compared to TRPM6 and TRPM8, presumably by interacting with multiple residues in the selectivity filter (Guan et al., 2021). 5-LOX inhibitors such as NDGA, AA861, and MK886, were also found to inhibit TRPM7 channel activity, in a manner independent of the effects on 5-LOX, at 10–20 μM (Chen H. C. et al., 2010). In addition, TG100-115, which is a PI3Kγ/δ inhibitor, was found to inhibit not only the TRPM7 kinase activity with an IC₅₀ of 1.07 μM but also the TRPM7 channel activity (Song et al., 2017).

Several anesthetic drugs were identified to be effective inhibitors of TRPM7 channels. Local anesthetic lidocaine inhibits TRPM7 currents with an IC₅₀ of 11.1–11.6 mM in a voltage-independent and frequency-dependent manner (Leng et al., 2015). A widely used clinical anesthetic benzodiazepine, midazolam, can suppress TRPM7 currents by treatment for seconds and also inhibit TRPM7 expression by treatment for 48 h (Chen J. et al., 2016).

In addition to these TRPM7 inhibitors belonging to five categories, VER155008, which is an adenosine-derivative inhibitor of heat shock protein 70 (Hsp70), was recently shown to potently suppress TRPM7 channel activity in a manner independent of the kinase activity without affecting TRPM2, TRPM3, TRPM6, and TRPM8 channels (Rössig et al., 2022).

A δ-opioid receptor antagonist, naltriben, was found to be an effective activator of TRPM7 (Hofmann et al., 2014). Naltriben voltage-independently activated TRPM7 channels with an EC₅₀ of 20.7 μM in a manner independent of intracellular Mg²⁺ and competitive with NS8593, but had no effect on TRPM2, TRPM8, and TRPV1 channels. The site of naltriben action is most likely localized in or near the TRP domain, because the S1107E mutant, which is a constitutively active channel insensitive to intracellular Mg²⁺, became insensitive to naltriben. A benzimidazole compound, milbefradil, which displays structural homology to benzimidazole NS8593, activated TRPM7-mediated Ca²⁺ entry with an EC₅₀ of 53 μM and activated TRPM7 currents at 100 μM with a physiological intracellular Mg²⁺ concentration (0.9 mM) but failed to activate with a higher [Mg²⁺]_i (1.8 mM), whereas milbefradil failed to activate TRPM3, TRPA1, and TRPV1 channels (Schäfer et al., 2016). This study also showed that the S1104E mutation of TRPM7 became insensitive to melbefradil. However, it must be pointed out that milbefradil inhibits voltage-dependent T-type Ca²⁺ channels (Bezprozvanny and Tsien, 1995; Viana et al., 1997) and volume-sensitive VSOR/VRAC Cl⁻ channels (Nilius et al., 1997b) as well.

Three-dimensional structures of TRPM2 and TRPM7

In the last several years, the three-dimensional structures of TRP channels have become well elucidated owing to the studies with applying cryo-electron microscopy (cryo-EM), as recently reviewed (Cao, 2020; Huffer et al., 2020; Zubcevic, 2020). Here, such cryo-EM structures of TRPM2 and TRPM7 are shortly summarized below.

TRPM2

The three-dimensional structure of TRPM2 channel has been established by cryo-EM (Huang et al., 2020; Szollosi, 2021) using orthologous recombinant proteins from starlet sea anemone N. vectensis (nvTRPM2) (Zhang et al., 2018), zebrafish Danio rerio (drTRPM2) (Huang et al., 2018b; Yin et al., 2019), and human Homo sapience (hTRPM2 or hsTRPM2) (Huang et al., 2019; Wang L. et al., 2018; Yu et al., 2021). Like other six-transmembrane domain cation channels, TRPM2 proteins formed homotetramers with an overall shape reminiscent of a square prism or a bell with a height of up to 16 nm and a large cytosolic part (∼80%) (Figure 3A). The structure of the voltage sensor-like domain (formed by S1-S4) and of the pore domain (formed by S5-S6) resembles that of other voltage-gated cation channels (Figure 3B). However, unlike voltage-gated K⁺ channels, in TRPM2 (like in other TRPs), the voltage sensor-like domain lacks the conserved array of positively charged arginine and lysine and interacts with the S5-S6 of the adjacent subunit in a domain-swapping manner (Cao, 2020; Xia et al., 2019). Thus, TRPM2 is largely insensitive to voltage. The transmembrane portion of the pore is ∼5 nm long. It begins with an external vestibule with a diameter of ∼1 nm (for nvTRPM2) lined by a double ring of negative charges. The vestibule is followed by a short (∼1 nm) selectivity filter with a constriction of ∼0.52 nm in diameter, which was mostly invariant for all orthologues viewed in detergent micelles (Figure 3C). However, the ligand-free hTRPM2 reconstituted into the lipid nanodiscs had much narrower and ion-impermeable selectivity filter of ∼0.11 nm (Figure 3C), suggesting that it may serve as an upper gate which allowed passage of cysteine-modifying Ag⁺ only in the open but not in the closed state (Yu et al., 2021). The open TRPM2 pore is large enough to pass hydrated Na⁺ ions and tetramethylammonium but not N-methyl-D-glucosamine (NMDG). At around 3.5 nm from the entrance is located the gate which was interpreted as a lower gate by Yu et al. (Yu et al., 2021) formed by the S6 helices. Here, the pore is too tight (diameter is less than 0.2 nm for all orthologues in the closed state) to pass even a single water molecule. In the open state of the drTRPM2 bound to Ca²⁺ and ADP-ribose (ADPR), the lower gate widens up to a diameter of ∼0.9 nm allowing passage of hydrated Na⁺ and Ca²⁺ ions. This gate is followed by an internal vestibule, which is also negatively charged but narrower (diameter of 0.47 nm for nvTRPM2) compared to the external entrance. After passing the inner vestibule, ions come to the cytoplasmic cavity that has upper and lower chambers. This part is best described for the nvTRPM2 (Zhang et al., 2018). A bent tunnel with a diameter of over 0.4 nm connects the upper chamber of the cytoplasmic cavity with the Ca²⁺-binding site. This site is located near the membrane-cytosol interface but outside the central pore axis (Figure 3A). It is formed mostly by the ends of S2 helices and is accessible not only from the cytoplasmic cavity but also from the outside the protein via peripheral tunnels. Thus, the cytosolic parts of the channel form a porous structure with a complex system of cavities. The cytosolic Ca²⁺ ions first reach the Ca²⁺-binding site via peripheral tunnels moving nearly parallel to the membrane surface, then come to the upper cytoplasmic cavity, and only then may access the selectivity filter when the gate is open. Although a calmodulin-mediated mechanism was suggested for TRPM2 activation by cytosolic Ca²⁺ (Du et al., 2009a), mutations of the negatively charged amino acids at the Ca²⁺-binding site (E893A in nvTRPM2) of the channel protein itself greatly reduced or even abolished Ca²⁺-induced activation (Zhang et al., 2018), suggesting a key role of Ca²⁺ coordination within the Ca²⁺-binding pocket in the channel activation mechanism. ADPR, an obligate co-activator, binds to the U-shaped MHR1/2 and to the C-terminal NUDT9-H domain, which is unique for TRPM2 and is homologous to the mitochondrial ADPR pyrophosphatase NUDT9 (Huang et al., 2019; Huang et al., 2020; Szollosi, 2021) (Figures 3A, B). Based on the previous finding that nvTRPM2 but not hTRPM2 is activated by ADPR even after deletion of the NUDT9-H domain (Kühn et al., 2016) and on the comparison between the ADPR-binding sites of sea anemone, zebrafish, and human orthologues, it is speculated that the ADPR-binding site could be evolutionarily shifted from the MHR1/2 to the NUDT9-H domain of TRPM2 protein (Fliniaux et al., 2018) and that MHR1/2 could bind cADPR, which synergistically enhances the effect of ADPR (Fliegert et al., 2020). The ROS-dependent increase in ADPR production may link TRPM2-mediated Ca²⁺ influx to the inflammasome activation (Wang et al., 2020). MHR3/4 domains link the agonist-sensing regions (NUDT9-H and MHR1/2) with the pore and thus transduces chemical activation signals to the channel opening (Huang et al., 2018b; Huang et al., 2020). PIP₂ binding is also necessary for TRPM2 channel activity and is thought to occur near the Ca²⁺-binding site (Huang et al., 2020; Szollosi, 2021; Zhang et al., 2018), although its exact site is undetermined. Molecular and structural nature of the temperature sensing by TRPM2 awaits future elucidation, although a role of a dynamic protein-membrane lipid relationship was suggested as the general concept (Zubcevic, 2020).

TRPM7

Unlike TRPM2, TRPM7 is an Mg²⁺-permeable channel, which, in addition, possesses the protein kinase domain which is enzymatically active. The cryo-EM structure of the slightly truncated mTRPM7 protein fused to the maltose binding protein revealed an overall similarity to other TRP channels (Figure 4A) in terms of tetrameric assembly and orientation of helices (Duan et al., 2018; Huang et al., 2020). The tight lower gate at the cytoplasmic end of S6 (N1097) is similar to that of the TRPM2. The conduction pathway did not change upon removal of Mg²⁺ and other divalent cations (Figure 4C). The Mg²⁺-binding site is formed by the negative charge of Glu (E1047 for mTRPM7) and backbone carbonyl of Gly (G1046 for mTRPM7), which along with F1045 form the selectivity filter within the pore region (P-loop) of S5-S6 (Figure 2; Figure 4B). This region also contains a disulfide bond, which is stabilized by Mg²⁺ and important for regulation by glutathione. The structure of the mouse TRPM7 resolved by Duan et al. (Duan et al., 2018) did not contain the C-terminal kinase domain which possesses cysteine residues (C1809 and C1813 for mTRPM7) important for the second low-affinity Mg²⁺-binding site and for TRPM7 channel inhibition by oxidative stress (Inoue et al., 2021; Inoue et al., 2014) (Figure 2). Very recently, Nadezhdin et al. (Nadezhdin et al., 2023) analyzed cryo-EM structures of constitutively activated mTRPM7 channels with using the gain-of-function N1098Q mutant (Schmidt et al., 2022) and wild type mTRPM7 stimulated with a potent TRPM7 activator, naltriben. This study showed that the open-state of TRPM7 channel is associated with an increase in the pore size at the lower gate (near N1097) to ∼0.23 nm and turning of the tyrosine (Y1085) hydroxyls towards the ion conducting pathway thereby forming the narrowest point of the pore (Figure 4C). This study also identified a binding site for highly potent inhibitors, VER155008 and NS8593, which stabilize the closed conformation of TRPM7 channel. Although the cryo-EM structure of the kinase domain of mouse TRPM7 is still missing, this structure was previously revealed by X-ray crystallography and found to be similar to classical protein kinases such as PKA (Yamaguchi et al., 2001).

Roles of TRPM2 and TRPM7 in cell volume regulation and cell death induction/protection

Roles of TRPM2 and TRPM7 in cell volume regulation

Animal cells must cope with fluctuations of osmotic gradient across the cell membrane by two types of cell volume regulation mechanisms: cell volume recovery after osmotic shrinkage called RVI and that after osmotic swelling called RVD (see Reviews: Hoffmann et al., 2009; Okada, 2004; Wehner et al., 2003a). After hypertonic and hypotonic challenges, animal cells attain RVI and RVD mainly by net gain of most abundant extracellular small osmolytes Na⁺ and Cl⁻ and by net loss of most abundant intracellular small osmolytes K⁺ and Cl⁻, respectively, with accompanying fluxes of osmotically obligated water, thereby readjusting the intracellular osmolarity to the extracellular osmolarity. In these volume regulation processes, TRPM2 and TRPM7 play important roles in animal cells.

RVI and TRPM2

RVI is known to be accomplished by Na⁺-conductive hypertonicity-induced cation channels (HICCs) and/or Na⁺-permeable electroneutral transporters such as Na⁺/H⁺ antiporter (NHE), Na⁺-K⁺-Cl⁻ symporter (NKCC) and Na⁺-Cl⁻ symporter (NCC) (see Reviews: Hoffmann et al., 2009; Okada, 2004). Among them, HICC was shown to be the most effective mechanism of RVI (Wehner et al., 2006; Plettenberg et al., 2008). To attain volume-regulatory NaCl influx, parallel activation of some unidentified type of anion channel, tentatively labelled the hypertonicity-induced anion channel (HIAC) (Okada, 2016), is to be required. Such HIAC-like currents were notably observed in human hepatoma HepG2 cells (Bondarava et al., 2009).

HICC currents were, for the first time, recorded in response to an isotonic challenge in Intestine 407 cells equilibrated under hypotonic conditions, and were suggested to be involved in the post-RVD RVI process (Okada and Hazama, 1989). So far, two groups of HICCs have been reported: the one is amiloride-sensitive and Gd³⁺-insensitive, and another is amiloride-insensitive, Gd³⁺- and/or FFA-sensitive (Wehner et al., 2003a; Wehner et al., 2006). Amiloride-sensitive HICC currents were originally observed in rat hepatocytes and shown to be involved in RVI (Wehner et al., 1995). Molecular correlates for this type of HICC in hepatocytes and HepG2 cells have been suggested to be several members of ENaC (Böhmer and Wehner, 2001; Plettenberg et al., 2008; Bondarava et al., 2009). In addition to δENaC, recently TRPM2 and TRPM5 were also suggested to be implicated in the molecular architecture of HICC in HepG2 (Koos et al., 2018). Gd³⁺-sensitive amiloride-insensitive HICC currents involved in RVI were first found in airway epithelial cells (Chan and Nelson, 1992), and were shown to be also sensitive to FFA in mouse cortical collecting duct M-1 cells (Volk et al., 1995). The molecular entity of this type of HICC was identified as TRPM2-∆C plus CD38 in HeLa cells, and the RVI event was shown to be inhibited by knockdown of TRPM2 or CD38 (Numata et al., 2012). The molecular mechanism of TRPM2-mediated RVI is schematically depicted in Figure 5A.

Roles of TRPM2 and TRPM7 in cell volume regulation (CVR). **(A)** Roles of HICC (TRPM2-∆C *plus* CD38) and HIAC in CVR attained after cell shrinkage, RVI. Depolarization caused by HICC activation drives Cl⁻ influx via the HIAC pore. Resultant NaCl influx drives water influx leading to RVI. **(B)** Roles of TRPM7, VSOR, and Ca²⁺-activated K⁺ channel in CVR attained after cell swelling, RVD. Hyperpolarization predominantly caused by Ca²⁺-activated K⁺ channels drives Cl⁻ efflux via the VSOR channel pore. Resultant KCl efflux drives water efflux leading to RVD.

RVD and TRPM7

RVD is a prerequisite function for animal cells devoid of the cell wall which is covering plant cells. RVD is attained by net loss of mainly KCl (and partly intracellular small organic osmolytes). Now, activation of separate conductive pathways for K⁺ and Cl⁻ (and some negatively-charged amino acids) is known to be the predominant mechanism in most mammalian cells, although electroneutral KCl transport pathways such as K⁺-Cl⁻ symporter (KCC) are involved in RVD of erythrocytes (Hoffmann et al., 2009; Okada, 2004). First evidence for the fact that volume-regulatory KCl efflux is accomplished by parallel activation of K⁺ and Cl⁻ channels was provided by electrophysiological approaches in epithelial Intestine 407 cells (Hazama and Okada, 1988) and T lymphocytes (Cahalan and Lewis, 1988). Since a large variety of K⁺ channels are installed in the plasma membrane of animal cells, swollen cells exploit some of them as volume-regulatory K⁺ channels depending on cell types (Wilson and Mongin, 2018). In human Intestine 407 cells, a Ca²⁺-activated K⁺ channel was shown to serve as the volume-regulatory K⁺ channel (Hazama and Okada, 1988) and later molecularly identified as IK1 (Wang et al., 2003). For the volume-regulatory conductive Cl⁻ pathway, a new type of Cl⁻ channel was discovered to be activated by cell swelling in Intestine 407 cells (Hazama and Okada, 1988; Kubo and Okada, 1992) and T lymphocytes (Cahalan and Lewis, 1988). In contrast to involvements of various volume-regulatory K⁺ channels, only this type of Cl⁻ channel was shown to predominantly serve as the volume-regulatory Cl⁻ channel in most animal cells. This ubiquitous Cl⁻ channel has been well characterized and called the volume-sensitive outwardly rectifying anion channel: VSOR (Okada, 1997), the volume-regulated Cl⁻ channel: VRAC (Nilius et al., 1997a), or the volume-sensitive organic osmolyte/anion channel: VSOAC (Strange and Jackson, 1995). In 2014, the core molecule of VSOR was identified as LRRC8A (Qiu et al., 2014; Voss et al., 2014), and VSOR activity was shown to additionally require at least one of its paralogs (LRRC8C, LRRC8D, and/or LRRC8E) as the subcomponent of VSOR (Voss et al., 2014).

Essential roles of intracellular Ca²⁺ rise in RVD were shown in many cell types (Cala et al., 1986; Grinstein et al., 1982; Hazama and Okada, 1988; Hazama and Okada, 1990a; Rothstein and Mack, 1990; Wong and Chase, 1986). In the human epithelial cells, swelling was found to induce activation of Ca²⁺-permeable cation channels (Y. Okada et al., 1990) and then triggers Ca²⁺ release from the intracellular Ca²⁺ store and sizable cytosolic Ca²⁺ rise (Hazama and Okada, 1990b), thereby stimulating volume-regulatory Ca²⁺-activated K⁺ channels. Later, the molecular identity of swelling-activated Ca²⁺-permeable cation channel was identified as TRPM7 (Numata et al., 2007b) which exhibits direct mechano-stress sensitivity (Numata et al., 2007a). TRPM7-mediated Ca²⁺ influx is thus involved in RVD (Numata et al., 2007b) by triggering activation of volume-regulatory Ca²⁺-activated K⁺ channel. This Ca²⁺ inflow may also be involved in VSOR activation, because VSOR was shown to be activated by ROS (Browe and Baumgarten, 2004; Shimizu et al., 2004; Varela et al., 2004) through the NOX activation regulated by a local Ca²⁺ rise in the immediate vicinity of open Ca²⁺-permeable cation channels called Ca²⁺ nanodomain (Akita and Okada, 2014). It is noteworthy that NOX1 does physically interact not only with LRRC8A (Choi et al., 2016) but also with LRRC8C and LRRC8D (Choi et al., 2021). Recently, TRPM7 was also demonstrated to physically interact with LRRC8A thereby playing a role as an essential regulator for VSOR expression (Numata et al., 2021). Steady-state Ca²⁺ influx through TRPM7 enhances molecular expression of LRRC8A mRNA. In addition, the plasmalemmal presence of TRPM7 stabilizes the plasma membrane expression of LRRC8A protein through the protein-protein interaction between LRRC8A and the C-terminal α-kinase domain of TRPM7. Collectively, TRPM7 is involved in RVD in a multiple fashion: first by mediating swelling-induced Ca²⁺ influx leading to cytosolic Ca²⁺ rise, thereby activating volume-regulatory Ca²⁺-activated K⁺ channels and inducing hyperpolarization driving Cl⁻ efflux through any available Cl⁻ channels; second by mediating formation of the Ca²⁺ nanodomain, thereby activating volume-regulatory VSOR Cl⁻ channels; third by stimulating molecular expression of LRRC8A mRNA in swollen cells; and fourth by stabilizing plasmalemmal expression of LRRC8A through the physical interaction with LRRC8A protein. The molecular mechanism of TRPM7-mediated RVD is schematically illustrated in Figure 5B.

Roles of TRPM2 and TRPM7 in cell death

In a huge number of publications, both TRPM2 and TRPM7 have been reported to have pathophysiological relevance to cell death and tissue injury. Cell death-inducing machineries utilize not only VSOR/VRAC and ASOR/PAC anion channel activities (see Reviews: Okada et al., 2021a; Okada et al., 2021b) but also the activities of TRPM2 and TRPM7 that are sensor cation channels constitutively expressed. Cell death is classified into apoptosis and necrosis. Necrotic cell death can be distinguished to accidental and programmed necrosis, and the latter one is further sorted into pyroptosis, necroptosis, and ferroptosis. Here, we summarize how TRPM2 and TRPM7 are implicated in these cell death modes. It is noted that both types of TRPM members often exert as double-edged swords in cell death induction.

Inductive/protective roles of TRPM2 in cell death and tissue injury

Reactive oxygen species (ROS) are generated in many of pathological conditions such as ischemia/reperfusion (I/R) injury (Granger and Kvietys, 2015) and exposure to pathogenic factors leading to neurodegenerative disorders. These pathogenic factors include amyloid β (Aβ) peptide developing Parkinson’s disease (Hensley et al., 1994), methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) which is used to induce Alzheimer’s disease model (Wu et al., 2003), inflammatory cytokines, and others. ROS are well known to cause cell death and dysfunction. Pathological roles of ROS-activated TRPM2 channel in cell death have been extensively studied in various tissues and cell types including neuronal cells (see Review: Malko and Jiang, 2020). Hydrogen peroxide, a kind of ROS, has been used to mimic oxidative stress experimental models. The earliest study showed that TRPM2 (the former name, LTRPC2) activation in TRPM2-expressing HEK293T cells by H₂O₂ and TNFα leads to the cell death which is dependent on Ca²⁺ influx and is suppressed by a Ca²⁺ chelator and antisense oligonucleotides against TRPM2 (Hara et al., 2002). H₂O₂-induced cell death was also reproduced in primary neurons and was found to be attenuated by extracellular Ca²⁺ removal with abolishing TRPM2 activation. The effects of PARP inhibitors and downregulation of TRPM2 by siRNA confirmed an involvement of TRPM2 activation downstream of PARP activity in H₂O₂-induced neural death (Fonfria et al., 2005; Kaneko et al., 2006). An involvement of TRPM2 activation in H₂O₂-induced cell death was also evidenced by siRNA-mediated knockdown of Trpm2 in non-neuronal cells, such as immortalized mouse embryonic fibroblasts (Blenn et al., 2011) and mouse RAW264.7 macrophages (Zou et al., 2013). A dominant negative variant of TRPM2 (TRPM2-S) showed an inhibitory effect on cell death mediated by TRPM2 activation (Zhang et al., 2003), and PKC-mediated phosphorylation of TRPM2-S exhibited an inhibitory effect on TRPM2 activation and cell death (Hecquet et al., 2014). TRPM2 is reportedly involved in homeostasis of intracellular Zn²⁺ regulating cell death. H₂O₂-treatment of hippocampal neurons caused an intracellular Zn²⁺ increase by lysosomal dysfunction, Zn²⁺ release from lysosome, mitochondrial Zn²⁺ accumulation, mitochondrial fission, and cell death (Li et al., 2017). These H₂O₂-induced lysosomal/mitochondrial toxicities in neurons were attenuated by TRPM2 gene knockout and by a Zn²⁺-specific chelator, confirming contribution of TRPM2 and dysregulation of intracellular Zn²⁺ in neural cell death.

Involvements of TRPM2 in cell death induced by I/R or oxygen-glucose deprivation/reoxygenation (OGD/R) were demonstrated by TRPM2 gene knockdown or knockout in brain neurons (Jia et al., 2011; Shimizu et al., 2013; Verma et al., 2012; Ye et al., 2014) and myocardial cells (Hiroi et al., 2013). Bilirubin, which exerts as an direct activator for TRPM2, was most recently found to be released in the brain subjected to oxygen-glucose deprivation (OGD), and to aggravate brain damage in the stroke in a manner strongly sensitive to molecular perturbation of the bilirubin-binding site on TRPM2 (Liu et al., 2023).

Although TRPM2 plays inductive roles in cell death under a large variety of conditions, as summarized above, TRPM2 channel activity has also been reported to participate in protection from cell death under several specified conditions. TRPM2 was observed to protect neuroblastoma SH-SY5Y cells from H₂O₂-induced cell death (S. J. Chen et al., 2013) as well as against lung injury induced by lipopolysaccharide (LPS) (Di et al., 2011), I/R-induced adult heart injury (Miller et al., 2013; Miller et al., 2014; Hoffman et al., 2015), doxorubicin-induced death in breast cancer cells (Koh et al., 2015) and in SH-SY5Y cells (Hirschler-Laszkiewicz et al., 2022), and H₂O₂- or hyperthermia-induced tissue damage in the sea anemone (Ehrlich et al., 2022). Thus, activation of TRPM2 channels plays not only detrimental or death-inducing but also beneficial or protective roles depending on the cellular conditions.

Inductive roles of TRPM2 in apoptotic cell death

The most cases of H₂O₂-induced cell death in which TRPM2 is implicated are classified as apoptosis in a variety of cell types, including human monocytic U937 cells (W. Zhang et al., 2006), rat ventricular myocytes (Jiang et al., 2006), and mouse endothelial cells (Hecquet et al., 2014; Sun et al., 2012). TRPM2 was also found to play essential roles in apoptosis induction caused by stimulation with a variety of exogenous pathogens. These pathogens include TNFα in U937 cells (Zhang et al., 2006) and mouse ventricular myocytes (Roberge et al., 2014), interferon-γ (IFNγ) in mouse microglia (Akyuva et al., 2021) and human neuroblastoma SH-SY5Y cells (Güzel et al., 2021), morphine in mouse hippocampal neurons (Osmanlıoğlu et al., 2020), glyceryltrinitrate (GTN) in mouse trigeminal ganglion neurons (Yazğan and Nazıroğlu, 2021), zinc oxide nanoparticle in human brain vascular pericytes (Jiang et al., 2017), anti-malarian drug, hydroxychloroquine, in human retinal pigment epithelial cells (Ertuğrul et al., 2023), and uric acid in human AC16 cardiomyocytes (Wu et al., 2023). Essential roles of TRPM2 channel were also recently shown in apoptotic cell death induced by an anti-cancer drug, doxorubicin (DOX), in rat cardiac cells (Akyuva and Nazıroğlu, 2023; Yıldızhan et al., 2023) as well.

In the brain stroke, TRPM2 was shown to partake in I/R-induced neuronal apoptosis using TRPM2 knockout mice (Alim et al., 2013; Gelderblom et al., 2014). TRPM2 deficiency was found to be protective against such a brain injury by decreasing the ratio of synaptic NMDAR subunit (GluN2A) to extra-synaptic NMDAR subunit (GluN2B) in the hippocampus (Alim et al., 2013) and attenuating immune cell filtration into the ischemic hemisphere (Gelderblom et al., 2014). I/R- or OGD/R-induced apoptosis was also shown to involve TRPM2 activity in the mouse kidney (Gao et al., 2014) and rat pheochromocytoma PC12 cells (Pan et al., 2020). Traumatic brain injury (TBI) was found to upregulate TRPM2 expression in the rat cerebral cortex and hippocampus (Cook et al., 2010) and to cause apoptotic death in rat hippocampal neurons in a manner dependent on ROS production and sensitive to 2-APB (Yürüker et al., 2015).

TRPM2 channels have been demonstrated to play an important role in induction of apoptotic cell death associated with etiology of several major diseases, such as Alzheimer’s disease, diabetes mellitus, and Parkinson’s diseases. Accumulation of amyloid β (Aβ) is causative of Alzheimer’s disease. ROS-induced neuronal cell death following exposure to Aβ was attenuated by a PARP inhibitor and PARP siRNA (Fonfria et al., 2005). TRPM2 also takes part in Aβ-induced pathological conditions including ER-stress, synaptic loss, microglial activation, and age-related memory deficits (Ostapchenko et al., 2015). A critical role of TRPM2 activity was shown in Aβ-induced neuronal apoptosis (Çınar and Nazıroğlu, 2023; Li and Jiang, 2018). In pancreatic islet cells or β cells, activation of TRPM2 channels was found to be involved in apoptosis induced by H₂O₂ (Bari et al., 2009; Lange et al., 2009; Manna et al., 2015) and by diabetic stimuli, such as streptozocin (STZ) (Manna et al., 2015) and palmitate (Li et al., 2017). MPTP and its active metabolite, 1-methyl-4-phenylpyridinium ions (MPP⁺), are neurotoxins for dopaminergic neurons and thereby causing Parkinson’s disease (Burns et al., 1983). MPP⁺ was demonstrated to increase TRPM2 expression in the mouse substantia nigra (Sun et al., 2018) and induce ROS elevation and apoptosis in neuronal SH-SY5Y cells differentiated by the addition of retinoic acid for 6 days (Sun et al., 2018). Since increased TRPM2 immunoreactivity and apoptotic cell death in the rat ovary were found to be coupled to ovarian hyperstimulation syndrome (OHSS) (Şanlı et al., 2021), it is possible that TRPM2 is causatively related to apoptosis induction in this disease.

Inductive roles of TRPM2 in non-apoptotic cell death

Participation of TRPM2 channels has been reported also in non-apoptotic cell death, including aponecrosis, necrosis, and pyroptosis under certain conditions. Acetaminophen overdose was found to cause activation of TRPM2 currents and induction of necrotic cell death which exhibited some apoptotic features such as DNA fragmentation and membrane blebbing in a manner sensitive to TRPM2 knockdown and knockout (Kheradpezhouh et al., 2014). This cell death mode might be classified into aponecrosis or secondary necrosis (see Step-6 in Figure 3 depicted in Okada et al., 2019). In addition, TRPM2 was reported to be involved in bile acid-induced cell injury in pancreatic acinar cells that simultaneously exhibited both necrotic and apoptotic cell death (Fanczal et al., 2020). In mouse microglial cells, H₂O₂ or Zn²⁺, one of damage-associated molecular pattern molecules (DAMPs), was observed to elicit cytosolic Ca²⁺ rise and necrotic cell death, both of which were abolished by TRPM2 knockdown (Mortadza et al., 2017). In mouse mastocytoma P815 cells, farnesyl pyrophosphate (FPP), a mevalonate pathway intermediate, caused necrotic cell death with exhibiting cell swelling and membrane rupture in a manner partially sensitive to TRPM2 knockout (Chen et al., 2021). Physical and functional interactions between TRPM2 and extra-synaptic NMDA receptors were recently found to exacerbate excitotoxic (necrotic) cell death in mouse cortical neurons under ischemic brain injury (Zong et al., 2022a). Pyroptosis is a caspase-1/3-dependent programmed necrosis that exhibits NLRP3 inflammasome activation in association with inflammation (see Reviews: Green, 2019; Jiang et al., 2020; Kolbrink et al., 2020). ROS-induced TRPM2 activation was shown to be involved in NLRP3 inflammasome activation in bone marrow-derived macrophages stimulated by charged liposomes (Zhong et al., 2013), in human leukemia U937 cells exposed to high glucose (Tseng et al., 2016), in microglia stimulated with Aβ (Alawieyah Syed Mortadza et al., 2018; Aminzadeh et al., 2018), and in OGD/R-challenged PC12 cells (Pan et al., 2020). However, no study has addressed the pyroptotic cell death (due to membrane rupture) eventually induced by the N-terminus of gasdermin D/E in relation to TRPM2.

Inductive roles of TRPM7 in cell death

Since overexpression of TRPM7 in HEK293 cells was found to cause cell death (Nadler et al., 2001; Monteilh-Zoller et al., 2003; Schmitz et al., 2003), it was assumed that TRPM7 channels are somehow involved in cell death induction under pathophysiological conditions. In fact, Aarts et al. (Aarts et al., 2003), for the first time, found that TRPM7 plays an essential role in neuronal cell death caused by OGD. Prolonged OGD increased non-selective cation conductance (I_OGD) in cortical neurons independently of the activation of glutamate receptor. I_OGD was inhibited by a vitamin E derivative, an O₂ ⁻ scavenger and a NOS inhibitor suggesting OGD-induced current activation by reactive oxygen/nitrogen species (ROS/RNS). I_OGD led to Ca²⁺-overload followed by a further increase of ROS/RNS production and cell death which are inhibited by a TRPM7 blocker, Gd³⁺, and by TRPM7 siRNA. Subsequently, Sun et al. (Sun et al., 2009) demonstrated that suppression of TRPM7 expression by shRNA inhibits delayed neuronal cell death induced by transient global cerebral ischemia in rat hippocampal CA1 neurons, along with protective effects on ischemia-induced neuronal dysfunction such as defect of long-term potentiation and fear/spatial memories. In addition, molecular expression of TRPM7 was found to be upregulated in the hippocampus of rats subjected to I/R and in cultured rat hippocampal neurons during reoxygenation after transient OGD (Jiang et al., 2008). Similar ischemia-induced upregulation of TRPM7 was subsequently observed in rat brain tissues (Zhan et al., 2014; Zhang et al., 2012) and in the mouse brain (Chen et al., 2015). Downregulation of TRPM7 expression was found to be coupled to acquirement of resistance to an anticancer drug, DOX, in colon cancer LoVo cells (Castiglioni et al., 2015). Moreover, TRPM7 activated by Ca²⁺/Mg²⁺ removal was found to induce Zn²⁺ influx, thereby resulting in Zn²⁺ toxicity in mouse cortical neurons (Inoue et al., 2010). In the presence of extracellular Zn²⁺ ions, OGD was found to lead to cell toxicity in cortical neurons in a manner sensitive to Gd³⁺, a TRPM7 blocker, and TRPM7 shRNA.

Inductive/protective roles of TRPM7 in apoptotic cell death

Chen X et al. (2010) found that TRPM7 downregulation suppresses cell death induced by staurosporine (STS) and DOX, which are well-known apoptosis inducers, in HEK293 cells. Consecutively, Coombes et al. (Coombes et al., 2011) reported that H₂O₂ induces not only PI-positive (necrotic) but also TUNEL-positive (apoptotic) cell death in primary mouse cortical neurons in a manner sensitive to treatment with EGTA or 2-APB. Later, pharmacological studies also suggested that TRPM7 mediates apoptotic neuronal death caused by brain ischemia through modulation of CaMKII, calmodulin, and calcineurin (Turlova et al., 2021). These results strongly suggest that TRPM7 is involved in apoptosis induction under specified conditions. Indeed, Desai et al. (Desai et al., 2012) concluded that TRPM7 plays an inductive role in Fas-mediated apoptosis based on the following observations. TRPM7 KO attenuated Fas-mediated cell death in primary mouse T-cell. TRPM7 gene silencing by shRNA in Jurkat T-cell suppressed TRPM7 currents and PARP cleavage induced by Fas ligand (FasL). The cell death induction by FasL was suggested to be mediated by the channel function of TRPM7 but not the kinase activity of TRPM7 because the kinase-dead TRPM7 mutant (K1646A) exhibited no effect on FasL-induced caspase-3 activation and PARP cleavage, although the kinase domain is cleaved by caspase-8/3 during Fas stimulation. However, the kinase domain of TRPM7 was suggested to facilitate OGD/R-induced apoptosis in primary mouse cortical neurons through interacting with annexin A1 (Zhao et al., 2015). Subsequently, acetaminophen-induced apoptosis in human hepatoma HEPG2 cells was found to be partially suppressed by siRNA of TRPM7, though the inhibitory effect was less prominent than siRNAs for TRPC1, TRPV1, and TRPM2 (Badr et al., 2016). Also, intra-cortical injection of shRNA for TRPM7 was shown to suppress apoptosis in the cerebral cortex of rats subjected to TBI (Xu et al., 2018). In addition, high glucose-induced neuronal apoptosis was shown to be accompanied by molecular and functional upregulation of TRPM7 and suppressed by TRPM7 siRNA (Huang et al., 2018a). Furthermore, gene silencing of Trpm7 was demonstrated to inhibit apoptosis induced by an NO donor, sodium nitroprusside (SNP), in rat chondrocytes (Ma et al., 2021).

In contrast to the inductive role of TRPM7 in apoptotic processes, several pieces of molecular evidence for its protective role against apoptotic cell death have also been reported. TRPM7 knockdown was found to increase the rate of apoptotic cell death spontaneously observed during culturing the rat basophilic leukemic mast (RBL-2H3) cells (Ng et al., 2012). In human urinary bladder cancer (BCa) cells, apoptotic cell death was observed, in vitro, to be facilitated by TRPM7 knockdown (Cao et al., 2016). In this study, injection of antitumor carvacrol was found to reduce TRPM7 activity, thereby suppressing tumor growth in the mouse bladder cancer in vivo. Sun and his collaborators recently reported that apoptotic neuronal cell death induced by a Parkinson’s disease-related neurotoxin, MPP⁺, is protected by TRPM7 activation induced by isoproterenol (Sun et al., 2020a) and by TRPM7 overexpression (Sun et al., 2020b) in dopaminergic differentiated neuroblastoma SH-SY5Y cells. Moreover, in their in vivo studies, treatment with the neurotoxin, MPTP, was found to cause apoptotic tissue damage together with reduction of the TRPM7 level in mouse substantia nigra pars compacta (SNpc) region (Sun et al., 2020b). Consistently, they also observed increased expression of apoptotic proteins and decreased TRPM7 levels in the samples obtained from the SNpc region of human Parkinson’s disease patients (Sun et al., 2020b). It is warranted to clarify how TRPM7 plays opposite roles in apoptotic processes depending on experimental conditions.

Inductive roles of TRPM7 in non-apoptotic cell death

TRPM7 was shown to be activated by extracellular acidification (Jiang et al., 2005; Numata and Okada, 2008a) and involved in acid-induced necrotic cell death (Numata et al., 2019). Extracellular acidification (< pH 6.0) causes a persistent cell volume increase and cell death which were inhibited by TRPM7 downregulation using siRNA in HeLa cells (Numata et al., 2019). TRPM7 D1054A, an acid-activation-deficient mutant, abolished acidification-evoked cell volume increase and cell death, suggesting acid-evoked activation of TRPM7 leads to a necrotic volume increase (NVI) followed by necrotic cell death. TRPM7 is also likely to be implicated in two types of inflammatory programmed necrosis: caspase-1/3-dependent one called pyroptosis and RIPK-dependent one called necroptosis. The involvement of TRPM7 in pyroptosis was suggested by the pharmacological observations, as follows. First, cell swelling-induced release of an inflammatory cytokine, IL-1β, from human macrophages was inhibited by TRPM7 blockers, 2-APB and SKF-96365 (Compan et al., 2012). Second, LPS-induced release of IL-1β, IL-6, and TNFα from mouse small intestinal IEC-6 cells was inhibited by another TRPM7 blocker, NS8593 (Li et al., 2022). However, it must be pointed out that these recent studies examined the roles of TRPM7 in inflammatory responses but not those in eventual necroptotic cell death as yet. On the other hand, TRPM7 was shown to be involved in necroptotic cell death induced by the treatment with a combination of TNFα, Smac mimetic, and z-VAD-FMK (TSZ) in human colonic epithelial HT29 cells (Cai et al., 2014). The shRNA-mediated knockdown protected the cells from TSZ-induced necroptotic membrane rupture and to inhibit TSZ-induced TRPM7 current activation and Ca²⁺ influx.

Ionic mechanisms of cell death induction/protection involving TRPM2 and TRPM7

Since cell death induction is tightly coupled to dysfunction of cell volume regulation, in which TRPM2 and TRPM7, as already described, play important roles, the ionic mechanisms of cell death induction may, at least in part, involve TRPM2 and TRPM7 channel activities in relation to altered mechanisms of the cell volume regulation.

Roles of TRPM2 and TRPM7 in ionic mechanisms leading to apoptotic cell death

Normotonic cell shrinkage, termed AVD (Maeno et al., 2000), is an earliest and prerequisite event of apoptotic cell death processes (Hasegawa et al., 2012; Maeno et al., 2000; Maeno et al., 2006a; Nukui et al., 2006; Shimizu et al., 2007). The AVD induction is attained by KCl efflux that is accomplished by activation of K⁺ and Cl⁻ channels and drives water efflux (Okada et al., 2001). ROS are produced in response to I/R, OGD/R, and numbers of apoptosis-inducing chemicals and exert as the central mediators linking between apoptotic stimulants and intracellular apoptotic reactions. ROS can activate TRPM2 cation channels (Hara et al., 2002) through ADPR production (Figure 1) and VSOR/VRAC anion channels (Browe and Baumgarten, 2004; Shimizu et al., 2004; Varela et al., 2004) (Figure 6). TRPM2-mediated Ca²⁺ entry not only triggers apoptotic intracellular biochemical reactions (Nicotera and Orrenius, 1998; Orrenius et al., 2003; Rizzuto et al., 2003) but also stimulates Ca²⁺-activated K⁺ channels which are known to be involved in apoptosis induction (see Review: Burg et al., 2006). VSOR plays dual roles in apoptosis induction first by mediating AVD-inducing Cl⁻ efflux and second by mediating antioxidant GSH⁻ efflux driven by membrane hyperpolarization caused by K⁺ channel activation (Figure 6). TRPM7 was recently demonstrated to function as an essential regulator of VSOR by enhancing expression of LRRC8A mRNA via the mediation of Ca²⁺ influx and stabilizing the plasmalemmal expression of LRRC8A through the molecular interaction between LRRC8A and the C-terminal domain of TRPM7 (Numata et al., 2021). Thus, TRPM7 may play a facilitating role in apoptosis induction secondary by upregulating VSOR channel activity inducing AVD and by mediating GSH release (Figure 6).

Roles of TRPM2 and TRPM7 in the ionic mechanisms leading to apoptosis induction that requisitely involves AVD induction followed by RVI dysfunction or insufficiency. Hyperpolarization predominantly caused by Ca²⁺-activated K⁺ channels drives effluxes of Cl⁻ and GSH⁻ via the VSOR channel pore. Resultant KCl efflux drives water efflux leading to cell shrinkage. (See the text for details.).

To eventually induce apoptotic cell death, persistent cell shrinkage is to be complemented by RVI dysfunction or insufficiency. In fact, the RVI event was shown to be inhibited during apoptotic processes (Maeno et al., 2006b), through the Akt1 inhibition caused by ROS-induced ASK1 phosphorylation (Subramanyam et al., 2010). In many cell types, RVI is known to be produced by shrinkage-induced NaCl uptake through activation of NHE, NKCC, and/or HICC (Okada et al., 2019). In HeLa cells, the main mechanism of RVI was shown to be activation of HICC (Wehner et al., 2003b), the molecular correlate of which is TRPM2-∆C plus CD38 (Numata et al., 2012). Thus, it is possible that HICC activity is downregulated by some intracellular signals produced by apoptotic biochemical reactions, such as phosphorylated ASK1 (pASK1) (Figure 6).

Roles of TRPM2 and TRPM7 in ionic mechanisms leading to necrotic cell death

Necrosis is caused by plasma membrane rupture eventually resulted from persistent cell swelling induced by a variety of insults. Necrotic cell death starts with normotonic cell swelling, called NVI (Barros et al., 2001; Okada et al., 2001), which is caused by water uptake driven by influx of osmolytes, chiefly NaCl. Persistence of necrotic cell swelling is accomplished by impairment of RVD (Okada et al., 2004).

Accidental necrosis is induced by ischemia or hypoxia (I/H) and accidental or traumatic cell injury, because these insults result in ATP depletion within the cells and the resultant extracellular acidosis as well as accumulation of glutamate released from astrocytes in the brain (Okada et al., 2019), as schematically depicted in Figure 7. ATP depletion causes suppression of Na⁺-K⁺ pump (Na/K-P) activity, thereby resulting in oncotic cell swelling due to an impairment of the pump-leak balance (P-LB) mechanism (Okada et al., 2021a; Tosteson and Hoffman, 1960). In addition, ATP depletion augments TRPM7 channel activity (Nadler et al., 2001), thereby causing the influx of cations (mainly Na⁺) and membrane depolarization. Acidosis also stimulates ubiquitous TRPM7 cation channels (Jiang et al., 2005; Numata and Okada, 2008b) and the neuronal amiloride-sensitive acid-sensing ion channel (ASIC) (Waldmann et al., 1997; Waldmann et al., 1999), both of which also bring about Na⁺ influx and membrane depolarization. In addition, acidosis activates ASOR/PAC, which is a ubiquitously expressed anion channel (Okada et al., 2021b). Membrane depolarization elicited by activation of TRPM7 and ASIC cation channels drives Cl⁻ influx via activated ASOR anion channels. Furthermore, in brain neurons, exposure to excessive glutamate stimulates ionotropic glutamate receptors, NMDARs, which operate as non-selective cation channels and produces Na⁺ influx and membrane depolarization (Tymianski, 2011). TRPM2 physically interacts with and functionally augments extra-synaptic NMDARs (Zong et al., 2022a). TRPM2 is also known to be activated by a danger signal FPP (Chen et al., 2021) and H₂O₂ or Zn²⁺ (Mortadza et al., 2017). The excessive NaCl entry thus produced by these cation and anion channels drives water influx, causing cell swelling (Figure 7). Such accidental cell swelling involving TRPM2 and TRPM7 may cause necrosis and thus represent NVI induction. In accord with this view, TRPM2 knockout was shown to inhibit necrotic cell death induced by H₂O₂ or Zn²⁺ in mouse macrophages (Mortadza et al., 2017), by FPP in mouse mastrocytoma cells (Chen et al., 2021), and by ischemia in mouse neurons (Zong et al., 2022a). Also, acidotoxic necrosis was shown to be abolished by TRPM7 knockdown in HeLa cells (Numata et al., 2019). Cell swelling compelled under such ischemic, acidotoxic, and excitotoxic conditions may activate VSOR anion channels. However, operation of VSOR, the activity of which is much supported by the interaction with TRPM7, cannot serve as a pathway for volume-regulatory Cl⁻ efflux but rather exerts as a pathway for swelling-exaggerating Cl⁻ influx, because depolarization caused by activation of NMDAR, TRPM7, and/or TRPM2 should drive Cl⁻ flux to the inward (but not outward) direction, thereby bringing about the RVD dysfunction (Figure 7). Thus, both TRPM2 and TRPM7 are involved in accidental necrosis by participating in the NVI induction and in the following RVD dysfunction, thus attaining persistent cell swelling due to the continuous inflows of Na⁺, Cl⁻, and osmotically obliged water (Figure 7).

Roles of TRPM2 and TRPM7 in the ionic mechanisms leading to necrosis induction that requisitely involves NVI induction followed by RVD dysfunction. Depolarization caused by activation of TRPM7, ASIC, NMDAR, and TRPM2 drives Cl⁻ influx via the VSOR channel pore. Resultant NaCl influx drives water influx leading to cell swelling. (See the text for details.)

As described in the preceding sections, TRPM2 and TRPM7 were molecularly proved to be involved in pyroptosis and necroptosis, respectively. Swelling- and ROS-activated VSOR/VRAC anion channels were also implicated in pyroptosis (Daniels et al., 2016; Green et al., 2018; Yang et al., 2023; Ye et al., 2021). Depletion or release ATP was observed to be coupled to necroptosis (Leist et al., 1997; Jouan-Lanhouet et al., 2012) and pyroptosis (Yang et al., 2015). Persistent, sizable cell swelling was found to be associated with necroptosis (Chen X. et al., 2016) and pyroptosis (Chen X. et al., 2016; Compan et al., 2012; Fink and Cookson, 2006; Schorn et al., 2011; Yang et al., 2023). Together, it can be assumed that the ionic mechanisms of pyroptosis and necroptotic cells death processes are, at least in part, similar to those of accidental necrosis illustrated in Figure 7. However, no study has as yet been reported as to whether TRPM2 and TRPM7 are involved in another type of programmed necrosis called ferroptosis which is caspase-independent and Fe²⁺-dependent.

Conclusion and perspective

TRPM2 and TRPM7 are Ca²⁺-permeable non-selective cation channels playing sensor roles for chemical, thermal, and mechanical stimuli. They have unique biophysical, physiological, pharmacological, and structural properties. Both activities are essentially involved as central components of the processes in cell volume regulation/dysregulation and cell death induction/protection not only by conducting cations, mainly Na⁺ and Ca²⁺, but also by interacting with other membrane-spanning proteins including LRRC8A, a core component of VSOR anion channel, NMDAR cation channels, and a cyclic ADP ribose hydrolase, CD38. Taken together, in the last section, it was sought to delve into the ionic mechanisms of cell death induction by focusing altered activities of TRPM2/TRPM7.

TRPM2 and TRPM7 have been shown to be involved in cell death associated with a large variety of diseases such as stroke, Alzheimer’s disease, Parkinson’s disease, and diabetes mellitus, as noted in the previous sections. Besides these, TRPM2 and TRPM7 were reported to be somehow related to many other diseases, although it is not clear whether these cation channels are involved in cell death processes coupled to those diseases. TRPM2 was shown to be implicated in the pathogenesis of epilepsy (Zheng et al., 2020) and atherosclerosis (Zong et al., 2022b). Also, TRPM2 was suggested to be involved in the coronavirus disease 2019 (COVID-19) (Kouhpayeh et al., 2021), based on the facts that oxidative stress plays a major role in the pathogenesis, progression, and severity of COVID-19 (Beltrán-García et al., 2020; Cecchini and Cecchini, 2020; Delgado-Roche and Mesta, 2020) and that infection of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is known to induce apoptosis and necroptosis (Donia and Bokhari, 2021; Li et al., 2020). TRPM7 was demonstrated to be somehow associated with causes of fibrotic diseases (Du et al., 2010; Fang et al., 2013; Yu M. et al., 2013), cancer malignancy (Yee, 2017), and multiple sclerosis (Kamermans et al., 2019). Thus, further studies are warranted to clarify how TRPM2 and TRPM7 are molecularly and causatively involved in the etiology of these diseases. In any case, TRPM2 and TRPM7 are expected to be attractive targets for future treatments and drug developments.

Author contributions

YO conceived the project and finalized the manuscript. YO, RZS, TN, and MK wrote drafts for every section with input from all authors. TN, RZS, PGM, and YO prepared figures by splitting them up. KS-N prepared references. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Akyuva Y., Nazıroğlu M. (2023). Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells. Chem. Biol. Interact. 369, 110261. 10.1016/j.cbi.2022.110261 [DOI] [PubMed] [Google Scholar]
Aarts M., Iihara K., Wei W. L., Xiong Z. G., Arundine M., Cerwinski W., et al. (2003). A key role for TRPM7 channels in anoxic neuronal death. Cell 115 (7), 863–877. 10.1016/s0092-8674(03)01017-1 [DOI] [PubMed] [Google Scholar]
Abiria S. A., Krapivinsky G., Sah R., Santa-Cruz A. G., Chaudhuri D., Zhang J., et al. (2017). TRPM7 senses oxidative stress to release Zn²⁺ from unique intracellular vesicles. Proc. Natl. Acad. Sci. U. S. A. 114 (30), E6079–e6088. 10.1073/pnas.1707380114 [DOI] [PMC free article] [PubMed] [Google Scholar]
Abumaria N., Li W., Clarkson A. N. (2019). Role of the chanzyme TRPM7 in the nervous system in health and disease. Cell Mol. Life Sci. 76 (17), 3301–3310. 10.1007/s00018-019-03124-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
Akita T., Okada Y. (2014). Characteristics and roles of the volume-sensitive outwardly rectifying (VSOR) anion channel in the central nervous system. Neuroscience 275, 211–231. 10.1016/j.neuroscience.2014.06.015 [DOI] [PubMed] [Google Scholar]
Akyuva Y., Nazıroğlu M., Yıldızhan K. (2021). Selenium prevents interferon-gamma induced activation of TRPM2 channel and inhibits inflammation, mitochondrial oxidative stress, and apoptosis in microglia. Metab. Brain Dis. 36 (2), 285–298. 10.1007/s11011-020-00624-0 [DOI] [PubMed] [Google Scholar]
Alawieyah Syed Mortadza S., Sim J. A., Neubrand V. E., Jiang L. H. (2018). A critical role of TRPM2 channel in Aβ₄₂ -induced microglial activation and generation of tumor necrosis factor-α. Glia 66 (3), 562–575. 10.1002/glia.23265 [DOI] [PubMed] [Google Scholar]
Alim I., Teves L., Li R., Mori Y., Tymianski M. (2013). Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J. Neurosci. 33 (44), 17264–17277. 10.1523/jneurosci.1729-13.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
Aminzadeh M., Roghani M., Sarfallah A., Riazi G. H. (2018). TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease. Int. Immunopharmacol. 54, 78–85. 10.1016/j.intimp.2017.10.024 [DOI] [PubMed] [Google Scholar]
Badr H., Kozai D., Sakaguchi R., Numata T., Mori Y. (2016). Different contribution of redox-sensitive transient receptor potential channels to acetaminophen-induced death of human hepatoma cell line. Front. Pharmacol. 7, 19. 10.3389/fphar.2016.00019 [DOI] [PMC free article] [PubMed] [Google Scholar]
Balinas C., Cabanas H., Staines D., Marshall-Gradisnik S. (2019). Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 17 (1), 401. 10.1186/s12967-019-02155-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
Bari M. R., Akbar S., Eweida M., Kühn F. J., Gustafsson A. J., Lückhoff A., et al. (2009). H₂O₂-induced Ca²⁺ influx and its inhibition by N-(p-amylcinnamoyl) anthranilic acid in the beta-cells: involvement of TRPM2 channels. J. Cell Mol. Med. 13 (9), 3260–3267. 10.1111/j.1582-4934.2009.00737.x [DOI] [PMC free article] [PubMed] [Google Scholar]
Barros L. F., Hermosilla T., Castro J. (2001). Necrotic volume increase and the early physiology of necrosis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130 (3), 401–409. 10.1016/s1095-6433(01)00438-x [DOI] [PubMed] [Google Scholar]
Beck A., Kolisek M., Bagley L. A., Fleig A., Penner R. (2006). Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. Faseb J. 20 (7), 962–964. 10.1096/fj.05-5538fje [DOI] [PubMed] [Google Scholar]
Beesetty P., Wieczerzak K. B., Gibson J. N., Kaitsuka T., Luu C. T., Matsushita M., et al. (2018). Inactivation of TRPM7 kinase in mice results in enlarged spleens, reduced T-cell proliferation and diminished store-operated calcium entry. Sci. Rep. 8 (1), 3023. 10.1038/s41598-018-21004-w [DOI] [PMC free article] [PubMed] [Google Scholar]
Belrose J. C., Jackson M. F. (2018). TRPM2: a candidate therapeutic target for treating neurological diseases. Acta Pharmacol. Sin. 39 (5), 722–732. 10.1038/aps.2018.31 [DOI] [PMC free article] [PubMed] [Google Scholar]
Beltrán-García J., Osca-Verdegal R., Pallardó F. V., Ferreres J., Rodríguez M., Mulet S., et al. (2020). Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants (Basel) 9 (10), 936. 10.3390/antiox9100936 [DOI] [PMC free article] [PubMed] [Google Scholar]
Bessac B. F., Fleig A. (2007). TRPM7 channel is sensitive to osmotic gradients in human kidney cells. J. Physiol. 582 (3), 1073–1086. 10.1113/jphysiol.2007.130534 [DOI] [PMC free article] [PubMed] [Google Scholar]
Bezprozvanny I., Tsien R. W. (1995). Voltage-dependent blockade of diverse types of voltage-gated Ca²⁺ channels expressed in Xenopus oocytes by the Ca²⁺ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol. 48 (3), 540–549. [PubMed] [Google Scholar]
Blenn C., Wyrsch P., Bader J., Bollhalder M., Althaus F. R. (2011). Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca²⁺ fluxes in oxidative cell death. Cell Mol. Life Sci. 68 (8), 1455–1466. 10.1007/s00018-010-0533-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
Böhmer C., Wehner F. (2001). The epithelial Na⁺ channel (ENaC) is related to the hypertonicity-induced Na⁺ conductance in rat hepatocytes. FEBS Lett. 494 (1-2), 125–128. 10.1016/s0014-5793(01)02303-1 [DOI] [PubMed] [Google Scholar]
Bondarava M., Li T., Endl E., Wehner F. (2009). alpha-ENaC is a functional element of the hypertonicity-induced cation channel in HepG2 cells and it mediates proliferation. Pflugers Arch. 458 (4), 675–687. 10.1007/s00424-009-0649-z [DOI] [PMC free article] [PubMed] [Google Scholar]
Bousova K., Jirku M., Bumba L., Bednarova L., Sulc M., Franek M., et al. (2015). PIP₂ and PIP₃ interact with N-terminus region of TRPM4 channel. Biophys. Chem. 205, 24–32. 10.1016/j.bpc.2015.06.004 [DOI] [PubMed] [Google Scholar]
Brauchi S., Krapivinsky G., Krapivinsky L., Clapham D. E. (2008). TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 105 (24), 8304–8308. 10.1073/pnas.0800881105 [DOI] [PMC free article] [PubMed] [Google Scholar]
Broertjes J., Klarenbeek J., Habani Y., Langeslag M., Jalink K. (2019). TRPM7 residue S1269 mediates cAMP dependence of Ca²⁺ influx. PLoS One 14 (1), e0209563. 10.1371/journal.pone.0209563 [DOI] [PMC free article] [PubMed] [Google Scholar]
Browe D. M., Baumgarten C. M. (2004). Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl⁻ current elicited by beta1 integrin stretch in rabbit ventricular myocytes. J. Gen. Physiol. 124 (3), 273–287. 10.1085/jgp.200409040 [DOI] [PMC free article] [PubMed] [Google Scholar]
Buelow B., Song Y., Scharenberg A. M. (2008). The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes. J. Biol. Chem. 283 (36), 24571–24583. 10.1074/jbc.M802673200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Burg E. D., Remillard C. V., Yuan J. X. (2006). K⁺ channels in apoptosis. J. Membr. Biol. 209 (1), 3–20. 10.1007/s00232-005-0838-4 [DOI] [PubMed] [Google Scholar]
Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. (1983). A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U. S. A. 80 (14), 4546–4550. 10.1073/pnas.80.14.4546 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cahalan M. D., Lewis R. S. (1988). Role of potassium and chloride channels in volume regulation by T lymphocytes. Soc. Gen. Physiol. Ser. 43, 281–301. [PubMed] [Google Scholar]
Cai Z., Jitkaew S., Zhao J., Chiang H. C., Choksi S., Liu J., et al. (2014). Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16 (1), 55–65. 10.1038/ncb2883 [DOI] [PMC free article] [PubMed] [Google Scholar]
Caiafa P., Guastafierro T., Zampieri M. (2009). Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. Faseb J. 23 (3), 672–678. 10.1096/fj.08-123265 [DOI] [PubMed] [Google Scholar]
Cala P. M., Mandel L. J., Murphy E. (1986). Volume regulation by amphiuma red blood cells: cytosolic free Ca and alkali metal-H exchange. Am. J. Physiol. 250 (3), C423–C429. 10.1152/ajpcell.1986.250.3.C423 [DOI] [PubMed] [Google Scholar]
Cao E. (2020). Structural mechanisms of transient receptor potential ion channels. J. Gen. Physiol. 152 (3), e201811998. 10.1085/jgp.201811998 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cao R., Meng Z., Liu T., Wang G., Qian G., Cao T., et al. (2016). Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget 7 (45), 72941–72960. 10.18632/oncotarget.12146 [DOI] [PMC free article] [PubMed] [Google Scholar]
Castiglioni S., Cazzaniga A., Trapani V., Cappadone C., Farruggia G., Merolle L., et al. (2015). Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin. Sci. Rep. 5, 16538. 10.1038/srep16538 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cecchini R., Cecchini A. L. (2020). SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses 143, 110102. 10.1016/j.mehy.2020.110102 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chan H. C., Nelson D. J. (1992). Chloride-dependent cation conductance activated during cellular shrinkage. Science 257 (5070), 669–671. 10.1126/science.1379742 [DOI] [PubMed] [Google Scholar]
Che H., Yue J., Tse H. F., Li G. R. (2014). Functional TRPV and TRPM channels in human preadipocytes. Pflugers Arch. 466 (5), 947–959. 10.1007/s00424-013-1355-4 [DOI] [PubMed] [Google Scholar]
Chen G. L., Zeng B., Eastmond S., Elsenussi S. E., Boa A. N., Xu S. Z. (2012). Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels. Br. J. Pharmacol. 167 (6), 1232–1243. 10.1111/j.1476-5381.2012.02058.x [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen H. C., Xie J., Zhang Z., Su L. T., Yue L., Runnels L. W. (2010). Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 5 (6), e11161. 10.1371/journal.pone.0011161 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen J., Dou Y., Zheng X., Leng T., Lu X., Ouyang Y., et al. (2016). TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma. Tumour Biol. 37 (11), 14721–14731. 10.1007/s13277-016-5317-2 [DOI] [PubMed] [Google Scholar]
Chen J., Zhang X., Li L., Ma X., Yang C., Liu Z., et al. (2021). Farnesyl pyrophosphate is a new danger signal inducing acute cell death. PLoS Biol. 19 (4), e3001134. 10.1371/journal.pbio.3001134 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen S. J., Zhang W., Tong Q., Conrad K., Hirschler-Laszkiewicz I., Bayerl M., et al. (2013). Role of TRPM2 in cell proliferation and susceptibility to oxidative stress. Am. J. Physiol. Cell Physiol. 304 (6), C548–C560. 10.1152/ajpcell.00069.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen W., Xu B., Xiao A., Liu L., Fang X., Liu R., et al. (2015). TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury. Mol. Brain 8, 11. 10.1186/s13041-015-0102-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen X., He W. T., Hu L., Li J., Fang Y., Wang X., et al. (2016). Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 26 (9), 1007–1020. 10.1038/cr.2016.100 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chen X., Numata T., Li M., Mori Y., Orser B. A., Jackson M. F., et al. (2010). The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations. Mol. Brain 3, 38. 10.1186/1756-6606-3-38 [DOI] [PMC free article] [PubMed] [Google Scholar]
Choi H., Ettinger N., Rohrbough J., Dikalova A., Nguyen H. N., Lamb F. S. (2016). LRRC8A channels support TNFα-induced superoxide production by Nox1 which is required for receptor endocytosis. Free Radic. Biol. Med. 101, 413–423. 10.1016/j.freeradbiomed.2016.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Choi H., Rohrbough J. C., Nguyen H. N., Dikalova A., Lamb F. S. (2021). Oxidant-resistant LRRC8A/C anion channels support superoxide production by NADPH oxidase 1. J. Physiol. 599 (12), 3013–3036. 10.1113/jp281577 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chokshi R., Fruasaha P., Kozak J. A. (2012a). 2-aminoethyl diphenyl borinate (2-APB) inhibits TRPM7 channels through an intracellular acidification mechanism. Channels (Austin) 6 (5), 362–369. 10.4161/chan.21628 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chokshi R., Matsushita M., Kozak J. A. (2012b). Detailed examination of Mg²⁺ and pH sensitivity of human TRPM7 channels. Am. J. Physiol. Cell Physiol. 302 (7), C1004–C1011. 10.1152/ajpcell.00422.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chokshi R., Matsushita M., Kozak J. A. (2012c). Sensitivity of TRPM7 channels to Mg²⁺ characterized in cell-free patches of Jurkat T lymphocytes. Am. J. Physiol. Cell Physiol. 302 (11), C1642–C1651. 10.1152/ajpcell.00037.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
Chubanov V., Mederos y Schnitzler M., Meißner M., Schäfer S., Abstiens K., Hofmann T., et al. (2012). Natural and synthetic modulators of SK (K_ca2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharmacol. 166 (4), 1357–1376. 10.1111/j.1476-5381.2012.01855.x [DOI] [PMC free article] [PubMed] [Google Scholar]
Çınar R., Nazıroğlu M. (2023). TRPM2 channel inhibition attenuates amyloid β42-induced apoptosis and oxidative stress in the hippocampus of mice. Cell Mol. Neurobiol. 43 (3), 1335–1353. 10.1007/s10571-022-01253-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
Clark K., Langeslag M., van Leeuwen B., Ran L., Ryazanov A. G., Figdor C. G., et al. (2006). TRPM7, a novel regulator of actomyosin contractility and cell adhesion. Embo J. 25 (2), 290–301. 10.1038/sj.emboj.7600931 [DOI] [PMC free article] [PubMed] [Google Scholar]
Clark K., Middelbeek J., Dorovkov M. V., Figdor C. G., Ryazanov A. G., Lasonder E., et al. (2008a). The alpha-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC. FEBS Lett. 582 (20), 2993–2997. 10.1016/j.febslet.2008.07.043 [DOI] [PubMed] [Google Scholar]
Clark K., Middelbeek J., Lasonder E., Dulyaninova N. G., Morrice N. A., Ryazanov A. G., et al. (2008b). TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation. J. Mol. Biol. 378 (4), 790–803. 10.1016/j.jmb.2008.02.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
Compan V., Baroja-Mazo A., López-Castejón G., Gomez A. I., Martínez C. M., Angosto D., et al. (2012). Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37 (3), 487–500. 10.1016/j.immuni.2012.06.013 [DOI] [PubMed] [Google Scholar]
Cook N. L., Vink R., Helps S. C., Manavis J., van den Heuvel C. (2010). Transient receptor potential melastatin 2 expression is increased following experimental traumatic brain injury in rats. J. Mol. Neurosci. 42 (2), 192–199. 10.1007/s12031-010-9347-8 [DOI] [PubMed] [Google Scholar]
Coombes E., Jiang J., Chu X. P., Inoue K., Seeds J., Branigan D., et al. (2011). Pathophysiologically relevant levels of hydrogen peroxide induce glutamate-independent neurodegeneration that involves activation of transient receptor potential melastatin 7 channels. Antioxid. Redox Signal 14 (10), 1815–1827. 10.1089/ars.2010.3549 [DOI] [PMC free article] [PubMed] [Google Scholar]
Csanády L., Törocsik B. (2009). Four Ca²⁺ ions activate TRPM2 channels by binding in deep crevices near the pore but intracellularly of the gate. J. Gen. Physiol. 133 (2), 189–203. 10.1085/jgp.200810109 [DOI] [PMC free article] [PubMed] [Google Scholar]
Daniels M. J., Rivers-Auty J., Schilling T., Spencer N. G., Watremez W., Fasolino V., et al. (2016). Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. Nat. Commun. 7, 12504. 10.1038/ncomms12504 [DOI] [PMC free article] [PubMed] [Google Scholar]
de Baaij J. H., Hoenderop J. G., Bindels R. J. (2015). Magnesium in man: implications for health and disease. Physiol. Rev. 95 (1), 1–46. 10.1152/physrev.00012.2014 [DOI] [PubMed] [Google Scholar]
Deason-Towne F., Perraud A. L., Schmitz C. (2012). Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase. Cell Signal 24 (11), 2070–2075. 10.1016/j.cellsig.2012.06.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
Delgado-Roche L., Mesta F. (2020). Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch. Med. Res. 51 (5), 384–387. 10.1016/j.arcmed.2020.04.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
Demeuse P., Penner R., Fleig A. (2006). TRPM7 channel is regulated by magnesium nucleotides via its kinase domain. J. Gen. Physiol. 127 (4), 421–434. 10.1085/jgp.200509410 [DOI] [PMC free article] [PubMed] [Google Scholar]
Desai B. N., Krapivinsky G., Navarro B., Krapivinsky L., Carter B. C., Febvay S., et al. (2012). Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell 22 (6), 1149–1162. 10.1016/j.devcel.2012.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
Dhakal S., Lee Y. (2019). Transient receptor potential channels and metabolism. Mol. Cells 42 (8), 569–578. 10.14348/molcells.2019.0007 [DOI] [PMC free article] [PubMed] [Google Scholar]
Di A., Gao X. P., Qian F., Kawamura T., Han J., Hecquet C., et al. (2011). The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation. Nat. Immunol. 13 (1), 29–34. 10.1038/ni.2171 [DOI] [PMC free article] [PubMed] [Google Scholar]
Donia A., Bokhari H. (2021). Apoptosis induced by SARS-CoV-2: can we target it? Apoptosis 26 (1-2), 7–8. 10.1007/s10495-021-01656-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
Dorovkov M. V., Ryazanov A. G. (2004). Phosphorylation of annexin I by TRPM7 channel-kinase. J. Biol. Chem. 279 (49), 50643–50646. 10.1074/jbc.C400441200 [DOI] [PubMed] [Google Scholar]
Du J., Xie J., Yue L. (2009b). Modulation of TRPM2 by acidic pH and the underlying mechanisms for pH sensitivity. J. Gen. Physiol. 134 (6), 471–488. 10.1085/jgp.200910254 [DOI] [PMC free article] [PubMed] [Google Scholar]
Du J., Xie J., Yue L. (2009a). Intracellular calcium activates TRPM2 and its alternative spliced isoforms. Proc. Natl. Acad. Sci. U. S. A. 106 (17), 7239–7244. 10.1073/pnas.0811725106 [DOI] [PMC free article] [PubMed] [Google Scholar]
Du J., Xie J., Zhang Z., Tsujikawa H., Fusco D., Silverman D., et al. (2010). TRPM7-mediated Ca²⁺ signals confer fibrogenesis in human atrial fibrillation. Circ. Res. 106 (5), 992–1003. 10.1161/circresaha.109.206771 [DOI] [PMC free article] [PubMed] [Google Scholar]
Duan J., Li Z., Li J., Hulse R. E., Santa-Cruz A., Valinsky W. C., et al. (2018). Structure of the mammalian TRPM7, a magnesium channel required during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 115 (35), E8201–e8210. 10.1073/pnas.1810719115 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ehrlich W., Gahan J. M., Rentzsch F., Kühn F. J. P. (2022). TRPM2 causes sensitization to oxidative stress but attenuates high-temperature injury in the sea anemone Nematostella vectensis . J. Exp. Biol. 225 (6), jeb243717. 10.1242/jeb.243717 [DOI] [PubMed] [Google Scholar]
Elizondo M. R., Arduini B. L., Paulsen J., MacDonald E. L., Sabel J. L., Henion P. D., et al. (2005). Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr. Biol. 15 (7), 667–671. 10.1016/j.cub.2005.02.050 [DOI] [PubMed] [Google Scholar]
Ertuğrul A., Özkaya D., Nazıroğlu M. (2023). Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line. Graefes Arch. Clin. Exp. Ophthalmol. 2023, 1–16. 10.1007/s00417-023-06082-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
Esposito E., Cuzzocrea S. (2009). Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation. Front. Biosci. Landmark Ed. 14 (1), 263–296. 10.2741/3244 [DOI] [PubMed] [Google Scholar]
Fanczal J., Pallagi P., Görög M., Diszházi G., Almássy J., Madácsy T., et al. (2020). TRPM2-mediated extracellular Ca²⁺ entry promotes acinar cell necrosis in biliary acute pancreatitis. J. Physiol. 598 (6), 1253–1270. 10.1113/jp279047 [DOI] [PubMed] [Google Scholar]
Fang L., Zhan S., Huang C., Cheng X., Lv X., Si H., et al. (2013). TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol. Appl. Pharmacol. 272 (3), 713–725. 10.1016/j.taap.2013.08.009 [DOI] [PubMed] [Google Scholar]
Faouzi M., Kilch T., Horgen F. D., Fleig A., Penner R. (2017). The TRPM7 channel kinase regulates store-operated calcium entry. J. Physiol. 595 (10), 3165–3180. 10.1113/jp274006 [DOI] [PMC free article] [PubMed] [Google Scholar]
Fauzee N. J., Pan J., Wang Y. L. (2010). PARP and PARG inhibitors--new therapeutic targets in cancer treatment. Pathol. Oncol. Res. 16 (4), 469–478. 10.1007/s12253-010-9266-6 [DOI] [PubMed] [Google Scholar]
Fink S. L., Cookson B. T. (2006). Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 8 (11), 1812–1825. 10.1111/j.1462-5822.2006.00751.x [DOI] [PubMed] [Google Scholar]
Fleig A., Penner R. (2004). The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol. Sci. 25 (12), 633–639. 10.1016/j.tips.2004.10.004 [DOI] [PubMed] [Google Scholar]
Fliegert R., Bauche A., Wolf Pérez A. M., Watt J. M., Rozewitz M. D., Winzer R., et al. (2017a). 2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist. Nat. Chem. Biol. 13 (9), 1036–1044. 10.1038/nchembio.2415 [DOI] [PMC free article] [PubMed] [Google Scholar]
Fliegert R., Riekehr W. M., Guse A. H. (2020). Does cyclic ADP-ribose (cADPR) activate the non-selective cation channel TRPM2? Front. Immunol. 11, 2018. 10.3389/fimmu.2020.02018 [DOI] [PMC free article] [PubMed] [Google Scholar]
Fliegert R., Watt J. M., Schöbel A., Rozewitz M. D., Moreau C., Kirchberger T., et al. (2017b). Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349. Biochem. J. 474 (13), 2159–2175. 10.1042/bcj20170091 [DOI] [PMC free article] [PubMed] [Google Scholar]
Fliniaux I., Germain E., Farfariello V., Prevarskaya N. (2018). TRPs and Ca²⁺ in cell death and survival. Cell Calcium 69, 4–18. 10.1016/j.ceca.2017.07.002 [DOI] [PubMed] [Google Scholar]
Fonfria E., Marshall I. C., Benham C. D., Boyfield I., Brown J. D., Hill K., et al. (2004). TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 143 (1), 186–192. 10.1038/sj.bjp.0705914 [DOI] [PMC free article] [PubMed] [Google Scholar]
Fonfria E., Marshall I. C., Boyfield I., Skaper S. D., Hughes J. P., Owen D. E., et al. (2005). Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J. Neurochem. 95 (3), 715–723. 10.1111/j.1471-4159.2005.03396.x [DOI] [PubMed] [Google Scholar]
Franco L., Guida L., Bruzzone S., Zocchi E., Usai C., De Flora A. (1998). The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. Faseb J. 12 (14), 1507–1520. 10.1096/fasebj.12.14.1507 [DOI] [PubMed] [Google Scholar]
Gao G., Wang W., Tadagavadi R. K., Briley N. E., Love M. I., Miller B. A., et al. (2014). TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J. Clin. Invest. 124 (11), 4989–5001. 10.1172/jci76042 [DOI] [PMC free article] [PubMed] [Google Scholar]
García-Rodríguez S., Rosal-Vela A., Botta D., Cumba Garcia L. M., Zumaquero E., Prados-Maniviesa V., et al. (2018). CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism. Sci. Rep. 8 (1), 3357. 10.1038/s41598-018-21337-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
Gattkowski E., Johnsen A., Bauche A., Möckl F., Kulow F., Garcia Alai M., et al. (2019). Novel CaM-binding motif in its NudT9H domain contributes to temperature sensitivity of TRPM2. Biochim. Biophys. Acta Mol. Cell Res. 1866 (7), 1162–1170. 10.1016/j.bbamcr.2018.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
Gelderblom M., Melzer N., Schattling B., Göb E., Hicking G., Arunachalam P., et al. (2014). Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke. Stroke 45 (11), 3395–3402. 10.1161/strokeaha.114.005836 [DOI] [PubMed] [Google Scholar]
Granger D. N., Kvietys P. R. (2015). Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524–551. 10.1016/j.redox.2015.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
Green D. R. (2019). The coming decade of cell death research: five riddles. Cell 177 (5), 1094–1107. 10.1016/j.cell.2019.04.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
Green J. P., Yu S., Martín-Sánchez F., Pelegrin P., Lopez-Castejon G., Lawrence C. B., et al. (2018). Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc. Natl. Acad. Sci. U. S. A. 115 (40), E9371–e9380. 10.1073/pnas.1812744115 [DOI] [PMC free article] [PubMed] [Google Scholar]
Grinstein S., Dupre A., Rothstein A. (1982). Volume regulation by human lymphocytes. Role of calcium. J. Gen. Physiol. 79 (5), 849–868. 10.1085/jgp.79.5.849 [DOI] [PMC free article] [PubMed] [Google Scholar]
Grubisha O., Rafty L. A., Takanishi C. L., Xu X., Tong L., Perraud A. L., et al. (2006). Metabolite of SIR2 reaction modulates TRPM2 ion channel. J. Biol. Chem. 281 (20), 14057–14065. 10.1074/jbc.M513741200 [DOI] [PubMed] [Google Scholar]
Guan Z., Chen X., Fang S., Ji Y., Gao Z., Zheng Y. (2021). CCT128930 is a novel and potent antagonist of TRPM7 channel. Biochem. Biophys. Res. Commun. 560, 132–138. 10.1016/j.bbrc.2021.04.119 [DOI] [PubMed] [Google Scholar]
Guida L., Franco L., Bruzzone S., Sturla L., Zocchi E., Basile G., et al. (2004). Concentrative influx of functionally active cyclic ADP-ribose in dimethyl sulfoxide-differentiated HL-60 cells. J. Biol. Chem. 279 (21), 22066–22075. 10.1074/jbc.M314137200 [DOI] [PubMed] [Google Scholar]
Guinamard R., Simard C., Del Negro C. (2013). Flufenamic acid as an ion channel modulator. Pharmacol. Ther. 138 (2), 272–284. 10.1016/j.pharmthera.2013.01.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
Güzel M., Nazıroğlu M., Akpınar O., Çınar R. (2021). Interferon gamma-mediated oxidative stress induces apoptosis, neuroinflammation, zinc ion influx, and TRPM2 channel activation in neuronal cell line: modulator role of curcumin. Inflammation 44 (5), 1878–1894. 10.1007/s10753-021-01465-4 [DOI] [PubMed] [Google Scholar]
Gwanyanya A., Sipido K. R., Vereecke J., Mubagwa K. (2006). ATP and PIP₂ dependence of the magnesium-inhibited, TRPM7-like cation channel in cardiac myocytes. Am. J. Physiol. Cell Physiol. 291 (4), C627–C635. 10.1152/ajpcell.00074.2006 [DOI] [PubMed] [Google Scholar]
Hanano T., Hara Y., Shi J., Morita H., Umebayashi C., Mori E., et al. (2004). Involvement of TRPM7 in cell growth as a spontaneously activated Ca²⁺ entry pathway in human retinoblastoma cells. J. Pharmacol. Sci. 95 (4), 403–419. 10.1254/jphs.fp0040273 [DOI] [PubMed] [Google Scholar]
Hantute-Ghesquier A., Haustrate A., Prevarskaya N., Lehen'kyi V. (2018). TRPM family channels in cancer. Pharm. (Basel) 11 (2), 58. 10.3390/ph11020058 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T., et al. (2002). LTRPC2 Ca²⁺-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 9 (1), 163–173. 10.1016/s1097-2765(01)00438-5 [DOI] [PubMed] [Google Scholar]
Hasegawa Y., Shimizu T., Takahashi N., Okada Y. (2012). The apoptotic volume decrease is an upstream event of MAP kinase activation during Staurosporine-induced apoptosis in HeLa cells. Int. J. Mol. Sci. 13 (7), 9363–9379. 10.3390/ijms13079363 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hazama A., Okada Y. (1990a). Biphasic rises in cytosolic free Ca²⁺ in association with activation of K⁺ and Cl⁻ conductance during the regulatory volume decrease in cultured human epithelial cells. Pflugers Arch. 416 (6), 710–714. 10.1007/bf00370619 [DOI] [PubMed] [Google Scholar]
Hazama A., Okada Y. (1988). Ca²⁺ sensitivity of volume-regulatory K⁺ and Cl⁻ channels in cultured human epithelial cells. J. Physiol. 402, 687–702. 10.1113/jphysiol.1988.sp017229 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hazama A., Okada Y. (1990b). Involvement of Ca²⁺-induced Ca²⁺ release in the volume regulation of human epithelial cells exposed to a hypotonic medium. Biochem. Biophys. Res. Commun. 167 (1), 287–293. 10.1016/0006-291x(90)91763-i [DOI] [PubMed] [Google Scholar]
He Y., Yao G., Savoia C., Touyz R. M. (2005). Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ. Res. 96 (2), 207–215. 10.1161/01.RES.0000152967.88472.3e [DOI] [PubMed] [Google Scholar]
Hecquet C. M., Zhang M., Mittal M., Vogel S. M., Di A., Gao X., et al. (2014). Cooperative interaction of trp melastatin channel transient receptor potential (TRPM2) with its splice variant TRPM2 short variant is essential for endothelial cell apoptosis. Circ. Res. 114 (3), 469–479. 10.1161/circresaha.114.302414 [DOI] [PMC free article] [PubMed] [Google Scholar]
Heiner I., Eisfeld J., Lückhoff A. (2003). Role and regulation of TRP channels in neutrophil granulocytes. Cell Calcium 33 (5-6), 533–540. 10.1016/s0143-4160(03)00058-7 [DOI] [PubMed] [Google Scholar]
Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., et al. (1994). A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91 (8), 3270–3274. 10.1073/pnas.91.8.3270 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hermosura M. C., Monteilh-Zoller M. K., Scharenberg A. M., Penner R., Fleig A. (2002). Dissociation of the store-operated calcium current I(CRAC) and the Mg-nucleotide-regulated metal ion current MagNuM. J. Physiol. 539 (2), 445–458. 10.1113/jphysiol.2001.013361 [DOI] [PMC free article] [PubMed] [Google Scholar]
Higashida H., Yuhi T., Akther S., Amina S., Zhong J., Liang M., et al. (2018). Oxytocin release via activation of TRPM2 and CD38 in the hypothalamus during hyperthermia in mice: implication for autism spectrum disorder. Neurochem. Int. 119, 42–48. 10.1016/j.neuint.2017.07.009 [DOI] [PubMed] [Google Scholar]
Hill K., Benham C. D., McNulty S., Randall A. D. (2004a). Flufenamic acid is a pH-dependent antagonist of TRPM2 channels. Neuropharmacology 47 (3), 450–460. 10.1016/j.neuropharm.2004.04.014 [DOI] [PubMed] [Google Scholar]
Hill K., McNulty S., Randall A. D. (2004b). Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedeb. Arch. Pharmacol. 370 (4), 227–237. 10.1007/s00210-004-0981-y [DOI] [PubMed] [Google Scholar]
Hiroi T., Wajima T., Negoro T., Ishii M., Nakano Y., Kiuchi Y., et al. (2013). Neutrophil TRPM2 channels are implicated in the exacerbation of myocardial ischaemia/reperfusion injury. Cardiovasc Res. 97 (2), 271–281. 10.1093/cvr/cvs332 [DOI] [PubMed] [Google Scholar]
Hirschler-Laszkiewicz I., Festa F., Huang S., Moldovan G. L., Nicolae C., Dhoonmoon A., et al. (2022). The human ion channel TRPM2 modulates cell survival in neuroblastoma through E2F1 and FOXM1. Sci. Rep. 12 (1), 6311. 10.1038/s41598-022-10385-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hoffman N. E., Miller B. A., Wang J., Elrod J. W., Rajan S., Gao E., et al. (2015). Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenance. Am. J. Physiol. Heart Circ. Physiol. 308 (6), H637–H650. 10.1152/ajpheart.00720.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
Hoffmann E. K., Lambert I. H., Pedersen S. F. (2009). Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89 (1), 193–277. 10.1152/physrev.00037.2007 [DOI] [PubMed] [Google Scholar]
Hofmann T., Schäfer S., Linseisen M., Sytik L., Gudermann T., Chubanov V. (2014). Activation of TRPM7 channels by small molecules under physiological conditions. Pflugers Arch. 466 (12), 2177–2189. 10.1007/s00424-014-1488-0 [DOI] [PubMed] [Google Scholar]
Hu H. Z., Gu Q., Wang C., Colton C. K., Tang J., Kinoshita-Kawada M., et al. (2004). 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem. 279 (34), 35741–35748. 10.1074/jbc.M404164200 [DOI] [PubMed] [Google Scholar]
Huang Y., Fliegert R., Guse A. H., Lü W., Du J. (2020). A structural overview of the ion channels of the TRPM family. Cell Calcium 85, 102111. 10.1016/j.ceca.2019.102111 [DOI] [PMC free article] [PubMed] [Google Scholar]
Huang Y., Leng T. D., Inoue K., Yang T., Liu M., Horgen F. D., et al. (2018a). TRPM7 channels play a role in high glucose-induced endoplasmic reticulum stress and neuronal cell apoptosis. J. Biol. Chem. 293 (37), 14393–14406. 10.1074/jbc.RA117.001032 [DOI] [PMC free article] [PubMed] [Google Scholar]
Huang Y., Roth B., Lü W., Du J. (2019). Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel. Elife 8, e50175. 10.7554/eLife.50175 [DOI] [PMC free article] [PubMed] [Google Scholar]
Huang Y., Winkler P. A., Sun W., Lü W., Du J. (2018b). Architecture of the TRPM2 channel and its activation mechanism by ADP-ribose and calcium. Nature 562 (7725), 145–149. 10.1038/s41586-018-0558-4 [DOI] [PubMed] [Google Scholar]
Huffer K. E., Aleksandrova A. A., Jara-Oseguera A., Forrest L. R., Swartz K. J. (2020). Global alignment and assessment of TRP channel transmembrane domain structures to explore functional mechanisms. Elife 9, e58660. 10.7554/eLife.58660 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ikari A., Atomi K., Yamazaki Y., Sakai H., Hayashi H., Yamaguchi M., et al. (2013). Hyperosmolarity-induced up-regulation of claudin-4 mediated by NADPH oxidase-dependent H₂O₂ production and Sp1/c-Jun cooperation. Biochim. Biophys. Acta 1833 (12), 2617–2627. 10.1016/j.bbamcr.2013.06.016 [DOI] [PubMed] [Google Scholar]
Inoue H., Murayama T., Kobayashi T., Konishi M., Yokoyama U. (2021). The zinc-binding motif of TRPM7 acts as an oxidative stress sensor to regulate its channel activity. J. Gen. Physiol. 153 (6), e202012708. 10.1085/jgp.202012708 [DOI] [PMC free article] [PubMed] [Google Scholar]
Inoue H., Murayama T., Tashiro M., Sakurai T., Konishi M. (2014). Mg²⁺- and ATP-dependent inhibition of transient receptor potential melastatin 7 by oxidative stress. Free Radic. Biol. Med. 72, 257–266. 10.1016/j.freeradbiomed.2014.04.015 [DOI] [PubMed] [Google Scholar]
Inoue K., Branigan D., Xiong Z. G. (2010). Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J. Biol. Chem. 285 (10), 7430–7439. 10.1074/jbc.M109.040485 [DOI] [PMC free article] [PubMed] [Google Scholar]
Iordanov I., Mihályi C., Tóth B., Csanády L. (2016). The proposed channel-enzyme transient receptor potential melastatin 2 does not possess ADP ribose hydrolase activity. Elife 5, e17600. 10.7554/eLife.17600 [DOI] [PMC free article] [PubMed] [Google Scholar]
Iordanov I., Tóth B., Szollosi A., Csanády L. (2019). Enzyme activity and selectivity filter stability of ancient TRPM2 channels were simultaneously lost in early vertebrates. Elife 8, e44556. 10.7554/eLife.44556 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ishii M., Shimizu S., Hara Y., Hagiwara T., Miyazaki A., Mori Y., et al. (2006). Intracellular-produced hydroxyl radical mediates H₂O₂-induced Ca²⁺ influx and cell death in rat beta-cell line RIN-5F. Cell Calcium 39 (6), 487–494. 10.1016/j.ceca.2006.01.013 [DOI] [PubMed] [Google Scholar]
Jäger H., Dreker T., Buck A., Giehl K., Gress T., Grissmer S. (2004). Blockage of intermediate-conductance Ca²⁺-activated K⁺ channels inhibit human pancreatic cancer cell growth in vitro . Mol. Pharmacol. 65 (3), 630–638. 10.1124/mol.65.3.630 [DOI] [PubMed] [Google Scholar]
Jansen C., Sahni J., Suzuki S., Horgen F. D., Penner R., Fleig A. (2016). The coiled-coil domain of zebrafish TRPM7 regulates Mg·nucleotide sensitivity. Sci. Rep. 6, 33459. 10.1038/srep33459 [DOI] [PMC free article] [PubMed] [Google Scholar]
Jensen B. S., Strobaek D., Christophersen P., Jorgensen T. D., Hansen C., Silahtaroglu A., et al. (1998). Characterization of the cloned human intermediate-conductance Ca²⁺-activated K⁺ channel. Am. J. Physiol. 275 (3), C848–C856. 10.1152/ajpcell.1998.275.3.C848 [DOI] [PubMed] [Google Scholar]
Jia J., Verma S., Nakayama S., Quillinan N., Grafe M. R., Hurn P. D., et al. (2011). Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J. Cereb. Blood Flow. Metab. 31 (11), 2160–2168. 10.1038/jcbfm.2011.77 [DOI] [PMC free article] [PubMed] [Google Scholar]
Jiang H., Sha S. H., Forge A., Schacht J. (2006). Caspase-independent pathways of hair cell death induced by kanamycin in vivo . Cell Death Differ. 13 (1), 20–30. 10.1038/sj.cdd.4401706 [DOI] [PMC free article] [PubMed] [Google Scholar]
Jiang H., Tian S. L., Zeng Y., Li L. L., Shi J. (2008). TrkA pathway(s) is involved in regulation of TRPM7 expression in hippocampal neurons subjected to ischemic-reperfusion and oxygen-glucose deprivation. Brain Res. Bull. 76 (1-2), 124–130. 10.1016/j.brainresbull.2008.01.013 [DOI] [PubMed] [Google Scholar]
Jiang J., Li M., Yue L. (2005). Potentiation of TRPM7 inward currents by protons. J. Gen. Physiol. 126 (2), 137–150. 10.1085/jgp.200409185 [DOI] [PMC free article] [PubMed] [Google Scholar]
Jiang M., Qi L., Li L., Li Y. (2020). The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 6, 112. 10.1038/s41420-020-00349-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
Jiang Q., Gao Y., Wang C., Tao R., Wu Y., Zhan K., et al. (2017). Nitration of TRPM2 as a molecular switch induces autophagy during brain pericyte injury. Antioxid. Redox Signal 27 (16), 1297–1316. 10.1089/ars.2016.6873 [DOI] [PubMed] [Google Scholar]
Jouan-Lanhouet S., Arshad M. I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., et al. (2012). TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 19 (12), 2003–2014. 10.1038/cdd.2012.90 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kuras Z., Yun Y. H., Chimote A. A., Neumeier L., Conforti L. (2012). KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells. PLoS One 7 (8), e43859. 10.1371/journal.pone.0043859 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kamermans A., Planting K. E., Jalink K., van Horssen J., de Vries H. E. (2019). Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production. Glia 67 (1), 68–77. 10.1002/glia.23526 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kaneko S., Kawakami S., Hara Y., Wakamori M., Itoh E., Minami T., et al. (2006). A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J. Pharmacol. Sci. 101 (1), 66–76. 10.1254/jphs.fp0060128 [DOI] [PubMed] [Google Scholar]
Kashio M., Sokabe T., Shintaku K., Uematsu T., Fukuta N., Kobayashi N., et al. (2012). Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions. Proc. Natl. Acad. Sci. U. S. A. 109 (17), 6745–6750. 10.1073/pnas.1114193109 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kashio M., Tominaga M. (2017). The TRPM2 channel: A thermo-sensitive metabolic sensor. Channels (Austin) 11 (5), 426–433. 10.1080/19336950.2017.1344801 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kerschbaum H. H., Kozak J. A., Cahalan M. D. (2003). Polyvalent cations as permeant probes of MIC and TRPM7 pores. Biophys. J. 84 (4), 2293–2305. 10.1016/s0006-3495(03)75035-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kheradpezhouh E., Barritt G. J., Rychkov G. Y. (2016). Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 7, 1–7. 10.1016/j.redox.2015.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kheradpezhouh E., Ma L., Morphett A., Barritt G. J., Rychkov G. Y. (2014). TRPM2 channels mediate acetaminophen-induced liver damage. Proc. Natl. Acad. Sci. U. S. A. 111 (8), 3176–3181. 10.1073/pnas.1322657111 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kim B. J. (2013). Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J. Ginseng Res. 37 (2), 201–209. 10.5142/jgr.2013.37.201 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kim U. H., Han M. K., Park B. H., Kim H. R., An N. H. (1993). Function of NAD glycohydrolase in ADP-ribose uptake from NAD by human erythrocytes. Biochim. Biophys. Acta 1178 (2), 121–126. 10.1016/0167-4889(93)90001-6 [DOI] [PubMed] [Google Scholar]
Koh D. W., Powell D. P., Blake S. D., Hoffman J. L., Hopkins M. M., Feng X. (2015). Enhanced cytotoxicity in triple-negative and estrogen receptor-positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel. Oncol. Rep. 34 (3), 1589–1598. 10.3892/or.2015.4131 [DOI] [PMC free article] [PubMed] [Google Scholar]
Koike C., Numata T., Ueda H., Mori Y., Furukawa T. (2010). TRPM1: a vertebrate TRP channel responsible for retinal on bipolar function. Cell Calcium 48 (2-3), 95–101. 10.1016/j.ceca.2010.08.004 [DOI] [PubMed] [Google Scholar]
Kolbrink B., Riebeling T., Kunzendorf U., Krautwald S. (2020). Plasma membrane pores drive inflammatory cell death. Front. Cell Dev. Biol. 8, 817. 10.3389/fcell.2020.00817 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kolisek M., Beck A., Fleig A., Penner R. (2005). Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol. Cell 18 (1), 61–69. 10.1016/j.molcel.2005.02.033 [DOI] [PubMed] [Google Scholar]
Kollewe A., Chubanov V., Tseung F. T., Correia L., Schmidt E., Rössig A., et al. (2021). The molecular appearance of native TRPM7 channel complexes identified by high-resolution proteomics. Elife 10, e68544. 10.7554/eLife.68544 [DOI] [PMC free article] [PubMed] [Google Scholar]
Koos B., Christmann J., Plettenberg S., Käding D., Becker J., Keteku M., et al. (2018). Hypertonicity-induced cation channels in HepG2 cells: architecture and role in proliferation vs. apoptosis. J. Physiol. 596 (7), 1227–1241. 10.1113/jp275827 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kouhpayeh S., Shariati L., Boshtam M., Rahimmanesh I., Mirian M., Esmaeili Y., et al. (2021). The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy. Int. J. Mol. Sci. 22 (11), 5438. 10.3390/ijms22115438 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kozak J. A., Cahalan M. D. (2003). MIC channels are inhibited by internal divalent cations but not ATP. Biophys. J. 84 (2), 922–927. 10.1016/s0006-3495(03)74909-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kozak J. A., Kerschbaum H. H., Cahalan M. D. (2002). Distinct properties of CRAC and MIC channels in RBL cells. J. Gen. Physiol. 120 (2), 221–235. 10.1085/jgp.20028601 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kozak J. A., Matsushita M., Nairn A. C., Cahalan M. D. (2005). Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J. Gen. Physiol. 126 (5), 499–514. 10.1085/jgp.200509324 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kraft R., Grimm C., Frenzel H., Harteneck C. (2006). Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br. J. Pharmacol. 148 (3), 264–273. 10.1038/sj.bjp.0706739 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kraft R., Grimm C., Grosse K., Hoffmann A., Sauerbruch S., Kettenmann H., et al. (2004). Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am. J. Physiol. Cell Physiol. 286 (1), C129–C137. 10.1152/ajpcell.00331.2003 [DOI] [PubMed] [Google Scholar]
Krapivinsky G., Mochida S., Krapivinsky L., Cibulsky S. M., Clapham D. E. (2006). The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 52 (3), 485–496. 10.1016/j.neuron.2006.09.033 [DOI] [PubMed] [Google Scholar]
Kubo M., Okada Y. (1992). Volume-regulatory Cl⁻ channel currents in cultured human epithelial cells. J. Physiol. 456, 351–371. 10.1113/jphysiol.1992.sp019340 [DOI] [PMC free article] [PubMed] [Google Scholar]
Kühn F. J., Kühn C., Winking M., Hoffmann D. C., Lückhoff A. (2016). ADP-ribose activates the TRPM2 channel from the sea anemone nematostella vectensis independently of the NUDT9H domain. PLoS One 11 (6), e0158060. 10.1371/journal.pone.0158060 [DOI] [PMC free article] [PubMed] [Google Scholar]
Lang F., Busch G. L., Ritter M., Völkl H., Waldegger S., Gulbins E., et al. (1998). Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78 (1), 247–306. 10.1152/physrev.1998.78.1.247 [DOI] [PubMed] [Google Scholar]
Lange I., Penner R., Fleig A., Beck A. (2008). Synergistic regulation of endogenous TRPM2 channels by adenine dinucleotides in primary human neutrophils. Cell Calcium 44 (6), 604–615. 10.1016/j.ceca.2008.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
Lange I., Yamamoto S., Partida-Sanchez S., Mori Y., Fleig A., Penner R. (2009). TRPM2 functions as a lysosomal Ca²⁺-release channel in beta cells. Sci. Signal 2 (71), ra23. 10.1126/scisignal.2000278 [DOI] [PMC free article] [PubMed] [Google Scholar]
Langeslag M., Clark K., Moolenaar W. H., van Leeuwen F. N., Jalink K. (2007). Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J. Biol. Chem. 282 (1), 232–239. 10.1074/jbc.M605300200 [DOI] [PubMed] [Google Scholar]
Leist M., Single B., Castoldi A. F., Kühnle S., Nicotera P. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185 (8), 1481–1486. 10.1084/jem.185.8.1481 [DOI] [PMC free article] [PubMed] [Google Scholar]
Leng T. D., Lin J., Sun H. W., Zeng Z., O'Bryant Z., Inoue K., et al. (2015). Local anesthetic lidocaine inhibits TRPM7 current and TRPM7-mediated zinc toxicity. CNS Neurosci. Ther. 21 (1), 32–39. 10.1111/cns.12318 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li M., Du J., Jiang J., Ratzan W., Su L. T., Runnels L. W., et al. (2007). Molecular determinants of Mg²⁺ and Ca²⁺ permeability and pH sensitivity in TRPM6 and TRPM7. J. Biol. Chem. 282 (35), 25817–25830. 10.1074/jbc.M608972200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li M., Jiang J., Yue L. (2006). Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J. Gen. Physiol. 127 (5), 525–537. 10.1085/jgp.200609502 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li Q., Lei X., Liu H., Feng S., Cai C., Hu Y., et al. (2022). Transient receptor potential melastatin 7 aggravates necrotizing enterocolitis by promoting an inflammatory response in children. Transl. Pediatr. 11 (12), 2030–2039. 10.21037/tp-22-633 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li S., Zhang Y., Guan Z., Li H., Ye M., Chen X., et al. (2020). SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct. Target Ther. 5 (1), 235. 10.1038/s41392-020-00334-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li X., Jiang L. H. (2018). Multiple molecular mechanisms form a positive feedback loop driving amyloid β42 peptide-induced neurotoxicity via activation of the TRPM2 channel in hippocampal neurons. Cell Death Dis. 9 (2), 195. 10.1038/s41419-018-0270-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
Li X., Yang W., Jiang L. H. (2017). Alteration in intracellular Zn²⁺ homeostasis as a result of TRPM2 channel activation contributes to ROS-induced hippocampal neuronal death. Front. Mol. Neurosci. 10, 414. 10.3389/fnmol.2017.00414 [DOI] [PMC free article] [PubMed] [Google Scholar]
Liu H. W., Gong L. N., Lai K., Yu X. F., Liu Z. Q., Li M. X., et al. (2023). Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage. Neuron 111 (10), 1609–1625.e6. e1606. 10.1016/j.neuron.2023.02.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
Liu J., Zhao Y. J., Li W. H., Hou Y. N., Li T., Zhao Z. Y., et al. (2017). Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels. Proc. Natl. Acad. Sci. U. S. A. 114 (31), 8283–8288. 10.1073/pnas.1703718114 [DOI] [PMC free article] [PubMed] [Google Scholar]
Liu Y., Mikrani R., He Y., Faran Ashraf Baig M. M., Abbas M., Naveed M., et al. (2020). TRPM8 channels: A review of distribution and clinical role. Eur. J. Pharmacol. 882, 173312. 10.1016/j.ejphar.2020.173312 [DOI] [PubMed] [Google Scholar]
Liu Y. S., Liu Y. A., Huang C. J., Yen M. H., Tseng C. T., Chien S., et al. (2015). Mechanosensitive TRPM7 mediates shear stress and modulates osteogenic differentiation of mesenchymal stromal cells through Osterix pathway. Sci. Rep. 5, 16522. 10.1038/srep16522 [DOI] [PMC free article] [PubMed] [Google Scholar]
Luo X., Li M., Zhan K., Yang W., Zhang L., Wang K., et al. (2018). Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chem. Biol. Drug Des. 91 (2), 552–566. 10.1111/cbdd.13119 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ma G., Yang Y., Chen Y., Wei X., Ding J., Zhou R. P., et al. (2021). Blockade of TRPM7 alleviates chondrocyte apoptosis and articular cartilage damage in the adjuvant arthritis rat model through regulation of the indian hedgehog signaling pathway. Front. Pharmacol. 12, 655551. 10.3389/fphar.2021.655551 [DOI] [PMC free article] [PubMed] [Google Scholar]
Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. (2000). Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. U. S. A. 97 (17), 9487–9492. 10.1073/pnas.140216197 [DOI] [PMC free article] [PubMed] [Google Scholar]
Maeno E., Shimizu T., Okada Y. (2006a). Normotonic cell shrinkage induces apoptosis under extracellular low Cl conditions in human lymphoid and epithelial cells. Acta Physiol. (Oxf) 187 (1-2), 217–222. 10.1111/j.1748-1716.2006.01554.x [DOI] [PubMed] [Google Scholar]
Maeno E., Takahashi N., Okada Y. (2006b). Dysfunction of regulatory volume increase is a key component of apoptosis. FEBS Lett. 580 (27), 6513–6517. 10.1016/j.febslet.2006.10.074 [DOI] [PubMed] [Google Scholar]
Mahbub L., Kozlov G., Zong P., Lee E. L., Tetteh S., Nethramangalath T., et al. (2023). Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15. Elife 12, e86129. 10.7554/eLife.86129 [DOI] [PMC free article] [PubMed] [Google Scholar]
Malko P., Jiang L. H. (2020). TRPM2 channel-mediated cell death: an important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol. 37, 101755. 10.1016/j.redox.2020.101755 [DOI] [PMC free article] [PubMed] [Google Scholar]
Manna P. T., Munsey T. S., Abuarab N., Li F., Asipu A., Howell G., et al. (2015). TRPM2-mediated intracellular Zn²⁺ release triggers pancreatic β-cell death. Biochem. J. 466 (3), 537–546. 10.1042/bj20140747 [DOI] [PubMed] [Google Scholar]
Matsushita M., Kozak J. A., Shimizu Y., McLachlin D. T., Yamaguchi H., Wei F. Y., et al. (2005). Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J. Biol. Chem. 280 (21), 20793–20803. 10.1074/jbc.M413671200 [DOI] [PubMed] [Google Scholar]
McHugh D., Flemming R., Xu S. Z., Perraud A. L., Beech D. J. (2003). Critical intracellular Ca²⁺ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation. J. Biol. Chem. 278 (13), 11002–11006. 10.1074/jbc.M210810200 [DOI] [PubMed] [Google Scholar]
Mei Z. Z., Xia R., Beech D. J., Jiang L. H. (2006). Intracellular coiled-coil domain engaged in subunit interaction and assembly of melastatin-related transient receptor potential channel 2. J. Biol. Chem. 281 (50), 38748–38756. 10.1074/jbc.M607591200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Miller B. A., Hoffman N. E., Merali S., Zhang X. Q., Wang J., Rajan S., et al. (2014). TRPM2 channels protect against cardiac ischemia-reperfusion injury: role of mitochondria. J. Biol. Chem. 289 (11), 7615–7629. 10.1074/jbc.M113.533851 [DOI] [PMC free article] [PubMed] [Google Scholar]
Miller B. A., Wang J., Hirschler-Laszkiewicz I., Gao E., Song J., Zhang X. Q., et al. (2013). The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 304 (7), H1010–H1022. 10.1152/ajpheart.00906.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
Mittal M., Urao N., Hecquet C. M., Zhang M., Sudhahar V., Gao X. P., et al. (2015). Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization. Arterioscler. Thromb. Vasc. Biol. 35 (4), 877–887. 10.1161/atvbaha.114.304802 [DOI] [PMC free article] [PubMed] [Google Scholar]
Mittermeier L., Demirkhanyan L., Stadlbauer B., Breit A., Recordati C., Hilgendorff A., et al. (2019). TRPM7 is the central gatekeeper of intestinal mineral absorption essential for postnatal survival. Proc. Natl. Acad. Sci. U. S. A. 116 (10), 4706–4715. 10.1073/pnas.1810633116 [DOI] [PMC free article] [PubMed] [Google Scholar]
Monteilh-Zoller M. K., Hermosura M. C., Nadler M. J., Scharenberg A. M., Penner R., Fleig A. (2003). TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121 (1), 49–60. 10.1085/jgp.20028740 [DOI] [PMC free article] [PubMed] [Google Scholar]
Moreau C., Kirchberger T., Swarbrick J. M., Bartlett S. J., Fliegert R., Yorgan T., et al. (2013). Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists. J. Med. Chem. 56 (24), 10079–10102. 10.1021/jm401497a [DOI] [PMC free article] [PubMed] [Google Scholar]
Mortadza S. S., Sim J. A., Stacey M., Jiang L. H. (2017). Signalling mechanisms mediating Zn²⁺-induced TRPM2 channel activation and cell death in microglial cells. Sci. Rep. 7, 45032. 10.1038/srep45032 [DOI] [PMC free article] [PubMed] [Google Scholar]
Nadezhdin K. D., Correia L., Narangoda C., Patel D. S., Neuberger A., Gudermann T., et al. (2023). Structural mechanisms of TRPM7 activation and inhibition. Nat. Commun. 14 (1), 2639. 10.1038/s41467-023-38362-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
Nadler M. J., Hermosura M. C., Inabe K., Perraud A. L., Zhu Q., Stokes A. J., et al. (2001). LTRPC7 is a Mg·ATP-regulated divalent cation channel required for cell viability. Nature 411 (6837), 590–595. 10.1038/35079092 [DOI] [PubMed] [Google Scholar]
Nadolni W., Zierler S. (2018). The channel-kinase TRPM7 as novel regulator of immune system homeostasis. Cells 7 (8), 109. 10.3390/cells7080109 [DOI] [PMC free article] [PubMed] [Google Scholar]
Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ito F., et al. (1998). Molecular cloning of a novel putative Ca²⁺ channel protein (TRPC7) highly expressed in brain. Genomics 54 (1), 124–131. 10.1006/geno.1998.5551 [DOI] [PubMed] [Google Scholar]
Naziroğlu M., Lückhoff A. (2008). A calcium influx pathway regulated separately by oxidative stress and ADP-ribose in TRPM2 channels: single channel events. Neurochem. Res. 33 (7), 1256–1262. 10.1007/s11064-007-9577-5 [DOI] [PubMed] [Google Scholar]
Naziroğlu M. (2007). New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem. Res. 32 (11), 1990–2001. 10.1007/s11064-007-9386-x [DOI] [PubMed] [Google Scholar]
Negri S., Faris P., Berra-Romani R., Guerra G., Moccia F. (2019). Endothelial transient receptor potential channels and vascular remodeling: extracellular Ca²⁺ entry for angiogenesis, arteriogenesis and vasculogenesis. Front. Physiol. 10, 1618. 10.3389/fphys.2019.01618 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ng N. M., Jiang S. P., Lv Z. Q. (2012). Retrovirus-mediated siRNA targeting TRPM7 gene induces apoptosis in RBL-2H3 cells. Eur. Rev. Med. Pharmacol. Sci. 16 (9), 1172–1178. [PubMed] [Google Scholar]
Nicotera P., Orrenius S. (1998). The role of calcium in apoptosis. Cell Calcium 23 (2-3), 173–180. 10.1016/s0143-4160(98)90116-6 [DOI] [PubMed] [Google Scholar]
Nilius B., Eggermont J., Voets T., Buyse G., Manolopoulos V., Droogmans G. (1997a). Properties of volume-regulated anion channels in mammalian cells. Prog. Biophys. Mol. Biol. 68 (1), 69–119. 10.1016/s0079-6107(97)00021-7 [DOI] [PubMed] [Google Scholar]
Nilius B., Prenen J., Kamouchi M., Viana F., Voets T., Droogmans G. (1997b). Inhibition by mibefradil, a novel calcium channel antagonist, of Ca²⁺- and volume-activated Cl⁻ channels in macrovascular endothelial cells. Br. J. Pharmacol. 121 (3), 547–555. 10.1038/sj.bjp.0701140 [DOI] [PMC free article] [PubMed] [Google Scholar]
Nilius B., Prenen J., Vennekens R., Hoenderop J. G., Bindels R. J., Droogmans G. (2001). Pharmacological modulation of monovalent cation currents through the epithelial Ca²⁺ channel ECaC1. Br. J. Pharmacol. 134 (3), 453–462. 10.1038/sj.bjp.0704272 [DOI] [PMC free article] [PubMed] [Google Scholar]
Nuñez-Villena F., Becerra A., Echeverría C., Briceño N., Porras O., Armisén R., et al. (2011). Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid. Redox Signal 15 (9), 2425–2438. 10.1089/ars.2010.3825 [DOI] [PubMed] [Google Scholar]
Nukui M., Shimizu T., Okada Y. (2006). Normotonic cell shrinkage induced by Na⁺ deprivation results in apoptotic cell death in human epithelial HeLa cells. J. Physiol. Sci. 56 (5), 335–339. 10.2170/physiolsci.RP009606 [DOI] [PubMed] [Google Scholar]
Numata T., Okada Y. (2008a). Molecular determinants of sensitivity and conductivity of human TRPM7 to Mg²⁺ and Ca²⁺ . Channels (Austin) 2 (4), 283–286. 10.4161/chan.2.4.6695 [DOI] [PubMed] [Google Scholar]
Numata T., Okada Y. (2008b). Proton conductivity through the human TRPM7 channel and its molecular determinants. J. Biol. Chem. 283 (22), 15097–15103. 10.1074/jbc.M709261200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Numata T., Sato K., Christmann J., Marx R., Mori Y., Okada Y., et al. (2012). The ΔC splice-variant of TRPM2 is the hypertonicity-induced cation channel in HeLa cells, and the ecto-enzyme CD38 mediates its activation. J. Physiol. 590 (5), 1121–1138. 10.1113/jphysiol.2011.220947 [DOI] [PMC free article] [PubMed] [Google Scholar]
Numata T., Sato-Numata K., Hermosura M. C., Mori Y., Okada Y. (2021). TRPM7 is an essential regulator for volume-sensitive outwardly rectifying anion channel. Commun. Biol. 4 (1), 599. 10.1038/s42003-021-02127-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
Numata T., Sato-Numata K., Okada Y. (2019). TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells. Physiol. Rep. 7 (13), e14157. 10.14814/phy2.14157 [DOI] [PMC free article] [PubMed] [Google Scholar]
Numata T., Shimizu T., Okada Y. (2007a). Direct mechano-stress sensitivity of TRPM7 channel. Cell Physiol. Biochem. 19 (1-4), 1–8. 10.1159/000099187 [DOI] [PubMed] [Google Scholar]
Numata T., Shimizu T., Okada Y. (2007b). TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells. Am. J. Physiol. Cell Physiol. 292 (1), C460–C467. 10.1152/ajpcell.00367.2006 [DOI] [PubMed] [Google Scholar]
Numata T., Wehner F., Okada Y. (2007c). A novel inhibitor of hypertonicity-induced cation channels in HeLa cells. J. Physiol. Sci. 57 (4), 249–252. 10.2170/physiolsci.SC003007 [DOI] [PubMed] [Google Scholar]
Oancea E., Wolfe J. T., Clapham D. E. (2006). Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ. Res. 98 (2), 245–253. 10.1161/01.RES.0000200179.29375.cc [DOI] [PubMed] [Google Scholar]
Okada Y., Maeno E., Shimizu T., Dezaki K., Wang J., Morishima S. (2001). Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J. Physiol. 532 (1), 3–16. 10.1111/j.1469-7793.2001.0003g.x [DOI] [PMC free article] [PubMed] [Google Scholar]
Okada Y. (2016). Channelling frozen cells to survival after thawing: opening the door to cryo-physiology. J. Physiol. 594 (6), 1523–1524. 10.1113/jp271842 [DOI] [PMC free article] [PubMed] [Google Scholar]
Okada Y., Hazama A. (1989). Volume-regulatory ion channels in epithelial cells. Physiology 4 (6), 238–242. 10.1152/physiologyonline.1989.4.6.238 [DOI] [Google Scholar]
Okada Y., Hazama A., Yuan W. L. (1990). Stretch-induced activation of Ca²⁺-permeable ion channels is involved in the volume regulation of hypotonically swollen epithelial cells. Neurosci. Res. Suppl. 12, S5–S13. 10.1016/0921-8696(90)90004-m [DOI] [PubMed] [Google Scholar]
Okada Y. (2004). Ion channels and transporters involved in cell volume regulation and sensor mechanisms. Cell Biochem. Biophys. 41 (2), 233–258. 10.1385/cbb:41:2:233 [DOI] [PubMed] [Google Scholar]
Okada Y., Maeno E., Shimizu T., Manabe K., Mori S., Nabekura T. (2004). Dual roles of plasmalemmal chloride channels in induction of cell death. Pflugers Arch. 448 (3), 287–295. 10.1007/s00424-004-1276-3 [DOI] [PubMed] [Google Scholar]
Okada Y., Numata T., Sato-Numata K., Sabirov R. Z., Liu H., Mori S. I., et al. (2019). Roles of volume-regulatory anion channels, VSOR and Maxi-Cl, in apoptosis, cisplatin resistance, necrosis, ischemic cell death, stroke and myocardial infarction. Curr. Top. Membr. 83, 205–283. 10.1016/bs.ctm.2019.03.001 [DOI] [PubMed] [Google Scholar]
Okada Y., Sabirov R. Z., Sato-Numata K., Numata T. (2021a). Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 1: roles of VSOR/VRAC in cell volume regulation, release of double-edged signals and apoptotic/necrotic cell death. Front. Cell Dev. Biol. 8, 614040. 10.3389/fcell.2020.614040 [DOI] [PMC free article] [PubMed] [Google Scholar]
Okada Y., Sato-Numata K., Sabirov R. Z., Numata T. (2021b). Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 2: functional and molecular properties of ASOR/PAC channels and their roles in cell volume dysregulation and acidotoxic cell death. Front. Cell Dev. Biol. 9, 702317. 10.3389/fcell.2021.702317 [DOI] [PMC free article] [PubMed] [Google Scholar]
Okada Y. (1997). Volume expansion-sensing outward-rectifier Cl⁻ channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273 (3), C755–C789. 10.1152/ajpcell.1997.273.3.C755 [DOI] [PubMed] [Google Scholar]
Orrenius S., Zhivotovsky B., Nicotera P. (2003). Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (7), 552–565. 10.1038/nrm1150 [DOI] [PubMed] [Google Scholar]
Osmanlıoğlu H., Yıldırım M. K., Akyuva Y., Yıldızhan K., Nazıroğlu M. (2020). Morphine Induces apoptosis, inflammation, and mitochondrial oxidative stress via activation of TRPM2 channel and nitric oxide signaling pathways in the hippocampus. Mol. Neurobiol. 57 (8), 3376–3389. 10.1007/s12035-020-01975-6 [DOI] [PubMed] [Google Scholar]
Ostapchenko V. G., Chen M., Guzman M. S., Xie Y. F., Lavine N., Fan J., et al. (2015). The transient receptor potential melastatin 2 (TRPM2) channel contributes to β-amyloid oligomer-related neurotoxicity and memory impairment. J. Neurosci. 35 (45), 15157–15169. 10.1523/jneurosci.4081-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
Pan T., Zhu Q. J., Xu L. X., Ding X., Li J. Q., Sun B., et al. (2020). Knocking down TRPM2 expression reduces cell injury and NLRP3 inflammasome activation in PC12 cells subjected to oxygen-glucose deprivation. Neural Regen. Res. 15 (11), 2154–2161. 10.4103/1673-5374.282271 [DOI] [PMC free article] [PubMed] [Google Scholar]
Parnas M., Peters M., Dadon D., Lev S., Vertkin I., Slutsky I., et al. (2009). Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 45 (3), 300–309. 10.1016/j.ceca.2008.11.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
Partida-Sanchez S., Gasser A., Fliegert R., Siebrands C. C., Dammermann W., Shi G., et al. (2007). Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. J. Immunol. 179 (11), 7827–7839. 10.4049/jimmunol.179.11.7827 [DOI] [PubMed] [Google Scholar]
Perraud A. L., Fleig A., Dunn C. A., Bagley L. A., Launay P., Schmitz C., et al. (2001). ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411 (6837), 595–599. 10.1038/35079100 [DOI] [PubMed] [Google Scholar]
Perraud A. L., Schmitz C., Scharenberg A. M. (2003). TRPM2 Ca²⁺ permeable cation channels: from gene to biological function. Cell Calcium 33 (5-6), 519–531. 10.1016/s0143-4160(03)00057-5 [DOI] [PubMed] [Google Scholar]
Perraud A. L., Takanishi C. L., Shen B., Kang S., Smith M. K., Schmitz C., et al. (2005). Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J. Biol. Chem. 280 (7), 6138–6148. 10.1074/jbc.M411446200 [DOI] [PubMed] [Google Scholar]
Plettenberg S., Weiss E. C., Lemor R., Wehner F. (2008). Subunits alpha, beta and gamma of the epithelial Na⁺ channel (ENaC) are functionally related to the hypertonicity-induced cation channel (HICC) in rat hepatocytes. Pflugers Arch. 455 (6), 1089–1095. 10.1007/s00424-007-0355-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
Poblete H., Oyarzún I., Olivero P., Comer J., Zuñiga M., Sepulveda R. V., et al. (2015). Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) binding to transient receptor potential V1 (TRPV1) channels. J. Biol. Chem. 290 (4), 2086–2098. 10.1074/jbc.M114.613620 [DOI] [PMC free article] [PubMed] [Google Scholar]
Qin X., Yue Z., Sun B., Yang W., Xie J., Ni E., et al. (2013). Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br. J. Pharmacol. 168 (6), 1294–1312. 10.1111/bph.12012 [DOI] [PMC free article] [PubMed] [Google Scholar]
Qiu Z., Dubin A. E., Mathur J., Tu B., Reddy K., Miraglia L. J., et al. (2014). SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel. Cell 157 (2), 447–458. 10.1016/j.cell.2014.03.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
Rah S. Y., Kwak J. Y., Chung Y. J., Kim U. H. (2015). ADP-ribose/TRPM2-mediated Ca²⁺ signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells. Sci. Rep. 5, 9482. 10.1038/srep09482 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ritter M., Mongin A. A., Valenti G., Okada Y. (2021). Editorial: ion and water transport in cell death. Front. Cell Dev. Biol. 9, 757033. 10.3389/fcell.2021.757033 [DOI] [PMC free article] [PubMed] [Google Scholar]
Rizzuto R., Pinton P., Ferrari D., Chami M., Szabadkai G., Magalhães P. J., et al. (2003). Calcium and apoptosis: facts and hypotheses. Oncogene 22 (53), 8619–8627. 10.1038/sj.onc.1207105 [DOI] [PubMed] [Google Scholar]
Roberge S., Roussel J., Andersson D. C., Meli A. C., Vidal B., Blandel F., et al. (2014). TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. Cardiovasc Res. 103 (1), 90–99. 10.1093/cvr/cvu112 [DOI] [PubMed] [Google Scholar]
Rohács T., Lopes C. M., Michailidis I., Logothetis D. E. (2005). PI(4,5)P₂ regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci. 8 (5), 626–634. 10.1038/nn1451 [DOI] [PubMed] [Google Scholar]
Romagnani A., Vettore V., Rezzonico-Jost T., Hampe S., Rottoli E., Nadolni W., et al. (2017). TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut. Nat. Commun. 8 (1), 1917. 10.1038/s41467-017-01960-z [DOI] [PMC free article] [PubMed] [Google Scholar]
Rössig A., Hill K., Nörenberg W., Weidenbach S., Zierler S., Schaefer M., et al. (2022). Pharmacological agents selectively acting on the channel moieties of TRPM6 and TRPM7. Cell Calcium 106, 102640. 10.1016/j.ceca.2022.102640 [DOI] [PubMed] [Google Scholar]
Rothstein A., Mack E. (1990). Volume-activated K⁺ and Cl⁻ pathways of dissociated epithelial cells (MDCK): role of Ca²⁺ . Am. J. Physiol. 258 (5), C827–C834. 10.1152/ajpcell.1990.258.5.C827 [DOI] [PubMed] [Google Scholar]
Runnels L. W., Yue L., Clapham D. E. (2002). The TRPM7 channel is inactivated by PIP₂ hydrolysis. Nat. Cell Biol. 4 (5), 329–336. 10.1038/ncb781 [DOI] [PubMed] [Google Scholar]
Runnels L. W., Yue L., Clapham D. E. (2001). TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291 (5506), 1043–1047. 10.1126/science.1058519 [DOI] [PubMed] [Google Scholar]
Ryazanova L. V., Rondon L. J., Zierler S., Hu Z., Galli J., Yamaguchi T. P., et al. (2010). TRPM7 is essential for Mg²⁺ homeostasis in mammals. Nat. Commun. 1, 109. 10.1038/ncomms1108 [DOI] [PMC free article] [PubMed] [Google Scholar]
Şanlı C., Atılgan R., Kuloğlu T., Pala Ş., Aydın Türk B., Keser H. B., et al. (2021). Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology. Turk J. Med. Sci. 51 (2), 787–795. 10.3906/sag-2005-297 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sano Y., Inamura K., Miyake A., Mochizuki S., Yokoi H., Matsushime H., et al. (2001). Immunocyte Ca²⁺ influx system mediated by LTRPC2. Science 293 (5533), 1327–1330. 10.1126/science.1062473 [DOI] [PubMed] [Google Scholar]
Schäfer S., Ferioli S., Hofmann T., Zierler S., Gudermann T., Chubanov V. (2016). Mibefradil represents a new class of benzimidazole TRPM7 channel agonists. Pflugers Arch. 468 (4), 623–634. 10.1007/s00424-015-1772-7 [DOI] [PubMed] [Google Scholar]
Schlingmann K. P., Waldegger S., Konrad M., Chubanov V., Gudermann T. (2007). TRPM6 and TRPM7--Gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta 1772 (8), 813–821. 10.1016/j.bbadis.2007.03.009 [DOI] [PubMed] [Google Scholar]
Schmidt E., Narangoda C., Nörenberg W., Egawa M., Rössig A., Leonhardt M., et al. (2022). Structural mechanism of TRPM7 channel regulation by intracellular magnesium. Cell Mol. Life Sci. 79 (5), 225. 10.1007/s00018-022-04192-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
Schmitz C., Perraud A. L., Johnson C. O., Inabe K., Smith M. K., Penner R., et al. (2003). Regulation of vertebrate cellular Mg²⁺ homeostasis by TRPM7. Cell 114 (2), 191–200. 10.1016/s0092-8674(03)00556-7 [DOI] [PubMed] [Google Scholar]
Schorn C., Frey B., Lauber K., Janko C., Strysio M., Keppeler H., et al. (2011). Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem. 286 (1), 35–41. 10.1074/jbc.M110.139048 [DOI] [PMC free article] [PubMed] [Google Scholar]
Shimizu S., Yonezawa R., Hagiwara T., Yoshida T., Takahashi N., Hamano S., et al. (2014). Inhibitory effects of AG490 on H₂O₂-induced TRPM2-mediated Ca²⁺ entry. Eur. J. Pharmacol. 742, 22–30. 10.1016/j.ejphar.2014.08.023 [DOI] [PubMed] [Google Scholar]
Shimizu T., Dietz R. M., Cruz-Torres I., Strnad F., Garske A. K., Moreno M., et al. (2016). Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Exp. Neurol. 283, 151–156. 10.1016/j.expneurol.2016.06.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
Shimizu T., Macey T. A., Quillinan N., Klawitter J., Perraud A. L., Traystman R. J., et al. (2013). Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J. Cereb. Blood Flow. Metab. 33 (10), 1549–1555. 10.1038/jcbfm.2013.105 [DOI] [PMC free article] [PubMed] [Google Scholar]
Shimizu T., Maeno E., Okada Y. (2007). Prerequisite role of persistent cell shrinkage in apoptosis of human epithelial cells. Sheng Li Xue Bao 59 (4), 512–516. [PubMed] [Google Scholar]
Shimizu T., Numata T., Okada Y. (2004). A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl⁻ channel. Proc. Natl. Acad. Sci. U. S. A. 101 (17), 6770–6773. 10.1073/pnas.0401604101 [DOI] [PMC free article] [PubMed] [Google Scholar]
Simon F., Varela D., Cabello-Verrugio C. (2013). Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal 25 (7), 1614–1624. 10.1016/j.cellsig.2013.03.023 [DOI] [PubMed] [Google Scholar]
Singh A., Hildebrand M. E., Garcia E., Snutch T. P. (2010). The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. Br. J. Pharmacol. 160 (6), 1464–1475. 10.1111/j.1476-5381.2010.00786.x [DOI] [PMC free article] [PubMed] [Google Scholar]
Smith M. A., Herson P. S., Lee K., Pinnock R. D., Ashford M. L. (2003). Hydrogen-peroxide-induced toxicity of rat striatal neurones involves activation of a non-selective cation channel. J. Physiol. 547 (2), 417–425. 10.1113/jphysiol.2002.034561 [DOI] [PMC free article] [PubMed] [Google Scholar]
Song C., Bae Y., Jun J., Lee H., Kim N. D., Lee K. B., et al. (2017). Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion. Biochim. Biophys. Acta Gen. Subj. 1861 (4), 947–957. 10.1016/j.bbagen.2017.01.034 [DOI] [PubMed] [Google Scholar]
Song K., Wang H., Kamm G. B., Pohle J., Reis F. C., Heppenstall P., et al. (2016). The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia. Science 353 (6306), 1393–1398. 10.1126/science.aaf7537 [DOI] [PMC free article] [PubMed] [Google Scholar]
Starkus J., Beck A., Fleig A., Penner R. (2007). Regulation of TRPM2 by extra- and intracellular calcium. J. Gen. Physiol. 130 (4), 427–440. 10.1085/jgp.200709836 [DOI] [PMC free article] [PubMed] [Google Scholar]
Starkus J. G., Fleig A., Penner R. (2010). The calcium-permeable non-selective cation channel TRPM2 is modulated by cellular acidification. J. Physiol. 588 (8), 1227–1240. 10.1113/jphysiol.2010.187476 [DOI] [PMC free article] [PubMed] [Google Scholar]
Strange K., Jackson P. S. (1995). Swelling-activated organic osmolyte efflux: a new role for anion channels. Kidney Int. 48 (4), 994–1003. 10.1038/ki.1995.381 [DOI] [PubMed] [Google Scholar]
Su L. T., Agapito M. A., Li M., Simonson W. T., Huttenlocher A., Habas R., et al. (2006). TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J. Biol. Chem. 281 (16), 11260–11270. 10.1074/jbc.M512885200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Subramanyam M., Takahashi N., Hasegawa Y., Mohri T., Okada Y. (2010). Inhibition of protein kinase Akt1 by apoptosis signal-regulating kinase-1 (ASK1) is involved in apoptotic inhibition of regulatory volume increase. J. Biol. Chem. 285 (9), 6109–6117. 10.1074/jbc.M109.072785 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sumoza-Toledo A., Penner R. (2011). TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. 589 (7), 1515–1525. 10.1113/jphysiol.2010.201855 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sun H. S., Jackson M. F., Martin L. J., Jansen K., Teves L., Cui H., et al. (2009). Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat. Neurosci. 12 (10), 1300–1307. 10.1038/nn.2395 [DOI] [PubMed] [Google Scholar]
Sun L., Yau H. Y., Wong W. Y., Li R. A., Huang Y., Yao X. (2012). Role of TRPM2 in H₂O₂-induced cell apoptosis in endothelial cells. PLoS One 7 (8), e43186. 10.1371/journal.pone.0043186 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sun Y., Kamat A., Singh B. B. (2020a). Isoproterenol-dependent activation of TRPM7 protects against neurotoxin-induced loss of neuroblastoma cells. Front. Physiol. 11, 305. 10.3389/fphys.2020.00305 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sun Y., Sukumaran P., Selvaraj S., Cilz N. I., Schaar A., Lei S., et al. (2018). TRPM2 promotes neurotoxin MPP⁺/MPTP-induced cell death. Mol. Neurobiol. 55 (1), 409–420. 10.1007/s12035-016-0338-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
Sun Y., Sukumaran P., Singh B. B. (2020b). Magnesium-induced cell survival Is dependent on TRPM7 expression and function. Mol. Neurobiol. 57 (1), 528–538. 10.1007/s12035-019-01713-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
Szollosi A. (2021). Two decades of evolution of our understanding of the transient receptor potential melastatin 2 (TRPM2) cation channel. Life (Basel) 11 (5), 397. 10.3390/life11050397 [DOI] [PMC free article] [PubMed] [Google Scholar]
Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., et al. (1993). Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol. Chem. 268 (35), 26052–26054. 10.1016/s0021-9258(19)74275-6 [DOI] [PubMed] [Google Scholar]
Tan C. H., McNaughton P. A. (2016). The TRPM2 ion channel is required for sensitivity to warmth. Nature 536 (7617), 460–463. 10.1038/nature19074 [DOI] [PMC free article] [PubMed] [Google Scholar]
Thomas G. P., Karmazyn M., Zygmunt A. C., Antzelevitch C., Narayanan N. (1999). The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in Guinea-pig ventricular myocytes. Br. J. Pharmacol. 126 (7), 1531–1533. 10.1038/sj.bjp.0702475 [DOI] [PMC free article] [PubMed] [Google Scholar]
Tian Y., Yang T., Yu S., Liu C., He M., Hu C. (2018). Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels. J. Cell Mol. Med. 22 (12), 6327–6337. 10.1111/jcmm.13931 [DOI] [PMC free article] [PubMed] [Google Scholar]
Toda T., Yamamoto S., Yonezawa R., Mori Y., Shimizu S. (2016). Inhibitory effects of Tyrphostin AG-related compounds on oxidative stress-sensitive transient receptor potential channel activation. Eur. J. Pharmacol. 786, 19–28. 10.1016/j.ejphar.2016.05.033 [DOI] [PubMed] [Google Scholar]
Togashi K., Hara Y., Tominaga T., Higashi T., Konishi Y., Mori Y., et al. (2006). TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. Embo J. 25 (9), 1804–1815. 10.1038/sj.emboj.7601083 [DOI] [PMC free article] [PubMed] [Google Scholar]
Togashi K., Inada H., Tominaga M. (2008). Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB). Br. J. Pharmacol. 153 (6), 1324–1330. 10.1038/sj.bjp.0707675 [DOI] [PMC free article] [PubMed] [Google Scholar]
Tong L., Denu J. M. (2010). Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 1804 (8), 1617–1625. 10.1016/j.bbapap.2010.02.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
Tong Q., Zhang W., Conrad K., Mostoller K., Cheung J. Y., Peterson B. Z., et al. (2006). Regulation of the transient receptor potential channel TRPM2 by the Ca²⁺ sensor calmodulin. J. Biol. Chem. 281 (14), 9076–9085. 10.1074/jbc.M510422200 [DOI] [PubMed] [Google Scholar]
Tosteson D. C., Hoffman J. F. (1960). Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J. Gen. Physiol. 44 (1), 169–194. 10.1085/jgp.44.1.169 [DOI] [PMC free article] [PubMed] [Google Scholar]
Tóth B., Csanády L. (2012). Pore collapse underlies irreversible inactivation of TRPM2 cation channel currents. Proc. Natl. Acad. Sci. U. S. A. 109 (33), 13440–13445. 10.1073/pnas.1204702109 [DOI] [PMC free article] [PubMed] [Google Scholar]
Tóth B., Iordanov I., Csanády L. (2015). Ruling out pyridine dinucleotides as true TRPM2 channel activators reveals novel direct agonist ADP-ribose-2'-phosphate. J. Gen. Physiol. 145 (5), 419–430. 10.1085/jgp.201511377 [DOI] [PMC free article] [PubMed] [Google Scholar]
Touyz R. M., He Y., Montezano A. C., Yao G., Chubanov V., Gudermann T., et al. (2006). Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (1), R73–R78. 10.1152/ajpregu.00515.2005 [DOI] [PubMed] [Google Scholar]
Tseng H. H., Vong C. T., Kwan Y. W., Lee S. M., Hoi M. P. (2016). TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells. Sci. Rep. 6, 35016. 10.1038/srep35016 [DOI] [PMC free article] [PubMed] [Google Scholar]
Turlova E., Bae C. Y. J., Deurloo M., Chen W., Barszczyk A., Horgen F. D., et al. (2016). TRPM7 regulates axonal outgrowth and maturation of primary hippocampal neurons. Mol. Neurobiol. 53 (1), 595–610. 10.1007/s12035-014-9032-y [DOI] [PMC free article] [PubMed] [Google Scholar]
Turlova E., Feng Z. P., Sun H. S. (2018). The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia. Acta Pharmacol. Sin. 39 (5), 713–721. 10.1038/aps.2017.194 [DOI] [PMC free article] [PubMed] [Google Scholar]
Turlova E., Wong R., Xu B., Li F., Du L., Habbous S., et al. (2021). TRPM7 mediates neuronal cell Death upstream of calcium/calmodulin-dependent protein kinase II and calcineurin mechanism in neonatal hypoxic-ischemic brain injury. Transl. Stroke Res. 12 (1), 164–184. 10.1007/s12975-020-00810-3 [DOI] [PubMed] [Google Scholar]
Tymianski M. (2011). Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat. Neurosci. 14 (11), 1369–1373. 10.1038/nn.2951 [DOI] [PubMed] [Google Scholar]
Varela D., Simon F., Riveros A., Jørgensen F., Stutzin A. (2004). NAD(P)H oxidase-derived H₂O₂ signals chloride channel activation in cell volume regulation and cell proliferation. J. Biol. Chem. 279 (14), 13301–13304. 10.1074/jbc.C400020200 [DOI] [PubMed] [Google Scholar]
Vennekens R., Mesuere M., Philippaert K. (2018). TRPM5 in the battle against diabetes and obesity. Acta Physiol. (Oxf) 222 (2), e12949. 10.1111/apha.12949 [DOI] [PubMed] [Google Scholar]
Verma S., Quillinan N., Yang Y. F., Nakayama S., Cheng J., Kelley M. H., et al. (2012). TRPM2 channel activation following in vitro ischemia contributes to male hippocampal cell death. Neurosci. Lett. 530 (1), 41–46. 10.1016/j.neulet.2012.09.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
Viana F., Van den Bosch L., Missiaen L., Vandenberghe W., Droogmans G., Nilius B., et al. (1997). Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 22 (4), 299–311. 10.1016/s0143-4160(97)90068-3 [DOI] [PubMed] [Google Scholar]
Volk T., Frömter E., Korbmacher C. (1995). Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells. Proc. Natl. Acad. Sci. U. S. A. 92 (18), 8478–8482. 10.1073/pnas.92.18.8478 [DOI] [PMC free article] [PubMed] [Google Scholar]
Voss F. K., Ullrich F., Münch J., Lazarow K., Lutter D., Mah N., et al. (2014). Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science 344 (6184), 634–638. 10.1126/science.1252826 [DOI] [PubMed] [Google Scholar]
Vriens J., Voets T. (2019). Heat sensing involves a TRiPlet of ion channels. Br. J. Pharmacol. 176 (20), 3893–3898. 10.1111/bph.14812 [DOI] [PMC free article] [PubMed] [Google Scholar]
Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M. (1997). A proton-gated cation channel involved in acid-sensing. Nature 386 (6621), 173–177. 10.1038/386173a0 [DOI] [PubMed] [Google Scholar]
Waldmann R., Champigny G., Lingueglia E., De Weille J. R., Heurteaux C., Lazdunski M. (1999). H⁺-gated cation channels. Ann. N. Y. Acad. Sci. 868, 67–76. 10.1111/j.1749-6632.1999.tb11274.x [DOI] [PubMed] [Google Scholar]
Wang C., Naruse K., Takahashi K. (2018). Role of the TRPM4 channel in cardiovascular physiology and pathophysiology. Cells 7 (6), 62. 10.3390/cells7060062 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wang H. Y., Shimizu T., Numata T., Okada Y. (2007). Role of acid-sensitive outwardly rectifying anion channels in acidosis-induced cell death in human epithelial cells. Pflugers Arch. 454 (2), 223–233. 10.1007/s00424-006-0193-z [DOI] [PubMed] [Google Scholar]
Wang J., Morishima S., Okada Y. (2003). Ik channels are involved in the regulatory volume decrease in human epithelial cells. Am. J. Physiol. Cell Physiol. 284 (1), C77–C84. 10.1152/ajpcell.00132.2002 [DOI] [PubMed] [Google Scholar]
Wang L., Fu T. M., Zhou Y., Xia S., Greka A., Wu H. (2018). Structures and gating mechanism of human TRPM2. Science 362 (6421), eaav4809. 10.1126/science.aav4809 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wang L., Negro R., Wu H. (2020). TRPM2, linking oxidative stress and Ca²⁺ permeation to NLRP3 inflammasome activation. Curr. Opin. Immunol. 62, 131–135. 10.1016/j.coi.2020.01.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wehage E., Eisfeld J., Heiner I., Jüngling E., Zitt C., Lückhoff A. (2002). Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose. J. Biol. Chem. 277 (26), 23150–23156. 10.1074/jbc.M112096200 [DOI] [PubMed] [Google Scholar]
Wehner F., Bondarava M., ter Veld F., Endl E., Nürnberger H. R., Li T. (2006). Hypertonicity-induced cation channels. Acta Physiol. (Oxf) 187 (1-2), 21–25. 10.1111/j.1748-1716.2006.01561.x [DOI] [PubMed] [Google Scholar]
Wehner F., Olsen H., Tinel H., Kinne-Saffran E., Kinne R. K. (2003a). Cell volume regulation: osmolytes, osmolyte transport, and signal transduction. Rev. Physiol. Biochem. Pharmacol. 148, 1–80. 10.1007/s10254-003-0009-x [DOI] [PubMed] [Google Scholar]
Wehner F., Sauer H., Kinne R. K. (1995). Hypertonic stress increases the Na⁺ conductance of rat hepatocytes in primary culture. J. Gen. Physiol. 105 (4), 507–535. 10.1085/jgp.105.4.507 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wehner F., Shimizu T., Sabirov R., Okada Y. (2003b). Hypertonic activation of a non-selective cation conductance in HeLa cells and its contribution to cell volume regulation. FEBS Lett. 551 (1-3), 20–24. 10.1016/s0014-5793(03)00868-8 [DOI] [PubMed] [Google Scholar]
Wei C., Wang X., Chen M., Ouyang K., Song L. S., Cheng H. (2009). Calcium flickers steer cell migration. Nature 457 (7231), 901–905. 10.1038/nature07577 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wilson C. S., Mongin A. A. (2018). Cell volume control in healthy brain and neuropathologies. Curr. Top. Membr. 81, 385–455. 10.1016/bs.ctm.2018.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
Won J., Vang H., Kim J. H., Lee P. R., Kang Y., Oh S. B. (2018). TRPM7 mediates mechanosensitivity in adult rat odontoblasts. J. Dent. Res. 97 (9), 1039–1046. 10.1177/0022034518759947 [DOI] [PubMed] [Google Scholar]
Wong K. K., Banham A. H., Yaacob N. S., Nur Husna S. M. (2019). The oncogenic roles of TRPM ion channels in cancer. J. Cell Physiol. 234, 14556–14573. 10.1002/jcp.28168 [DOI] [PubMed] [Google Scholar]
Wong S. M., Chase H. S., Jr. (1986). Role of intracellular calcium in cellular volume regulation. Am. J. Physiol. 250 (6), C841–C852. 10.1152/ajpcell.1986.250.6.C841 [DOI] [PubMed] [Google Scholar]
Wu D. C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., et al. (2003). NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (10), 6145–6150. 10.1073/pnas.0937239100 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wu H., Dai R., Wang M., Chen C. (2023). Uric acid promotes myocardial infarction injury via activating pyrin domain-containing 3 inflammasome and reactive oxygen species/transient receptor potential melastatin 2/Ca²⁺ pathway. BMC Cardiovasc Disord. 23 (1), 10. 10.1186/s12872-023-03040-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
Wuensch T., Thilo F., Krueger K., Scholze A., Ristow M., Tepel M. (2010). High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes 59 (4), 844–849. 10.2337/db09-1100 [DOI] [PMC free article] [PubMed] [Google Scholar]
Xia R., Mei Z. Z., Mao H. J., Yang W., Dong L., Bradley H., et al. (2008). Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel 2. J. Biol. Chem. 283 (41), 27426–27432. 10.1074/jbc.M801049200 [DOI] [PMC free article] [PubMed] [Google Scholar]
Xia S., Wang L., Fu T. M., Wu H. (2019). Mechanism of TRPM2 channel gating revealed by cryo-EM. Febs J. 286 (17), 3333–3339. 10.1111/febs.14939 [DOI] [PMC free article] [PubMed] [Google Scholar]
Xiao E., Yang H. Q., Gan Y. H., Duan D. H., He L. H., Guo Y., et al. (2015). Brief reports: TRPM7 senses mechanical stimulation inducing osteogenesis in human bone marrow mesenchymal stem cells. Stem Cells 33 (2), 615–621. 10.1002/stem.1858 [DOI] [PubMed] [Google Scholar]
Xie J., Sun B., Du J., Yang W., Chen H. C., Overton J. D., et al. (2011). Phosphatidylinositol 4,5-bisphosphate (PIP₂) controls magnesium gatekeeper TRPM6 activity. Sci. Rep. 1, 146. 10.1038/srep00146 [DOI] [PMC free article] [PubMed] [Google Scholar]
Xu H. L., Liu M. D., Yuan X. H., Liu C. X. (2018). Suppression of cortical TRPM7 protein attenuates oxidative damage after traumatic brain injury via Akt/endothelial nitric oxide synthase pathway. Neurochem. Int. 112, 197–205. 10.1016/j.neuint.2017.07.010 [DOI] [PubMed] [Google Scholar]
Xu S. Z., Zeng F., Boulay G., Grimm C., Harteneck C., Beech D. J. (2005). Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 145 (4), 405–414. 10.1038/sj.bjp.0706197 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yamaguchi H., Matsushita M., Nairn A. C., Kuriyan J. (2001). Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol. Cell 7 (5), 1047–1057. 10.1016/s1097-2765(01)00256-8 [DOI] [PubMed] [Google Scholar]
Yang D., He Y., Muñoz-Planillo R., Liu Q., Núñez G. (2015). Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43 (5), 923–932. 10.1016/j.immuni.2015.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yang J., Chen J., Del Carmen Vitery M., Osei-Owusu J., Chu J., Yu H., et al. (2019). PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel. Science 364 (6438), 395–399. 10.1126/science.aav9739 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yang T., Zhang A., Honeggar M., Kohan D. E., Mizel D., Sanders K., et al. (2005). Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin. J. Biol. Chem. 280 (41), 34966–34973. 10.1074/jbc.M502430200 [DOI] [PubMed] [Google Scholar]
Yang W., Manna P. T., Zou J., Luo J., Beech D. J., Sivaprasadarao A., et al. (2011). Zinc inactivates melastatin transient receptor potential 2 channels via the outer pore. J. Biol. Chem. 286 (27), 23789–23798. 10.1074/jbc.M111.247478 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yang W., Zou J., Xia R., Vaal M. L., Seymour V. A., Luo J., et al. (2010). State-dependent inhibition of TRPM2 channel by acidic pH. J. Biol. Chem. 285 (40), 30411–30418. 10.1074/jbc.M110.139774 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yang X., Li C., Liao X., Liu S., Li X., Hou X., et al. (2023). Paclitaxel induces pyroptosis by inhibiting the volume-sensitive chloride channel leucine-rich repeat-containing 8a in ovarian cancer cells. Oncol. Rep. 49 (6), 115. 10.3892/or.2023.8552 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yazğan Y., Nazıroğlu M. (2021). Involvement of TRPM2 in the neurobiology of experimental migraine: focus on oxidative stress and apoptosis. Mol. Neurobiol. 58 (11), 5581–5601. 10.1007/s12035-021-02503-w [DOI] [PubMed] [Google Scholar]
Ye M., Yang W., Ainscough J. F., Hu X. P., Li X., Sedo A., et al. (2014). TRPM2 channel deficiency prevents delayed cytosolic Zn²⁺ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis. 5 (11), e1541. 10.1038/cddis.2014.494 [DOI] [PMC free article] [PubMed] [Google Scholar]
Ye X., Liu X., Wei W., Yu H., Jin X., Yu J., et al. (2021). Volume-activated chloride channels contribute to lipopolysaccharide plus nigericin-induced pyroptosis in bone marrow-derived macrophages. Biochem. Pharmacol. 193, 114791. 10.1016/j.bcp.2021.114791 [DOI] [PubMed] [Google Scholar]
Yee N. S. (2017). Role of TRPM7 in cancer: potential as molecular biomarker and therapeutic target. Pharm. (Basel) 10 (2), 39. 10.3390/ph10020039 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yee N. S., Kazi A. A., Yee R. K. (2014). Cellular and developmental biology of TRPM7 channel-kinase: implicated roles in cancer. Cells 3 (3), 751–777. 10.3390/cells3030751 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yıldızhan K., Huyut Z., Altındağ F. (2023). Involvement of TRPM2 channel on doxorubicin-induced experimental cardiotoxicity model: protective role of selenium. Biol. Trace Elem. Res. 201 (5), 2458–2469. 10.1007/s12011-022-03377-2 [DOI] [PubMed] [Google Scholar]
Yin Y., Wu M., Hsu A. L., Borschel W. F., Borgnia M. J., Lander G. C., et al. (2019). Visualizing structural transitions of ligand-dependent gating of the TRPM2 channel. Nat. Commun. 10 (1), 3740. 10.1038/s41467-019-11733-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yu H., Zhang Z., Lis A., Penner R., Fleig A. (2013). TRPM7 is regulated by halides through its kinase domain. Cell Mol. Life Sci. 70 (15), 2757–2771. 10.1007/s00018-013-1284-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yu M., Huang C., Huang Y., Wu X., Li X., Li J. (2013). Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts. Inflamm. Res. 62 (11), 961–970. 10.1007/s00011-013-0653-9 [DOI] [PubMed] [Google Scholar]
Yu P., Liu Z., Yu X., Ye P., Liu H., Xue X., et al. (2019). Direct gating of the TRPM2 channel by cADPR via specific interactions with the ADPR binding pocket. Cell Rep. 27 (12), 3684–3695. e3684. 10.1016/j.celrep.2019.05.067 [DOI] [PubMed] [Google Scholar]
Yu W., Jiang L. H., Zheng Y., Hu X., Luo J., Yang W. (2014). Inactivation of TRPM2 channels by extracellular divalent copper. PLoS One 9 (11), e112071. 10.1371/journal.pone.0112071 [DOI] [PMC free article] [PubMed] [Google Scholar]
Yu X., Xie Y., Zhang X., Ma C., Liu L., Zhen W., et al. (2021). Structural and functional basis of the selectivity filter as a gate in human TRPM2 channel. Cell Rep. 37 (7), 110025. 10.1016/j.celrep.2021.110025 [DOI] [PubMed] [Google Scholar]
Yürüker V., Nazıroğlu M., Şenol N. (2015). Reduction in traumatic brain injury-induced oxidative stress, apoptosis, and calcium entry in rat hippocampus by melatonin: possible involvement of TRPM2 channels. Metab. Brain Dis. 30 (1), 223–231. 10.1007/s11011-014-9623-3 [DOI] [PubMed] [Google Scholar]
Zeng B., Chen G. L., Xu S. Z. (2012). Divalent copper is a potent extracellular blocker for TRPM2 channel. Biochem. Biophys. Res. Commun. 424 (2), 279–284. 10.1016/j.bbrc.2012.06.107 [DOI] [PubMed] [Google Scholar]
Zhan H. Q., Li P. F., Li S. Y., Yan F. L., Yang J., Liu R. L., et al. (2014). Influence of lactuside B on the expression of AQP4 and TRPM7 mRNAs in the cerebral cortex after cerebral ischemia injury. Eur. Rev. Med. Pharmacol. Sci. 18 (8), 1151–1157. [PubMed] [Google Scholar]
Zhang H., Yu P., Lin H., Jin Z., Zhao S., Zhang Y., et al. (2021). The discovery of novel ACA derivatives as specific TRPM2 inhibitors that reduce ischemic injury both in vitro and in vivo . J. Med. Chem. 64 (7), 3976–3996. 10.1021/acs.jmedchem.0c02129 [DOI] [PubMed] [Google Scholar]
Zhang W., Chu X., Tong Q., Cheung J. Y., Conrad K., Masker K., et al. (2003). A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J. Biol. Chem. 278 (18), 16222–16229. 10.1074/jbc.M300298200 [DOI] [PubMed] [Google Scholar]
Zhang W., Hirschler-Laszkiewicz I., Tong Q., Conrad K., Sun S. C., Penn L., et al. (2006). TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage. Am. J. Physiol. Cell Physiol. 290 (4), C1146–C1159. 10.1152/ajpcell.00205.2005 [DOI] [PubMed] [Google Scholar]
Zhang W., Tong Q., Conrad K., Wozney J., Cheung J. Y., Miller B. A. (2007). Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1. Am. J. Physiol. Cell Physiol. 292 (5), C1746–C1758. 10.1152/ajpcell.00569.2006 [DOI] [PubMed] [Google Scholar]
Zhang X., Chen Q., Wang Y., Peng W., Cai H. (2014). Effects of curcumin on ion channels and transporters. Front. Physiol. 5, 94. 10.3389/fphys.2014.00094 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zhang Y., Zhou L., Zhang X., Bai J., Shi M., Zhao G. (2012). Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia. Neurol. Sci. 33 (5), 1125–1131. 10.1007/s10072-011-0916-6 [DOI] [PubMed] [Google Scholar]
Zhang Z., Tóth B., Szollosi A., Chen J., Csanády L. (2018). Structure of a TRPM2 channel in complex with Ca²⁺ explains unique gating regulation. Elife 7, e36409. 10.7554/eLife.36409 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zhao R., Afthinos A., Zhu T., Mistriotis P., Li Y., Serra S. A., et al. (2019). Cell sensing and decision-making in confinement: the role of TRPM7 in a tug of war between hydraulic pressure and cross-sectional area. Sci. Adv. 5 (7), eaaw7243. 10.1126/sciadv.aaw7243 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zhao Y. J., Lam C. M., Lee H. C. (2012). The membrane-bound enzyme CD38 exists in two opposing orientations. Sci. Signal 5 (241), ra67. 10.1126/scisignal.2002700 [DOI] [PubMed] [Google Scholar]
Zhao Y., Wang J., Jiang H., Yu Z., Li X., Shi J. (2015). Following OGD/R, annexin 1 nuclear translocation and subsequent induction of apoptosis in neurons are assisted by myosin IIA in a TRPM7 kinase-dependent manner. Mol. Neurobiol. 51 (2), 729–742. 10.1007/s12035-014-8781-y [DOI] [PubMed] [Google Scholar]
Zhelay T., Wieczerzak K. B., Beesetty P., Alter G. M., Matsushita M., Kozak J. A. (2018). Depletion of plasma membrane-associated phosphoinositides mimics inhibition of TRPM7 channels by cytosolic Mg²⁺, spermine, and pH. J. Biol. Chem. 293 (47), 18151–18167. 10.1074/jbc.RA118.004066 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zheng Q., Zhu T., Hu H., Zhao Y., Ying Y., Luo X., et al. (2020). TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice. Brain Res. Bull. 155, 48–60. 10.1016/j.brainresbull.2019.11.018 [DOI] [PubMed] [Google Scholar]
Zhong Z., Zhai Y., Liang S., Mori Y., Han R., Sutterwala F. S., et al. (2013). TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun. 4, 1611. 10.1038/ncomms2608 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zierler S., Yao G., Zhang Z., Kuo W. C., Pörzgen P., Penner R., et al. (2011). Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J. Biol. Chem. 286 (45), 39328–39335. 10.1074/jbc.M111.264341 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zocchi E., Franco L., Guida L., Benatti U., Bargellesi A., Malavasi F., et al. (1993). A single protein immunologically identified as CD38 displays NAD⁺ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem. Biophys. Res. Commun. 196 (3), 1459–1465. 10.1006/bbrc.1993.2416 [DOI] [PubMed] [Google Scholar]
Zong P., Feng J., Yue Z., Li Y., Wu G., Sun B., et al. (2022a). Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury. Neuron 110 (12), 1944–1958.e8. e1948. 10.1016/j.neuron.2022.03.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zong P., Feng J., Yue Z., Yu A. S., Vacher J., Jellison E. R., et al. (2022b). TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages. Nat. Cardiovasc Res. 1 (4), 344–360. 10.1038/s44161-022-00027-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
Zou J., Ainscough J. F., Yang W., Sedo A., Yu S. P., Mei Z. Z., et al. (2013). A differential role of macrophage TRPM2 channels in Ca²⁺ signaling and cell death in early responses to H₂O₂. Am. J. Physiol. Cell Physiol. 305 (1), C61–C69. 10.1152/ajpcell.00390.2012 [DOI] [PubMed] [Google Scholar]
Zubcevic L. (2020). TRP channels, conformational flexibility, and the lipid membrane. J. Membr. Biol. 253 (4), 299–308. 10.1007/s00232-020-00127-0 [DOI] [PubMed] [Google Scholar]

[B1] Akyuva Y., Nazıroğlu M. (2023). Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells. Chem. Biol. Interact. 369, 110261. 10.1016/j.cbi.2022.110261 [DOI] [PubMed] [Google Scholar]

[B2] Aarts M., Iihara K., Wei W. L., Xiong Z. G., Arundine M., Cerwinski W., et al. (2003). A key role for TRPM7 channels in anoxic neuronal death. Cell 115 (7), 863–877. 10.1016/s0092-8674(03)01017-1 [DOI] [PubMed] [Google Scholar]

[B3] Abiria S. A., Krapivinsky G., Sah R., Santa-Cruz A. G., Chaudhuri D., Zhang J., et al. (2017). TRPM7 senses oxidative stress to release Zn²⁺ from unique intracellular vesicles. Proc. Natl. Acad. Sci. U. S. A. 114 (30), E6079–e6088. 10.1073/pnas.1707380114 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B4] Abumaria N., Li W., Clarkson A. N. (2019). Role of the chanzyme TRPM7 in the nervous system in health and disease. Cell Mol. Life Sci. 76 (17), 3301–3310. 10.1007/s00018-019-03124-2 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B5] Akita T., Okada Y. (2014). Characteristics and roles of the volume-sensitive outwardly rectifying (VSOR) anion channel in the central nervous system. Neuroscience 275, 211–231. 10.1016/j.neuroscience.2014.06.015 [DOI] [PubMed] [Google Scholar]

[B6] Akyuva Y., Nazıroğlu M., Yıldızhan K. (2021). Selenium prevents interferon-gamma induced activation of TRPM2 channel and inhibits inflammation, mitochondrial oxidative stress, and apoptosis in microglia. Metab. Brain Dis. 36 (2), 285–298. 10.1007/s11011-020-00624-0 [DOI] [PubMed] [Google Scholar]

[B7] Alawieyah Syed Mortadza S., Sim J. A., Neubrand V. E., Jiang L. H. (2018). A critical role of TRPM2 channel in Aβ₄₂ -induced microglial activation and generation of tumor necrosis factor-α. Glia 66 (3), 562–575. 10.1002/glia.23265 [DOI] [PubMed] [Google Scholar]

[B8] Alim I., Teves L., Li R., Mori Y., Tymianski M. (2013). Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J. Neurosci. 33 (44), 17264–17277. 10.1523/jneurosci.1729-13.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B9] Aminzadeh M., Roghani M., Sarfallah A., Riazi G. H. (2018). TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease. Int. Immunopharmacol. 54, 78–85. 10.1016/j.intimp.2017.10.024 [DOI] [PubMed] [Google Scholar]

[B10] Badr H., Kozai D., Sakaguchi R., Numata T., Mori Y. (2016). Different contribution of redox-sensitive transient receptor potential channels to acetaminophen-induced death of human hepatoma cell line. Front. Pharmacol. 7, 19. 10.3389/fphar.2016.00019 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B11] Balinas C., Cabanas H., Staines D., Marshall-Gradisnik S. (2019). Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 17 (1), 401. 10.1186/s12967-019-02155-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B12] Bari M. R., Akbar S., Eweida M., Kühn F. J., Gustafsson A. J., Lückhoff A., et al. (2009). H₂O₂-induced Ca²⁺ influx and its inhibition by N-(p-amylcinnamoyl) anthranilic acid in the beta-cells: involvement of TRPM2 channels. J. Cell Mol. Med. 13 (9), 3260–3267. 10.1111/j.1582-4934.2009.00737.x [DOI] [PMC free article] [PubMed] [Google Scholar]

[B13] Barros L. F., Hermosilla T., Castro J. (2001). Necrotic volume increase and the early physiology of necrosis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130 (3), 401–409. 10.1016/s1095-6433(01)00438-x [DOI] [PubMed] [Google Scholar]

[B14] Beck A., Kolisek M., Bagley L. A., Fleig A., Penner R. (2006). Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. Faseb J. 20 (7), 962–964. 10.1096/fj.05-5538fje [DOI] [PubMed] [Google Scholar]

[B15] Beesetty P., Wieczerzak K. B., Gibson J. N., Kaitsuka T., Luu C. T., Matsushita M., et al. (2018). Inactivation of TRPM7 kinase in mice results in enlarged spleens, reduced T-cell proliferation and diminished store-operated calcium entry. Sci. Rep. 8 (1), 3023. 10.1038/s41598-018-21004-w [DOI] [PMC free article] [PubMed] [Google Scholar]

[B16] Belrose J. C., Jackson M. F. (2018). TRPM2: a candidate therapeutic target for treating neurological diseases. Acta Pharmacol. Sin. 39 (5), 722–732. 10.1038/aps.2018.31 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B17] Beltrán-García J., Osca-Verdegal R., Pallardó F. V., Ferreres J., Rodríguez M., Mulet S., et al. (2020). Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants (Basel) 9 (10), 936. 10.3390/antiox9100936 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B18] Bessac B. F., Fleig A. (2007). TRPM7 channel is sensitive to osmotic gradients in human kidney cells. J. Physiol. 582 (3), 1073–1086. 10.1113/jphysiol.2007.130534 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B19] Bezprozvanny I., Tsien R. W. (1995). Voltage-dependent blockade of diverse types of voltage-gated Ca²⁺ channels expressed in Xenopus oocytes by the Ca²⁺ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol. 48 (3), 540–549. [PubMed] [Google Scholar]

[B20] Blenn C., Wyrsch P., Bader J., Bollhalder M., Althaus F. R. (2011). Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca²⁺ fluxes in oxidative cell death. Cell Mol. Life Sci. 68 (8), 1455–1466. 10.1007/s00018-010-0533-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B21] Böhmer C., Wehner F. (2001). The epithelial Na⁺ channel (ENaC) is related to the hypertonicity-induced Na⁺ conductance in rat hepatocytes. FEBS Lett. 494 (1-2), 125–128. 10.1016/s0014-5793(01)02303-1 [DOI] [PubMed] [Google Scholar]

[B22] Bondarava M., Li T., Endl E., Wehner F. (2009). alpha-ENaC is a functional element of the hypertonicity-induced cation channel in HepG2 cells and it mediates proliferation. Pflugers Arch. 458 (4), 675–687. 10.1007/s00424-009-0649-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[B23] Bousova K., Jirku M., Bumba L., Bednarova L., Sulc M., Franek M., et al. (2015). PIP₂ and PIP₃ interact with N-terminus region of TRPM4 channel. Biophys. Chem. 205, 24–32. 10.1016/j.bpc.2015.06.004 [DOI] [PubMed] [Google Scholar]

[B24] Brauchi S., Krapivinsky G., Krapivinsky L., Clapham D. E. (2008). TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 105 (24), 8304–8308. 10.1073/pnas.0800881105 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B25] Broertjes J., Klarenbeek J., Habani Y., Langeslag M., Jalink K. (2019). TRPM7 residue S1269 mediates cAMP dependence of Ca²⁺ influx. PLoS One 14 (1), e0209563. 10.1371/journal.pone.0209563 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B26] Browe D. M., Baumgarten C. M. (2004). Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl⁻ current elicited by beta1 integrin stretch in rabbit ventricular myocytes. J. Gen. Physiol. 124 (3), 273–287. 10.1085/jgp.200409040 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B27] Buelow B., Song Y., Scharenberg A. M. (2008). The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes. J. Biol. Chem. 283 (36), 24571–24583. 10.1074/jbc.M802673200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B28] Burg E. D., Remillard C. V., Yuan J. X. (2006). K⁺ channels in apoptosis. J. Membr. Biol. 209 (1), 3–20. 10.1007/s00232-005-0838-4 [DOI] [PubMed] [Google Scholar]

[B29] Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. (1983). A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U. S. A. 80 (14), 4546–4550. 10.1073/pnas.80.14.4546 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B30] Cahalan M. D., Lewis R. S. (1988). Role of potassium and chloride channels in volume regulation by T lymphocytes. Soc. Gen. Physiol. Ser. 43, 281–301. [PubMed] [Google Scholar]

[B31] Cai Z., Jitkaew S., Zhao J., Chiang H. C., Choksi S., Liu J., et al. (2014). Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16 (1), 55–65. 10.1038/ncb2883 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B32] Caiafa P., Guastafierro T., Zampieri M. (2009). Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. Faseb J. 23 (3), 672–678. 10.1096/fj.08-123265 [DOI] [PubMed] [Google Scholar]

[B33] Cala P. M., Mandel L. J., Murphy E. (1986). Volume regulation by amphiuma red blood cells: cytosolic free Ca and alkali metal-H exchange. Am. J. Physiol. 250 (3), C423–C429. 10.1152/ajpcell.1986.250.3.C423 [DOI] [PubMed] [Google Scholar]

[B34] Cao E. (2020). Structural mechanisms of transient receptor potential ion channels. J. Gen. Physiol. 152 (3), e201811998. 10.1085/jgp.201811998 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B35] Cao R., Meng Z., Liu T., Wang G., Qian G., Cao T., et al. (2016). Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget 7 (45), 72941–72960. 10.18632/oncotarget.12146 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B36] Castiglioni S., Cazzaniga A., Trapani V., Cappadone C., Farruggia G., Merolle L., et al. (2015). Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin. Sci. Rep. 5, 16538. 10.1038/srep16538 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B37] Cecchini R., Cecchini A. L. (2020). SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses 143, 110102. 10.1016/j.mehy.2020.110102 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B38] Chan H. C., Nelson D. J. (1992). Chloride-dependent cation conductance activated during cellular shrinkage. Science 257 (5070), 669–671. 10.1126/science.1379742 [DOI] [PubMed] [Google Scholar]

[B39] Che H., Yue J., Tse H. F., Li G. R. (2014). Functional TRPV and TRPM channels in human preadipocytes. Pflugers Arch. 466 (5), 947–959. 10.1007/s00424-013-1355-4 [DOI] [PubMed] [Google Scholar]

[B40] Chen G. L., Zeng B., Eastmond S., Elsenussi S. E., Boa A. N., Xu S. Z. (2012). Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels. Br. J. Pharmacol. 167 (6), 1232–1243. 10.1111/j.1476-5381.2012.02058.x [DOI] [PMC free article] [PubMed] [Google Scholar]

[B41] Chen H. C., Xie J., Zhang Z., Su L. T., Yue L., Runnels L. W. (2010). Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 5 (6), e11161. 10.1371/journal.pone.0011161 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B42] Chen J., Dou Y., Zheng X., Leng T., Lu X., Ouyang Y., et al. (2016). TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma. Tumour Biol. 37 (11), 14721–14731. 10.1007/s13277-016-5317-2 [DOI] [PubMed] [Google Scholar]

[B43] Chen J., Zhang X., Li L., Ma X., Yang C., Liu Z., et al. (2021). Farnesyl pyrophosphate is a new danger signal inducing acute cell death. PLoS Biol. 19 (4), e3001134. 10.1371/journal.pbio.3001134 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B44] Chen S. J., Zhang W., Tong Q., Conrad K., Hirschler-Laszkiewicz I., Bayerl M., et al. (2013). Role of TRPM2 in cell proliferation and susceptibility to oxidative stress. Am. J. Physiol. Cell Physiol. 304 (6), C548–C560. 10.1152/ajpcell.00069.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B45] Chen W., Xu B., Xiao A., Liu L., Fang X., Liu R., et al. (2015). TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury. Mol. Brain 8, 11. 10.1186/s13041-015-0102-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B46] Chen X., He W. T., Hu L., Li J., Fang Y., Wang X., et al. (2016). Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 26 (9), 1007–1020. 10.1038/cr.2016.100 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B47] Chen X., Numata T., Li M., Mori Y., Orser B. A., Jackson M. F., et al. (2010). The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations. Mol. Brain 3, 38. 10.1186/1756-6606-3-38 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B48] Choi H., Ettinger N., Rohrbough J., Dikalova A., Nguyen H. N., Lamb F. S. (2016). LRRC8A channels support TNFα-induced superoxide production by Nox1 which is required for receptor endocytosis. Free Radic. Biol. Med. 101, 413–423. 10.1016/j.freeradbiomed.2016.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B49] Choi H., Rohrbough J. C., Nguyen H. N., Dikalova A., Lamb F. S. (2021). Oxidant-resistant LRRC8A/C anion channels support superoxide production by NADPH oxidase 1. J. Physiol. 599 (12), 3013–3036. 10.1113/jp281577 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B50] Chokshi R., Fruasaha P., Kozak J. A. (2012a). 2-aminoethyl diphenyl borinate (2-APB) inhibits TRPM7 channels through an intracellular acidification mechanism. Channels (Austin) 6 (5), 362–369. 10.4161/chan.21628 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B51] Chokshi R., Matsushita M., Kozak J. A. (2012b). Detailed examination of Mg²⁺ and pH sensitivity of human TRPM7 channels. Am. J. Physiol. Cell Physiol. 302 (7), C1004–C1011. 10.1152/ajpcell.00422.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B52] Chokshi R., Matsushita M., Kozak J. A. (2012c). Sensitivity of TRPM7 channels to Mg²⁺ characterized in cell-free patches of Jurkat T lymphocytes. Am. J. Physiol. Cell Physiol. 302 (11), C1642–C1651. 10.1152/ajpcell.00037.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B53] Chubanov V., Mederos y Schnitzler M., Meißner M., Schäfer S., Abstiens K., Hofmann T., et al. (2012). Natural and synthetic modulators of SK (K_ca2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharmacol. 166 (4), 1357–1376. 10.1111/j.1476-5381.2012.01855.x [DOI] [PMC free article] [PubMed] [Google Scholar]

[B54] Çınar R., Nazıroğlu M. (2023). TRPM2 channel inhibition attenuates amyloid β42-induced apoptosis and oxidative stress in the hippocampus of mice. Cell Mol. Neurobiol. 43 (3), 1335–1353. 10.1007/s10571-022-01253-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B55] Clark K., Langeslag M., van Leeuwen B., Ran L., Ryazanov A. G., Figdor C. G., et al. (2006). TRPM7, a novel regulator of actomyosin contractility and cell adhesion. Embo J. 25 (2), 290–301. 10.1038/sj.emboj.7600931 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B56] Clark K., Middelbeek J., Dorovkov M. V., Figdor C. G., Ryazanov A. G., Lasonder E., et al. (2008a). The alpha-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC. FEBS Lett. 582 (20), 2993–2997. 10.1016/j.febslet.2008.07.043 [DOI] [PubMed] [Google Scholar]

[B57] Clark K., Middelbeek J., Lasonder E., Dulyaninova N. G., Morrice N. A., Ryazanov A. G., et al. (2008b). TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation. J. Mol. Biol. 378 (4), 790–803. 10.1016/j.jmb.2008.02.057 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B58] Compan V., Baroja-Mazo A., López-Castejón G., Gomez A. I., Martínez C. M., Angosto D., et al. (2012). Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37 (3), 487–500. 10.1016/j.immuni.2012.06.013 [DOI] [PubMed] [Google Scholar]

[B59] Cook N. L., Vink R., Helps S. C., Manavis J., van den Heuvel C. (2010). Transient receptor potential melastatin 2 expression is increased following experimental traumatic brain injury in rats. J. Mol. Neurosci. 42 (2), 192–199. 10.1007/s12031-010-9347-8 [DOI] [PubMed] [Google Scholar]

[B60] Coombes E., Jiang J., Chu X. P., Inoue K., Seeds J., Branigan D., et al. (2011). Pathophysiologically relevant levels of hydrogen peroxide induce glutamate-independent neurodegeneration that involves activation of transient receptor potential melastatin 7 channels. Antioxid. Redox Signal 14 (10), 1815–1827. 10.1089/ars.2010.3549 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B61] Csanády L., Törocsik B. (2009). Four Ca²⁺ ions activate TRPM2 channels by binding in deep crevices near the pore but intracellularly of the gate. J. Gen. Physiol. 133 (2), 189–203. 10.1085/jgp.200810109 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B62] Daniels M. J., Rivers-Auty J., Schilling T., Spencer N. G., Watremez W., Fasolino V., et al. (2016). Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. Nat. Commun. 7, 12504. 10.1038/ncomms12504 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B63] de Baaij J. H., Hoenderop J. G., Bindels R. J. (2015). Magnesium in man: implications for health and disease. Physiol. Rev. 95 (1), 1–46. 10.1152/physrev.00012.2014 [DOI] [PubMed] [Google Scholar]

[B64] Deason-Towne F., Perraud A. L., Schmitz C. (2012). Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase. Cell Signal 24 (11), 2070–2075. 10.1016/j.cellsig.2012.06.015 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B65] Delgado-Roche L., Mesta F. (2020). Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch. Med. Res. 51 (5), 384–387. 10.1016/j.arcmed.2020.04.019 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B66] Demeuse P., Penner R., Fleig A. (2006). TRPM7 channel is regulated by magnesium nucleotides via its kinase domain. J. Gen. Physiol. 127 (4), 421–434. 10.1085/jgp.200509410 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B67] Desai B. N., Krapivinsky G., Navarro B., Krapivinsky L., Carter B. C., Febvay S., et al. (2012). Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell 22 (6), 1149–1162. 10.1016/j.devcel.2012.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B68] Dhakal S., Lee Y. (2019). Transient receptor potential channels and metabolism. Mol. Cells 42 (8), 569–578. 10.14348/molcells.2019.0007 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B69] Di A., Gao X. P., Qian F., Kawamura T., Han J., Hecquet C., et al. (2011). The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation. Nat. Immunol. 13 (1), 29–34. 10.1038/ni.2171 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B70] Donia A., Bokhari H. (2021). Apoptosis induced by SARS-CoV-2: can we target it? Apoptosis 26 (1-2), 7–8. 10.1007/s10495-021-01656-2 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B71] Dorovkov M. V., Ryazanov A. G. (2004). Phosphorylation of annexin I by TRPM7 channel-kinase. J. Biol. Chem. 279 (49), 50643–50646. 10.1074/jbc.C400441200 [DOI] [PubMed] [Google Scholar]

[B72] Du J., Xie J., Yue L. (2009b). Modulation of TRPM2 by acidic pH and the underlying mechanisms for pH sensitivity. J. Gen. Physiol. 134 (6), 471–488. 10.1085/jgp.200910254 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B73] Du J., Xie J., Yue L. (2009a). Intracellular calcium activates TRPM2 and its alternative spliced isoforms. Proc. Natl. Acad. Sci. U. S. A. 106 (17), 7239–7244. 10.1073/pnas.0811725106 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B74] Du J., Xie J., Zhang Z., Tsujikawa H., Fusco D., Silverman D., et al. (2010). TRPM7-mediated Ca²⁺ signals confer fibrogenesis in human atrial fibrillation. Circ. Res. 106 (5), 992–1003. 10.1161/circresaha.109.206771 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B75] Duan J., Li Z., Li J., Hulse R. E., Santa-Cruz A., Valinsky W. C., et al. (2018). Structure of the mammalian TRPM7, a magnesium channel required during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 115 (35), E8201–e8210. 10.1073/pnas.1810719115 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B76] Ehrlich W., Gahan J. M., Rentzsch F., Kühn F. J. P. (2022). TRPM2 causes sensitization to oxidative stress but attenuates high-temperature injury in the sea anemone Nematostella vectensis . J. Exp. Biol. 225 (6), jeb243717. 10.1242/jeb.243717 [DOI] [PubMed] [Google Scholar]

[B77] Elizondo M. R., Arduini B. L., Paulsen J., MacDonald E. L., Sabel J. L., Henion P. D., et al. (2005). Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr. Biol. 15 (7), 667–671. 10.1016/j.cub.2005.02.050 [DOI] [PubMed] [Google Scholar]

[B78] Ertuğrul A., Özkaya D., Nazıroğlu M. (2023). Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line. Graefes Arch. Clin. Exp. Ophthalmol. 2023, 1–16. 10.1007/s00417-023-06082-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B79] Esposito E., Cuzzocrea S. (2009). Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation. Front. Biosci. Landmark Ed. 14 (1), 263–296. 10.2741/3244 [DOI] [PubMed] [Google Scholar]

[B80] Fanczal J., Pallagi P., Görög M., Diszházi G., Almássy J., Madácsy T., et al. (2020). TRPM2-mediated extracellular Ca²⁺ entry promotes acinar cell necrosis in biliary acute pancreatitis. J. Physiol. 598 (6), 1253–1270. 10.1113/jp279047 [DOI] [PubMed] [Google Scholar]

[B81] Fang L., Zhan S., Huang C., Cheng X., Lv X., Si H., et al. (2013). TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol. Appl. Pharmacol. 272 (3), 713–725. 10.1016/j.taap.2013.08.009 [DOI] [PubMed] [Google Scholar]

[B82] Faouzi M., Kilch T., Horgen F. D., Fleig A., Penner R. (2017). The TRPM7 channel kinase regulates store-operated calcium entry. J. Physiol. 595 (10), 3165–3180. 10.1113/jp274006 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B83] Fauzee N. J., Pan J., Wang Y. L. (2010). PARP and PARG inhibitors--new therapeutic targets in cancer treatment. Pathol. Oncol. Res. 16 (4), 469–478. 10.1007/s12253-010-9266-6 [DOI] [PubMed] [Google Scholar]

[B84] Fink S. L., Cookson B. T. (2006). Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 8 (11), 1812–1825. 10.1111/j.1462-5822.2006.00751.x [DOI] [PubMed] [Google Scholar]

[B85] Fleig A., Penner R. (2004). The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol. Sci. 25 (12), 633–639. 10.1016/j.tips.2004.10.004 [DOI] [PubMed] [Google Scholar]

[B86] Fliegert R., Bauche A., Wolf Pérez A. M., Watt J. M., Rozewitz M. D., Winzer R., et al. (2017a). 2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist. Nat. Chem. Biol. 13 (9), 1036–1044. 10.1038/nchembio.2415 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B87] Fliegert R., Riekehr W. M., Guse A. H. (2020). Does cyclic ADP-ribose (cADPR) activate the non-selective cation channel TRPM2? Front. Immunol. 11, 2018. 10.3389/fimmu.2020.02018 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B88] Fliegert R., Watt J. M., Schöbel A., Rozewitz M. D., Moreau C., Kirchberger T., et al. (2017b). Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349. Biochem. J. 474 (13), 2159–2175. 10.1042/bcj20170091 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B89] Fliniaux I., Germain E., Farfariello V., Prevarskaya N. (2018). TRPs and Ca²⁺ in cell death and survival. Cell Calcium 69, 4–18. 10.1016/j.ceca.2017.07.002 [DOI] [PubMed] [Google Scholar]

[B90] Fonfria E., Marshall I. C., Benham C. D., Boyfield I., Brown J. D., Hill K., et al. (2004). TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 143 (1), 186–192. 10.1038/sj.bjp.0705914 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B91] Fonfria E., Marshall I. C., Boyfield I., Skaper S. D., Hughes J. P., Owen D. E., et al. (2005). Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J. Neurochem. 95 (3), 715–723. 10.1111/j.1471-4159.2005.03396.x [DOI] [PubMed] [Google Scholar]

[B92] Franco L., Guida L., Bruzzone S., Zocchi E., Usai C., De Flora A. (1998). The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. Faseb J. 12 (14), 1507–1520. 10.1096/fasebj.12.14.1507 [DOI] [PubMed] [Google Scholar]

[B93] Gao G., Wang W., Tadagavadi R. K., Briley N. E., Love M. I., Miller B. A., et al. (2014). TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J. Clin. Invest. 124 (11), 4989–5001. 10.1172/jci76042 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B94] García-Rodríguez S., Rosal-Vela A., Botta D., Cumba Garcia L. M., Zumaquero E., Prados-Maniviesa V., et al. (2018). CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism. Sci. Rep. 8 (1), 3357. 10.1038/s41598-018-21337-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B95] Gattkowski E., Johnsen A., Bauche A., Möckl F., Kulow F., Garcia Alai M., et al. (2019). Novel CaM-binding motif in its NudT9H domain contributes to temperature sensitivity of TRPM2. Biochim. Biophys. Acta Mol. Cell Res. 1866 (7), 1162–1170. 10.1016/j.bbamcr.2018.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B96] Gelderblom M., Melzer N., Schattling B., Göb E., Hicking G., Arunachalam P., et al. (2014). Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke. Stroke 45 (11), 3395–3402. 10.1161/strokeaha.114.005836 [DOI] [PubMed] [Google Scholar]

[B97] Granger D. N., Kvietys P. R. (2015). Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524–551. 10.1016/j.redox.2015.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B98] Green D. R. (2019). The coming decade of cell death research: five riddles. Cell 177 (5), 1094–1107. 10.1016/j.cell.2019.04.024 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B99] Green J. P., Yu S., Martín-Sánchez F., Pelegrin P., Lopez-Castejon G., Lawrence C. B., et al. (2018). Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc. Natl. Acad. Sci. U. S. A. 115 (40), E9371–e9380. 10.1073/pnas.1812744115 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B100] Grinstein S., Dupre A., Rothstein A. (1982). Volume regulation by human lymphocytes. Role of calcium. J. Gen. Physiol. 79 (5), 849–868. 10.1085/jgp.79.5.849 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B101] Grubisha O., Rafty L. A., Takanishi C. L., Xu X., Tong L., Perraud A. L., et al. (2006). Metabolite of SIR2 reaction modulates TRPM2 ion channel. J. Biol. Chem. 281 (20), 14057–14065. 10.1074/jbc.M513741200 [DOI] [PubMed] [Google Scholar]

[B102] Guan Z., Chen X., Fang S., Ji Y., Gao Z., Zheng Y. (2021). CCT128930 is a novel and potent antagonist of TRPM7 channel. Biochem. Biophys. Res. Commun. 560, 132–138. 10.1016/j.bbrc.2021.04.119 [DOI] [PubMed] [Google Scholar]

[B103] Guida L., Franco L., Bruzzone S., Sturla L., Zocchi E., Basile G., et al. (2004). Concentrative influx of functionally active cyclic ADP-ribose in dimethyl sulfoxide-differentiated HL-60 cells. J. Biol. Chem. 279 (21), 22066–22075. 10.1074/jbc.M314137200 [DOI] [PubMed] [Google Scholar]

[B104] Guinamard R., Simard C., Del Negro C. (2013). Flufenamic acid as an ion channel modulator. Pharmacol. Ther. 138 (2), 272–284. 10.1016/j.pharmthera.2013.01.012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B105] Güzel M., Nazıroğlu M., Akpınar O., Çınar R. (2021). Interferon gamma-mediated oxidative stress induces apoptosis, neuroinflammation, zinc ion influx, and TRPM2 channel activation in neuronal cell line: modulator role of curcumin. Inflammation 44 (5), 1878–1894. 10.1007/s10753-021-01465-4 [DOI] [PubMed] [Google Scholar]

[B106] Gwanyanya A., Sipido K. R., Vereecke J., Mubagwa K. (2006). ATP and PIP₂ dependence of the magnesium-inhibited, TRPM7-like cation channel in cardiac myocytes. Am. J. Physiol. Cell Physiol. 291 (4), C627–C635. 10.1152/ajpcell.00074.2006 [DOI] [PubMed] [Google Scholar]

[B107] Hanano T., Hara Y., Shi J., Morita H., Umebayashi C., Mori E., et al. (2004). Involvement of TRPM7 in cell growth as a spontaneously activated Ca²⁺ entry pathway in human retinoblastoma cells. J. Pharmacol. Sci. 95 (4), 403–419. 10.1254/jphs.fp0040273 [DOI] [PubMed] [Google Scholar]

[B108] Hantute-Ghesquier A., Haustrate A., Prevarskaya N., Lehen'kyi V. (2018). TRPM family channels in cancer. Pharm. (Basel) 11 (2), 58. 10.3390/ph11020058 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B109] Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T., et al. (2002). LTRPC2 Ca²⁺-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 9 (1), 163–173. 10.1016/s1097-2765(01)00438-5 [DOI] [PubMed] [Google Scholar]

[B110] Hasegawa Y., Shimizu T., Takahashi N., Okada Y. (2012). The apoptotic volume decrease is an upstream event of MAP kinase activation during Staurosporine-induced apoptosis in HeLa cells. Int. J. Mol. Sci. 13 (7), 9363–9379. 10.3390/ijms13079363 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B111] Hazama A., Okada Y. (1990a). Biphasic rises in cytosolic free Ca²⁺ in association with activation of K⁺ and Cl⁻ conductance during the regulatory volume decrease in cultured human epithelial cells. Pflugers Arch. 416 (6), 710–714. 10.1007/bf00370619 [DOI] [PubMed] [Google Scholar]

[B112] Hazama A., Okada Y. (1988). Ca²⁺ sensitivity of volume-regulatory K⁺ and Cl⁻ channels in cultured human epithelial cells. J. Physiol. 402, 687–702. 10.1113/jphysiol.1988.sp017229 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B113] Hazama A., Okada Y. (1990b). Involvement of Ca²⁺-induced Ca²⁺ release in the volume regulation of human epithelial cells exposed to a hypotonic medium. Biochem. Biophys. Res. Commun. 167 (1), 287–293. 10.1016/0006-291x(90)91763-i [DOI] [PubMed] [Google Scholar]

[B114] He Y., Yao G., Savoia C., Touyz R. M. (2005). Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ. Res. 96 (2), 207–215. 10.1161/01.RES.0000152967.88472.3e [DOI] [PubMed] [Google Scholar]

[B115] Hecquet C. M., Zhang M., Mittal M., Vogel S. M., Di A., Gao X., et al. (2014). Cooperative interaction of trp melastatin channel transient receptor potential (TRPM2) with its splice variant TRPM2 short variant is essential for endothelial cell apoptosis. Circ. Res. 114 (3), 469–479. 10.1161/circresaha.114.302414 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B116] Heiner I., Eisfeld J., Lückhoff A. (2003). Role and regulation of TRP channels in neutrophil granulocytes. Cell Calcium 33 (5-6), 533–540. 10.1016/s0143-4160(03)00058-7 [DOI] [PubMed] [Google Scholar]

[B117] Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., et al. (1994). A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91 (8), 3270–3274. 10.1073/pnas.91.8.3270 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B118] Hermosura M. C., Monteilh-Zoller M. K., Scharenberg A. M., Penner R., Fleig A. (2002). Dissociation of the store-operated calcium current I(CRAC) and the Mg-nucleotide-regulated metal ion current MagNuM. J. Physiol. 539 (2), 445–458. 10.1113/jphysiol.2001.013361 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B119] Higashida H., Yuhi T., Akther S., Amina S., Zhong J., Liang M., et al. (2018). Oxytocin release via activation of TRPM2 and CD38 in the hypothalamus during hyperthermia in mice: implication for autism spectrum disorder. Neurochem. Int. 119, 42–48. 10.1016/j.neuint.2017.07.009 [DOI] [PubMed] [Google Scholar]

[B120] Hill K., Benham C. D., McNulty S., Randall A. D. (2004a). Flufenamic acid is a pH-dependent antagonist of TRPM2 channels. Neuropharmacology 47 (3), 450–460. 10.1016/j.neuropharm.2004.04.014 [DOI] [PubMed] [Google Scholar]

[B121] Hill K., McNulty S., Randall A. D. (2004b). Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedeb. Arch. Pharmacol. 370 (4), 227–237. 10.1007/s00210-004-0981-y [DOI] [PubMed] [Google Scholar]

[B122] Hiroi T., Wajima T., Negoro T., Ishii M., Nakano Y., Kiuchi Y., et al. (2013). Neutrophil TRPM2 channels are implicated in the exacerbation of myocardial ischaemia/reperfusion injury. Cardiovasc Res. 97 (2), 271–281. 10.1093/cvr/cvs332 [DOI] [PubMed] [Google Scholar]

[B123] Hirschler-Laszkiewicz I., Festa F., Huang S., Moldovan G. L., Nicolae C., Dhoonmoon A., et al. (2022). The human ion channel TRPM2 modulates cell survival in neuroblastoma through E2F1 and FOXM1. Sci. Rep. 12 (1), 6311. 10.1038/s41598-022-10385-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B124] Hoffman N. E., Miller B. A., Wang J., Elrod J. W., Rajan S., Gao E., et al. (2015). Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenance. Am. J. Physiol. Heart Circ. Physiol. 308 (6), H637–H650. 10.1152/ajpheart.00720.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B125] Hoffmann E. K., Lambert I. H., Pedersen S. F. (2009). Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89 (1), 193–277. 10.1152/physrev.00037.2007 [DOI] [PubMed] [Google Scholar]

[B126] Hofmann T., Schäfer S., Linseisen M., Sytik L., Gudermann T., Chubanov V. (2014). Activation of TRPM7 channels by small molecules under physiological conditions. Pflugers Arch. 466 (12), 2177–2189. 10.1007/s00424-014-1488-0 [DOI] [PubMed] [Google Scholar]

[B127] Hu H. Z., Gu Q., Wang C., Colton C. K., Tang J., Kinoshita-Kawada M., et al. (2004). 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem. 279 (34), 35741–35748. 10.1074/jbc.M404164200 [DOI] [PubMed] [Google Scholar]

[B128] Huang Y., Fliegert R., Guse A. H., Lü W., Du J. (2020). A structural overview of the ion channels of the TRPM family. Cell Calcium 85, 102111. 10.1016/j.ceca.2019.102111 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B129] Huang Y., Leng T. D., Inoue K., Yang T., Liu M., Horgen F. D., et al. (2018a). TRPM7 channels play a role in high glucose-induced endoplasmic reticulum stress and neuronal cell apoptosis. J. Biol. Chem. 293 (37), 14393–14406. 10.1074/jbc.RA117.001032 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B130] Huang Y., Roth B., Lü W., Du J. (2019). Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel. Elife 8, e50175. 10.7554/eLife.50175 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B131] Huang Y., Winkler P. A., Sun W., Lü W., Du J. (2018b). Architecture of the TRPM2 channel and its activation mechanism by ADP-ribose and calcium. Nature 562 (7725), 145–149. 10.1038/s41586-018-0558-4 [DOI] [PubMed] [Google Scholar]

[B132] Huffer K. E., Aleksandrova A. A., Jara-Oseguera A., Forrest L. R., Swartz K. J. (2020). Global alignment and assessment of TRP channel transmembrane domain structures to explore functional mechanisms. Elife 9, e58660. 10.7554/eLife.58660 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B133] Ikari A., Atomi K., Yamazaki Y., Sakai H., Hayashi H., Yamaguchi M., et al. (2013). Hyperosmolarity-induced up-regulation of claudin-4 mediated by NADPH oxidase-dependent H₂O₂ production and Sp1/c-Jun cooperation. Biochim. Biophys. Acta 1833 (12), 2617–2627. 10.1016/j.bbamcr.2013.06.016 [DOI] [PubMed] [Google Scholar]

[B134] Inoue H., Murayama T., Kobayashi T., Konishi M., Yokoyama U. (2021). The zinc-binding motif of TRPM7 acts as an oxidative stress sensor to regulate its channel activity. J. Gen. Physiol. 153 (6), e202012708. 10.1085/jgp.202012708 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B135] Inoue H., Murayama T., Tashiro M., Sakurai T., Konishi M. (2014). Mg²⁺- and ATP-dependent inhibition of transient receptor potential melastatin 7 by oxidative stress. Free Radic. Biol. Med. 72, 257–266. 10.1016/j.freeradbiomed.2014.04.015 [DOI] [PubMed] [Google Scholar]

[B136] Inoue K., Branigan D., Xiong Z. G. (2010). Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J. Biol. Chem. 285 (10), 7430–7439. 10.1074/jbc.M109.040485 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B137] Iordanov I., Mihályi C., Tóth B., Csanády L. (2016). The proposed channel-enzyme transient receptor potential melastatin 2 does not possess ADP ribose hydrolase activity. Elife 5, e17600. 10.7554/eLife.17600 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B138] Iordanov I., Tóth B., Szollosi A., Csanády L. (2019). Enzyme activity and selectivity filter stability of ancient TRPM2 channels were simultaneously lost in early vertebrates. Elife 8, e44556. 10.7554/eLife.44556 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B139] Ishii M., Shimizu S., Hara Y., Hagiwara T., Miyazaki A., Mori Y., et al. (2006). Intracellular-produced hydroxyl radical mediates H₂O₂-induced Ca²⁺ influx and cell death in rat beta-cell line RIN-5F. Cell Calcium 39 (6), 487–494. 10.1016/j.ceca.2006.01.013 [DOI] [PubMed] [Google Scholar]

[B140] Jäger H., Dreker T., Buck A., Giehl K., Gress T., Grissmer S. (2004). Blockage of intermediate-conductance Ca²⁺-activated K⁺ channels inhibit human pancreatic cancer cell growth in vitro . Mol. Pharmacol. 65 (3), 630–638. 10.1124/mol.65.3.630 [DOI] [PubMed] [Google Scholar]

[B141] Jansen C., Sahni J., Suzuki S., Horgen F. D., Penner R., Fleig A. (2016). The coiled-coil domain of zebrafish TRPM7 regulates Mg·nucleotide sensitivity. Sci. Rep. 6, 33459. 10.1038/srep33459 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B142] Jensen B. S., Strobaek D., Christophersen P., Jorgensen T. D., Hansen C., Silahtaroglu A., et al. (1998). Characterization of the cloned human intermediate-conductance Ca²⁺-activated K⁺ channel. Am. J. Physiol. 275 (3), C848–C856. 10.1152/ajpcell.1998.275.3.C848 [DOI] [PubMed] [Google Scholar]

[B143] Jia J., Verma S., Nakayama S., Quillinan N., Grafe M. R., Hurn P. D., et al. (2011). Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J. Cereb. Blood Flow. Metab. 31 (11), 2160–2168. 10.1038/jcbfm.2011.77 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B144] Jiang H., Sha S. H., Forge A., Schacht J. (2006). Caspase-independent pathways of hair cell death induced by kanamycin in vivo . Cell Death Differ. 13 (1), 20–30. 10.1038/sj.cdd.4401706 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B145] Jiang H., Tian S. L., Zeng Y., Li L. L., Shi J. (2008). TrkA pathway(s) is involved in regulation of TRPM7 expression in hippocampal neurons subjected to ischemic-reperfusion and oxygen-glucose deprivation. Brain Res. Bull. 76 (1-2), 124–130. 10.1016/j.brainresbull.2008.01.013 [DOI] [PubMed] [Google Scholar]

[B146] Jiang J., Li M., Yue L. (2005). Potentiation of TRPM7 inward currents by protons. J. Gen. Physiol. 126 (2), 137–150. 10.1085/jgp.200409185 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B147] Jiang M., Qi L., Li L., Li Y. (2020). The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 6, 112. 10.1038/s41420-020-00349-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B148] Jiang Q., Gao Y., Wang C., Tao R., Wu Y., Zhan K., et al. (2017). Nitration of TRPM2 as a molecular switch induces autophagy during brain pericyte injury. Antioxid. Redox Signal 27 (16), 1297–1316. 10.1089/ars.2016.6873 [DOI] [PubMed] [Google Scholar]

[B149] Jouan-Lanhouet S., Arshad M. I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., et al. (2012). TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 19 (12), 2003–2014. 10.1038/cdd.2012.90 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B150] Kuras Z., Yun Y. H., Chimote A. A., Neumeier L., Conforti L. (2012). KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells. PLoS One 7 (8), e43859. 10.1371/journal.pone.0043859 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B151] Kamermans A., Planting K. E., Jalink K., van Horssen J., de Vries H. E. (2019). Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production. Glia 67 (1), 68–77. 10.1002/glia.23526 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B152] Kaneko S., Kawakami S., Hara Y., Wakamori M., Itoh E., Minami T., et al. (2006). A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J. Pharmacol. Sci. 101 (1), 66–76. 10.1254/jphs.fp0060128 [DOI] [PubMed] [Google Scholar]

[B153] Kashio M., Sokabe T., Shintaku K., Uematsu T., Fukuta N., Kobayashi N., et al. (2012). Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions. Proc. Natl. Acad. Sci. U. S. A. 109 (17), 6745–6750. 10.1073/pnas.1114193109 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B154] Kashio M., Tominaga M. (2017). The TRPM2 channel: A thermo-sensitive metabolic sensor. Channels (Austin) 11 (5), 426–433. 10.1080/19336950.2017.1344801 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B155] Kerschbaum H. H., Kozak J. A., Cahalan M. D. (2003). Polyvalent cations as permeant probes of MIC and TRPM7 pores. Biophys. J. 84 (4), 2293–2305. 10.1016/s0006-3495(03)75035-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B156] Kheradpezhouh E., Barritt G. J., Rychkov G. Y. (2016). Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 7, 1–7. 10.1016/j.redox.2015.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B157] Kheradpezhouh E., Ma L., Morphett A., Barritt G. J., Rychkov G. Y. (2014). TRPM2 channels mediate acetaminophen-induced liver damage. Proc. Natl. Acad. Sci. U. S. A. 111 (8), 3176–3181. 10.1073/pnas.1322657111 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B158] Kim B. J. (2013). Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J. Ginseng Res. 37 (2), 201–209. 10.5142/jgr.2013.37.201 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B159] Kim U. H., Han M. K., Park B. H., Kim H. R., An N. H. (1993). Function of NAD glycohydrolase in ADP-ribose uptake from NAD by human erythrocytes. Biochim. Biophys. Acta 1178 (2), 121–126. 10.1016/0167-4889(93)90001-6 [DOI] [PubMed] [Google Scholar]

[B160] Koh D. W., Powell D. P., Blake S. D., Hoffman J. L., Hopkins M. M., Feng X. (2015). Enhanced cytotoxicity in triple-negative and estrogen receptor-positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel. Oncol. Rep. 34 (3), 1589–1598. 10.3892/or.2015.4131 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B161] Koike C., Numata T., Ueda H., Mori Y., Furukawa T. (2010). TRPM1: a vertebrate TRP channel responsible for retinal on bipolar function. Cell Calcium 48 (2-3), 95–101. 10.1016/j.ceca.2010.08.004 [DOI] [PubMed] [Google Scholar]

[B162] Kolbrink B., Riebeling T., Kunzendorf U., Krautwald S. (2020). Plasma membrane pores drive inflammatory cell death. Front. Cell Dev. Biol. 8, 817. 10.3389/fcell.2020.00817 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B163] Kolisek M., Beck A., Fleig A., Penner R. (2005). Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol. Cell 18 (1), 61–69. 10.1016/j.molcel.2005.02.033 [DOI] [PubMed] [Google Scholar]

[B164] Kollewe A., Chubanov V., Tseung F. T., Correia L., Schmidt E., Rössig A., et al. (2021). The molecular appearance of native TRPM7 channel complexes identified by high-resolution proteomics. Elife 10, e68544. 10.7554/eLife.68544 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B165] Koos B., Christmann J., Plettenberg S., Käding D., Becker J., Keteku M., et al. (2018). Hypertonicity-induced cation channels in HepG2 cells: architecture and role in proliferation vs. apoptosis. J. Physiol. 596 (7), 1227–1241. 10.1113/jp275827 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B166] Kouhpayeh S., Shariati L., Boshtam M., Rahimmanesh I., Mirian M., Esmaeili Y., et al. (2021). The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy. Int. J. Mol. Sci. 22 (11), 5438. 10.3390/ijms22115438 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B167] Kozak J. A., Cahalan M. D. (2003). MIC channels are inhibited by internal divalent cations but not ATP. Biophys. J. 84 (2), 922–927. 10.1016/s0006-3495(03)74909-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B168] Kozak J. A., Kerschbaum H. H., Cahalan M. D. (2002). Distinct properties of CRAC and MIC channels in RBL cells. J. Gen. Physiol. 120 (2), 221–235. 10.1085/jgp.20028601 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B169] Kozak J. A., Matsushita M., Nairn A. C., Cahalan M. D. (2005). Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J. Gen. Physiol. 126 (5), 499–514. 10.1085/jgp.200509324 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B170] Kraft R., Grimm C., Frenzel H., Harteneck C. (2006). Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br. J. Pharmacol. 148 (3), 264–273. 10.1038/sj.bjp.0706739 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B171] Kraft R., Grimm C., Grosse K., Hoffmann A., Sauerbruch S., Kettenmann H., et al. (2004). Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am. J. Physiol. Cell Physiol. 286 (1), C129–C137. 10.1152/ajpcell.00331.2003 [DOI] [PubMed] [Google Scholar]

[B172] Krapivinsky G., Mochida S., Krapivinsky L., Cibulsky S. M., Clapham D. E. (2006). The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 52 (3), 485–496. 10.1016/j.neuron.2006.09.033 [DOI] [PubMed] [Google Scholar]

[B173] Kubo M., Okada Y. (1992). Volume-regulatory Cl⁻ channel currents in cultured human epithelial cells. J. Physiol. 456, 351–371. 10.1113/jphysiol.1992.sp019340 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B174] Kühn F. J., Kühn C., Winking M., Hoffmann D. C., Lückhoff A. (2016). ADP-ribose activates the TRPM2 channel from the sea anemone nematostella vectensis independently of the NUDT9H domain. PLoS One 11 (6), e0158060. 10.1371/journal.pone.0158060 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B175] Lang F., Busch G. L., Ritter M., Völkl H., Waldegger S., Gulbins E., et al. (1998). Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78 (1), 247–306. 10.1152/physrev.1998.78.1.247 [DOI] [PubMed] [Google Scholar]

[B176] Lange I., Penner R., Fleig A., Beck A. (2008). Synergistic regulation of endogenous TRPM2 channels by adenine dinucleotides in primary human neutrophils. Cell Calcium 44 (6), 604–615. 10.1016/j.ceca.2008.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B177] Lange I., Yamamoto S., Partida-Sanchez S., Mori Y., Fleig A., Penner R. (2009). TRPM2 functions as a lysosomal Ca²⁺-release channel in beta cells. Sci. Signal 2 (71), ra23. 10.1126/scisignal.2000278 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B178] Langeslag M., Clark K., Moolenaar W. H., van Leeuwen F. N., Jalink K. (2007). Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J. Biol. Chem. 282 (1), 232–239. 10.1074/jbc.M605300200 [DOI] [PubMed] [Google Scholar]

[B179] Leist M., Single B., Castoldi A. F., Kühnle S., Nicotera P. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185 (8), 1481–1486. 10.1084/jem.185.8.1481 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B180] Leng T. D., Lin J., Sun H. W., Zeng Z., O'Bryant Z., Inoue K., et al. (2015). Local anesthetic lidocaine inhibits TRPM7 current and TRPM7-mediated zinc toxicity. CNS Neurosci. Ther. 21 (1), 32–39. 10.1111/cns.12318 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B181] Li M., Du J., Jiang J., Ratzan W., Su L. T., Runnels L. W., et al. (2007). Molecular determinants of Mg²⁺ and Ca²⁺ permeability and pH sensitivity in TRPM6 and TRPM7. J. Biol. Chem. 282 (35), 25817–25830. 10.1074/jbc.M608972200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B182] Li M., Jiang J., Yue L. (2006). Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J. Gen. Physiol. 127 (5), 525–537. 10.1085/jgp.200609502 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B183] Li Q., Lei X., Liu H., Feng S., Cai C., Hu Y., et al. (2022). Transient receptor potential melastatin 7 aggravates necrotizing enterocolitis by promoting an inflammatory response in children. Transl. Pediatr. 11 (12), 2030–2039. 10.21037/tp-22-633 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B184] Li S., Zhang Y., Guan Z., Li H., Ye M., Chen X., et al. (2020). SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct. Target Ther. 5 (1), 235. 10.1038/s41392-020-00334-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B185] Li X., Jiang L. H. (2018). Multiple molecular mechanisms form a positive feedback loop driving amyloid β42 peptide-induced neurotoxicity via activation of the TRPM2 channel in hippocampal neurons. Cell Death Dis. 9 (2), 195. 10.1038/s41419-018-0270-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B186] Li X., Yang W., Jiang L. H. (2017). Alteration in intracellular Zn²⁺ homeostasis as a result of TRPM2 channel activation contributes to ROS-induced hippocampal neuronal death. Front. Mol. Neurosci. 10, 414. 10.3389/fnmol.2017.00414 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B187] Liu H. W., Gong L. N., Lai K., Yu X. F., Liu Z. Q., Li M. X., et al. (2023). Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage. Neuron 111 (10), 1609–1625.e6. e1606. 10.1016/j.neuron.2023.02.022 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B188] Liu J., Zhao Y. J., Li W. H., Hou Y. N., Li T., Zhao Z. Y., et al. (2017). Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels. Proc. Natl. Acad. Sci. U. S. A. 114 (31), 8283–8288. 10.1073/pnas.1703718114 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B189] Liu Y., Mikrani R., He Y., Faran Ashraf Baig M. M., Abbas M., Naveed M., et al. (2020). TRPM8 channels: A review of distribution and clinical role. Eur. J. Pharmacol. 882, 173312. 10.1016/j.ejphar.2020.173312 [DOI] [PubMed] [Google Scholar]

[B190] Liu Y. S., Liu Y. A., Huang C. J., Yen M. H., Tseng C. T., Chien S., et al. (2015). Mechanosensitive TRPM7 mediates shear stress and modulates osteogenic differentiation of mesenchymal stromal cells through Osterix pathway. Sci. Rep. 5, 16522. 10.1038/srep16522 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B191] Luo X., Li M., Zhan K., Yang W., Zhang L., Wang K., et al. (2018). Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chem. Biol. Drug Des. 91 (2), 552–566. 10.1111/cbdd.13119 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B192] Ma G., Yang Y., Chen Y., Wei X., Ding J., Zhou R. P., et al. (2021). Blockade of TRPM7 alleviates chondrocyte apoptosis and articular cartilage damage in the adjuvant arthritis rat model through regulation of the indian hedgehog signaling pathway. Front. Pharmacol. 12, 655551. 10.3389/fphar.2021.655551 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B193] Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. (2000). Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. U. S. A. 97 (17), 9487–9492. 10.1073/pnas.140216197 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B194] Maeno E., Shimizu T., Okada Y. (2006a). Normotonic cell shrinkage induces apoptosis under extracellular low Cl conditions in human lymphoid and epithelial cells. Acta Physiol. (Oxf) 187 (1-2), 217–222. 10.1111/j.1748-1716.2006.01554.x [DOI] [PubMed] [Google Scholar]

[B195] Maeno E., Takahashi N., Okada Y. (2006b). Dysfunction of regulatory volume increase is a key component of apoptosis. FEBS Lett. 580 (27), 6513–6517. 10.1016/j.febslet.2006.10.074 [DOI] [PubMed] [Google Scholar]

[B196] Mahbub L., Kozlov G., Zong P., Lee E. L., Tetteh S., Nethramangalath T., et al. (2023). Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15. Elife 12, e86129. 10.7554/eLife.86129 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B197] Malko P., Jiang L. H. (2020). TRPM2 channel-mediated cell death: an important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol. 37, 101755. 10.1016/j.redox.2020.101755 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B198] Manna P. T., Munsey T. S., Abuarab N., Li F., Asipu A., Howell G., et al. (2015). TRPM2-mediated intracellular Zn²⁺ release triggers pancreatic β-cell death. Biochem. J. 466 (3), 537–546. 10.1042/bj20140747 [DOI] [PubMed] [Google Scholar]

[B199] Matsushita M., Kozak J. A., Shimizu Y., McLachlin D. T., Yamaguchi H., Wei F. Y., et al. (2005). Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J. Biol. Chem. 280 (21), 20793–20803. 10.1074/jbc.M413671200 [DOI] [PubMed] [Google Scholar]

[B200] McHugh D., Flemming R., Xu S. Z., Perraud A. L., Beech D. J. (2003). Critical intracellular Ca²⁺ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation. J. Biol. Chem. 278 (13), 11002–11006. 10.1074/jbc.M210810200 [DOI] [PubMed] [Google Scholar]

[B201] Mei Z. Z., Xia R., Beech D. J., Jiang L. H. (2006). Intracellular coiled-coil domain engaged in subunit interaction and assembly of melastatin-related transient receptor potential channel 2. J. Biol. Chem. 281 (50), 38748–38756. 10.1074/jbc.M607591200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B202] Miller B. A., Hoffman N. E., Merali S., Zhang X. Q., Wang J., Rajan S., et al. (2014). TRPM2 channels protect against cardiac ischemia-reperfusion injury: role of mitochondria. J. Biol. Chem. 289 (11), 7615–7629. 10.1074/jbc.M113.533851 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B203] Miller B. A., Wang J., Hirschler-Laszkiewicz I., Gao E., Song J., Zhang X. Q., et al. (2013). The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 304 (7), H1010–H1022. 10.1152/ajpheart.00906.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B204] Mittal M., Urao N., Hecquet C. M., Zhang M., Sudhahar V., Gao X. P., et al. (2015). Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization. Arterioscler. Thromb. Vasc. Biol. 35 (4), 877–887. 10.1161/atvbaha.114.304802 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B205] Mittermeier L., Demirkhanyan L., Stadlbauer B., Breit A., Recordati C., Hilgendorff A., et al. (2019). TRPM7 is the central gatekeeper of intestinal mineral absorption essential for postnatal survival. Proc. Natl. Acad. Sci. U. S. A. 116 (10), 4706–4715. 10.1073/pnas.1810633116 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B206] Monteilh-Zoller M. K., Hermosura M. C., Nadler M. J., Scharenberg A. M., Penner R., Fleig A. (2003). TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121 (1), 49–60. 10.1085/jgp.20028740 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B207] Moreau C., Kirchberger T., Swarbrick J. M., Bartlett S. J., Fliegert R., Yorgan T., et al. (2013). Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists. J. Med. Chem. 56 (24), 10079–10102. 10.1021/jm401497a [DOI] [PMC free article] [PubMed] [Google Scholar]

[B208] Mortadza S. S., Sim J. A., Stacey M., Jiang L. H. (2017). Signalling mechanisms mediating Zn²⁺-induced TRPM2 channel activation and cell death in microglial cells. Sci. Rep. 7, 45032. 10.1038/srep45032 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B209] Nadezhdin K. D., Correia L., Narangoda C., Patel D. S., Neuberger A., Gudermann T., et al. (2023). Structural mechanisms of TRPM7 activation and inhibition. Nat. Commun. 14 (1), 2639. 10.1038/s41467-023-38362-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B210] Nadler M. J., Hermosura M. C., Inabe K., Perraud A. L., Zhu Q., Stokes A. J., et al. (2001). LTRPC7 is a Mg·ATP-regulated divalent cation channel required for cell viability. Nature 411 (6837), 590–595. 10.1038/35079092 [DOI] [PubMed] [Google Scholar]

[B211] Nadolni W., Zierler S. (2018). The channel-kinase TRPM7 as novel regulator of immune system homeostasis. Cells 7 (8), 109. 10.3390/cells7080109 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B212] Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ito F., et al. (1998). Molecular cloning of a novel putative Ca²⁺ channel protein (TRPC7) highly expressed in brain. Genomics 54 (1), 124–131. 10.1006/geno.1998.5551 [DOI] [PubMed] [Google Scholar]

[B213] Naziroğlu M., Lückhoff A. (2008). A calcium influx pathway regulated separately by oxidative stress and ADP-ribose in TRPM2 channels: single channel events. Neurochem. Res. 33 (7), 1256–1262. 10.1007/s11064-007-9577-5 [DOI] [PubMed] [Google Scholar]

[B214] Naziroğlu M. (2007). New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem. Res. 32 (11), 1990–2001. 10.1007/s11064-007-9386-x [DOI] [PubMed] [Google Scholar]

[B215] Negri S., Faris P., Berra-Romani R., Guerra G., Moccia F. (2019). Endothelial transient receptor potential channels and vascular remodeling: extracellular Ca²⁺ entry for angiogenesis, arteriogenesis and vasculogenesis. Front. Physiol. 10, 1618. 10.3389/fphys.2019.01618 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B216] Ng N. M., Jiang S. P., Lv Z. Q. (2012). Retrovirus-mediated siRNA targeting TRPM7 gene induces apoptosis in RBL-2H3 cells. Eur. Rev. Med. Pharmacol. Sci. 16 (9), 1172–1178. [PubMed] [Google Scholar]

[B217] Nicotera P., Orrenius S. (1998). The role of calcium in apoptosis. Cell Calcium 23 (2-3), 173–180. 10.1016/s0143-4160(98)90116-6 [DOI] [PubMed] [Google Scholar]

[B218] Nilius B., Eggermont J., Voets T., Buyse G., Manolopoulos V., Droogmans G. (1997a). Properties of volume-regulated anion channels in mammalian cells. Prog. Biophys. Mol. Biol. 68 (1), 69–119. 10.1016/s0079-6107(97)00021-7 [DOI] [PubMed] [Google Scholar]

[B219] Nilius B., Prenen J., Kamouchi M., Viana F., Voets T., Droogmans G. (1997b). Inhibition by mibefradil, a novel calcium channel antagonist, of Ca²⁺- and volume-activated Cl⁻ channels in macrovascular endothelial cells. Br. J. Pharmacol. 121 (3), 547–555. 10.1038/sj.bjp.0701140 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B220] Nilius B., Prenen J., Vennekens R., Hoenderop J. G., Bindels R. J., Droogmans G. (2001). Pharmacological modulation of monovalent cation currents through the epithelial Ca²⁺ channel ECaC1. Br. J. Pharmacol. 134 (3), 453–462. 10.1038/sj.bjp.0704272 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B221] Nuñez-Villena F., Becerra A., Echeverría C., Briceño N., Porras O., Armisén R., et al. (2011). Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid. Redox Signal 15 (9), 2425–2438. 10.1089/ars.2010.3825 [DOI] [PubMed] [Google Scholar]

[B222] Nukui M., Shimizu T., Okada Y. (2006). Normotonic cell shrinkage induced by Na⁺ deprivation results in apoptotic cell death in human epithelial HeLa cells. J. Physiol. Sci. 56 (5), 335–339. 10.2170/physiolsci.RP009606 [DOI] [PubMed] [Google Scholar]

[B223] Numata T., Okada Y. (2008a). Molecular determinants of sensitivity and conductivity of human TRPM7 to Mg²⁺ and Ca²⁺ . Channels (Austin) 2 (4), 283–286. 10.4161/chan.2.4.6695 [DOI] [PubMed] [Google Scholar]

[B224] Numata T., Okada Y. (2008b). Proton conductivity through the human TRPM7 channel and its molecular determinants. J. Biol. Chem. 283 (22), 15097–15103. 10.1074/jbc.M709261200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B225] Numata T., Sato K., Christmann J., Marx R., Mori Y., Okada Y., et al. (2012). The ΔC splice-variant of TRPM2 is the hypertonicity-induced cation channel in HeLa cells, and the ecto-enzyme CD38 mediates its activation. J. Physiol. 590 (5), 1121–1138. 10.1113/jphysiol.2011.220947 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B226] Numata T., Sato-Numata K., Hermosura M. C., Mori Y., Okada Y. (2021). TRPM7 is an essential regulator for volume-sensitive outwardly rectifying anion channel. Commun. Biol. 4 (1), 599. 10.1038/s42003-021-02127-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B227] Numata T., Sato-Numata K., Okada Y. (2019). TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells. Physiol. Rep. 7 (13), e14157. 10.14814/phy2.14157 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B228] Numata T., Shimizu T., Okada Y. (2007a). Direct mechano-stress sensitivity of TRPM7 channel. Cell Physiol. Biochem. 19 (1-4), 1–8. 10.1159/000099187 [DOI] [PubMed] [Google Scholar]

[B229] Numata T., Shimizu T., Okada Y. (2007b). TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells. Am. J. Physiol. Cell Physiol. 292 (1), C460–C467. 10.1152/ajpcell.00367.2006 [DOI] [PubMed] [Google Scholar]

[B230] Numata T., Wehner F., Okada Y. (2007c). A novel inhibitor of hypertonicity-induced cation channels in HeLa cells. J. Physiol. Sci. 57 (4), 249–252. 10.2170/physiolsci.SC003007 [DOI] [PubMed] [Google Scholar]

[B231] Oancea E., Wolfe J. T., Clapham D. E. (2006). Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ. Res. 98 (2), 245–253. 10.1161/01.RES.0000200179.29375.cc [DOI] [PubMed] [Google Scholar]

[B232] Okada Y., Maeno E., Shimizu T., Dezaki K., Wang J., Morishima S. (2001). Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J. Physiol. 532 (1), 3–16. 10.1111/j.1469-7793.2001.0003g.x [DOI] [PMC free article] [PubMed] [Google Scholar]

[B233] Okada Y. (2016). Channelling frozen cells to survival after thawing: opening the door to cryo-physiology. J. Physiol. 594 (6), 1523–1524. 10.1113/jp271842 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B234] Okada Y., Hazama A. (1989). Volume-regulatory ion channels in epithelial cells. Physiology 4 (6), 238–242. 10.1152/physiologyonline.1989.4.6.238 [DOI] [Google Scholar]

[B235] Okada Y., Hazama A., Yuan W. L. (1990). Stretch-induced activation of Ca²⁺-permeable ion channels is involved in the volume regulation of hypotonically swollen epithelial cells. Neurosci. Res. Suppl. 12, S5–S13. 10.1016/0921-8696(90)90004-m [DOI] [PubMed] [Google Scholar]

[B236] Okada Y. (2004). Ion channels and transporters involved in cell volume regulation and sensor mechanisms. Cell Biochem. Biophys. 41 (2), 233–258. 10.1385/cbb:41:2:233 [DOI] [PubMed] [Google Scholar]

[B237] Okada Y., Maeno E., Shimizu T., Manabe K., Mori S., Nabekura T. (2004). Dual roles of plasmalemmal chloride channels in induction of cell death. Pflugers Arch. 448 (3), 287–295. 10.1007/s00424-004-1276-3 [DOI] [PubMed] [Google Scholar]

[B238] Okada Y., Numata T., Sato-Numata K., Sabirov R. Z., Liu H., Mori S. I., et al. (2019). Roles of volume-regulatory anion channels, VSOR and Maxi-Cl, in apoptosis, cisplatin resistance, necrosis, ischemic cell death, stroke and myocardial infarction. Curr. Top. Membr. 83, 205–283. 10.1016/bs.ctm.2019.03.001 [DOI] [PubMed] [Google Scholar]

[B239] Okada Y., Sabirov R. Z., Sato-Numata K., Numata T. (2021a). Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 1: roles of VSOR/VRAC in cell volume regulation, release of double-edged signals and apoptotic/necrotic cell death. Front. Cell Dev. Biol. 8, 614040. 10.3389/fcell.2020.614040 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B240] Okada Y., Sato-Numata K., Sabirov R. Z., Numata T. (2021b). Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 2: functional and molecular properties of ASOR/PAC channels and their roles in cell volume dysregulation and acidotoxic cell death. Front. Cell Dev. Biol. 9, 702317. 10.3389/fcell.2021.702317 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B241] Okada Y. (1997). Volume expansion-sensing outward-rectifier Cl⁻ channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273 (3), C755–C789. 10.1152/ajpcell.1997.273.3.C755 [DOI] [PubMed] [Google Scholar]

[B242] Orrenius S., Zhivotovsky B., Nicotera P. (2003). Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (7), 552–565. 10.1038/nrm1150 [DOI] [PubMed] [Google Scholar]

[B243] Osmanlıoğlu H., Yıldırım M. K., Akyuva Y., Yıldızhan K., Nazıroğlu M. (2020). Morphine Induces apoptosis, inflammation, and mitochondrial oxidative stress via activation of TRPM2 channel and nitric oxide signaling pathways in the hippocampus. Mol. Neurobiol. 57 (8), 3376–3389. 10.1007/s12035-020-01975-6 [DOI] [PubMed] [Google Scholar]

[B244] Ostapchenko V. G., Chen M., Guzman M. S., Xie Y. F., Lavine N., Fan J., et al. (2015). The transient receptor potential melastatin 2 (TRPM2) channel contributes to β-amyloid oligomer-related neurotoxicity and memory impairment. J. Neurosci. 35 (45), 15157–15169. 10.1523/jneurosci.4081-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B245] Pan T., Zhu Q. J., Xu L. X., Ding X., Li J. Q., Sun B., et al. (2020). Knocking down TRPM2 expression reduces cell injury and NLRP3 inflammasome activation in PC12 cells subjected to oxygen-glucose deprivation. Neural Regen. Res. 15 (11), 2154–2161. 10.4103/1673-5374.282271 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B246] Parnas M., Peters M., Dadon D., Lev S., Vertkin I., Slutsky I., et al. (2009). Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 45 (3), 300–309. 10.1016/j.ceca.2008.11.009 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B247] Partida-Sanchez S., Gasser A., Fliegert R., Siebrands C. C., Dammermann W., Shi G., et al. (2007). Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. J. Immunol. 179 (11), 7827–7839. 10.4049/jimmunol.179.11.7827 [DOI] [PubMed] [Google Scholar]

[B248] Perraud A. L., Fleig A., Dunn C. A., Bagley L. A., Launay P., Schmitz C., et al. (2001). ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411 (6837), 595–599. 10.1038/35079100 [DOI] [PubMed] [Google Scholar]

[B249] Perraud A. L., Schmitz C., Scharenberg A. M. (2003). TRPM2 Ca²⁺ permeable cation channels: from gene to biological function. Cell Calcium 33 (5-6), 519–531. 10.1016/s0143-4160(03)00057-5 [DOI] [PubMed] [Google Scholar]

[B250] Perraud A. L., Takanishi C. L., Shen B., Kang S., Smith M. K., Schmitz C., et al. (2005). Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J. Biol. Chem. 280 (7), 6138–6148. 10.1074/jbc.M411446200 [DOI] [PubMed] [Google Scholar]

[B251] Plettenberg S., Weiss E. C., Lemor R., Wehner F. (2008). Subunits alpha, beta and gamma of the epithelial Na⁺ channel (ENaC) are functionally related to the hypertonicity-induced cation channel (HICC) in rat hepatocytes. Pflugers Arch. 455 (6), 1089–1095. 10.1007/s00424-007-0355-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B252] Poblete H., Oyarzún I., Olivero P., Comer J., Zuñiga M., Sepulveda R. V., et al. (2015). Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) binding to transient receptor potential V1 (TRPV1) channels. J. Biol. Chem. 290 (4), 2086–2098. 10.1074/jbc.M114.613620 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B253] Qin X., Yue Z., Sun B., Yang W., Xie J., Ni E., et al. (2013). Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br. J. Pharmacol. 168 (6), 1294–1312. 10.1111/bph.12012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B254] Qiu Z., Dubin A. E., Mathur J., Tu B., Reddy K., Miraglia L. J., et al. (2014). SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel. Cell 157 (2), 447–458. 10.1016/j.cell.2014.03.024 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B255] Rah S. Y., Kwak J. Y., Chung Y. J., Kim U. H. (2015). ADP-ribose/TRPM2-mediated Ca²⁺ signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells. Sci. Rep. 5, 9482. 10.1038/srep09482 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B256] Ritter M., Mongin A. A., Valenti G., Okada Y. (2021). Editorial: ion and water transport in cell death. Front. Cell Dev. Biol. 9, 757033. 10.3389/fcell.2021.757033 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B257] Rizzuto R., Pinton P., Ferrari D., Chami M., Szabadkai G., Magalhães P. J., et al. (2003). Calcium and apoptosis: facts and hypotheses. Oncogene 22 (53), 8619–8627. 10.1038/sj.onc.1207105 [DOI] [PubMed] [Google Scholar]

[B258] Roberge S., Roussel J., Andersson D. C., Meli A. C., Vidal B., Blandel F., et al. (2014). TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. Cardiovasc Res. 103 (1), 90–99. 10.1093/cvr/cvu112 [DOI] [PubMed] [Google Scholar]

[B259] Rohács T., Lopes C. M., Michailidis I., Logothetis D. E. (2005). PI(4,5)P₂ regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci. 8 (5), 626–634. 10.1038/nn1451 [DOI] [PubMed] [Google Scholar]

[B260] Romagnani A., Vettore V., Rezzonico-Jost T., Hampe S., Rottoli E., Nadolni W., et al. (2017). TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut. Nat. Commun. 8 (1), 1917. 10.1038/s41467-017-01960-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[B261] Rössig A., Hill K., Nörenberg W., Weidenbach S., Zierler S., Schaefer M., et al. (2022). Pharmacological agents selectively acting on the channel moieties of TRPM6 and TRPM7. Cell Calcium 106, 102640. 10.1016/j.ceca.2022.102640 [DOI] [PubMed] [Google Scholar]

[B262] Rothstein A., Mack E. (1990). Volume-activated K⁺ and Cl⁻ pathways of dissociated epithelial cells (MDCK): role of Ca²⁺ . Am. J. Physiol. 258 (5), C827–C834. 10.1152/ajpcell.1990.258.5.C827 [DOI] [PubMed] [Google Scholar]

[B263] Runnels L. W., Yue L., Clapham D. E. (2002). The TRPM7 channel is inactivated by PIP₂ hydrolysis. Nat. Cell Biol. 4 (5), 329–336. 10.1038/ncb781 [DOI] [PubMed] [Google Scholar]

[B264] Runnels L. W., Yue L., Clapham D. E. (2001). TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291 (5506), 1043–1047. 10.1126/science.1058519 [DOI] [PubMed] [Google Scholar]

[B265] Ryazanova L. V., Rondon L. J., Zierler S., Hu Z., Galli J., Yamaguchi T. P., et al. (2010). TRPM7 is essential for Mg²⁺ homeostasis in mammals. Nat. Commun. 1, 109. 10.1038/ncomms1108 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B266] Şanlı C., Atılgan R., Kuloğlu T., Pala Ş., Aydın Türk B., Keser H. B., et al. (2021). Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology. Turk J. Med. Sci. 51 (2), 787–795. 10.3906/sag-2005-297 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B267] Sano Y., Inamura K., Miyake A., Mochizuki S., Yokoi H., Matsushime H., et al. (2001). Immunocyte Ca²⁺ influx system mediated by LTRPC2. Science 293 (5533), 1327–1330. 10.1126/science.1062473 [DOI] [PubMed] [Google Scholar]

[B268] Schäfer S., Ferioli S., Hofmann T., Zierler S., Gudermann T., Chubanov V. (2016). Mibefradil represents a new class of benzimidazole TRPM7 channel agonists. Pflugers Arch. 468 (4), 623–634. 10.1007/s00424-015-1772-7 [DOI] [PubMed] [Google Scholar]

[B269] Schlingmann K. P., Waldegger S., Konrad M., Chubanov V., Gudermann T. (2007). TRPM6 and TRPM7--Gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta 1772 (8), 813–821. 10.1016/j.bbadis.2007.03.009 [DOI] [PubMed] [Google Scholar]

[B270] Schmidt E., Narangoda C., Nörenberg W., Egawa M., Rössig A., Leonhardt M., et al. (2022). Structural mechanism of TRPM7 channel regulation by intracellular magnesium. Cell Mol. Life Sci. 79 (5), 225. 10.1007/s00018-022-04192-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B271] Schmitz C., Perraud A. L., Johnson C. O., Inabe K., Smith M. K., Penner R., et al. (2003). Regulation of vertebrate cellular Mg²⁺ homeostasis by TRPM7. Cell 114 (2), 191–200. 10.1016/s0092-8674(03)00556-7 [DOI] [PubMed] [Google Scholar]

[B272] Schorn C., Frey B., Lauber K., Janko C., Strysio M., Keppeler H., et al. (2011). Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem. 286 (1), 35–41. 10.1074/jbc.M110.139048 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B273] Shimizu S., Yonezawa R., Hagiwara T., Yoshida T., Takahashi N., Hamano S., et al. (2014). Inhibitory effects of AG490 on H₂O₂-induced TRPM2-mediated Ca²⁺ entry. Eur. J. Pharmacol. 742, 22–30. 10.1016/j.ejphar.2014.08.023 [DOI] [PubMed] [Google Scholar]

[B274] Shimizu T., Dietz R. M., Cruz-Torres I., Strnad F., Garske A. K., Moreno M., et al. (2016). Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Exp. Neurol. 283, 151–156. 10.1016/j.expneurol.2016.06.015 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B275] Shimizu T., Macey T. A., Quillinan N., Klawitter J., Perraud A. L., Traystman R. J., et al. (2013). Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J. Cereb. Blood Flow. Metab. 33 (10), 1549–1555. 10.1038/jcbfm.2013.105 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B276] Shimizu T., Maeno E., Okada Y. (2007). Prerequisite role of persistent cell shrinkage in apoptosis of human epithelial cells. Sheng Li Xue Bao 59 (4), 512–516. [PubMed] [Google Scholar]

[B277] Shimizu T., Numata T., Okada Y. (2004). A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl⁻ channel. Proc. Natl. Acad. Sci. U. S. A. 101 (17), 6770–6773. 10.1073/pnas.0401604101 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B278] Simon F., Varela D., Cabello-Verrugio C. (2013). Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal 25 (7), 1614–1624. 10.1016/j.cellsig.2013.03.023 [DOI] [PubMed] [Google Scholar]

[B279] Singh A., Hildebrand M. E., Garcia E., Snutch T. P. (2010). The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. Br. J. Pharmacol. 160 (6), 1464–1475. 10.1111/j.1476-5381.2010.00786.x [DOI] [PMC free article] [PubMed] [Google Scholar]

[B280] Smith M. A., Herson P. S., Lee K., Pinnock R. D., Ashford M. L. (2003). Hydrogen-peroxide-induced toxicity of rat striatal neurones involves activation of a non-selective cation channel. J. Physiol. 547 (2), 417–425. 10.1113/jphysiol.2002.034561 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B281] Song C., Bae Y., Jun J., Lee H., Kim N. D., Lee K. B., et al. (2017). Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion. Biochim. Biophys. Acta Gen. Subj. 1861 (4), 947–957. 10.1016/j.bbagen.2017.01.034 [DOI] [PubMed] [Google Scholar]

[B282] Song K., Wang H., Kamm G. B., Pohle J., Reis F. C., Heppenstall P., et al. (2016). The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia. Science 353 (6306), 1393–1398. 10.1126/science.aaf7537 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B283] Starkus J., Beck A., Fleig A., Penner R. (2007). Regulation of TRPM2 by extra- and intracellular calcium. J. Gen. Physiol. 130 (4), 427–440. 10.1085/jgp.200709836 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B284] Starkus J. G., Fleig A., Penner R. (2010). The calcium-permeable non-selective cation channel TRPM2 is modulated by cellular acidification. J. Physiol. 588 (8), 1227–1240. 10.1113/jphysiol.2010.187476 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B285] Strange K., Jackson P. S. (1995). Swelling-activated organic osmolyte efflux: a new role for anion channels. Kidney Int. 48 (4), 994–1003. 10.1038/ki.1995.381 [DOI] [PubMed] [Google Scholar]

[B286] Su L. T., Agapito M. A., Li M., Simonson W. T., Huttenlocher A., Habas R., et al. (2006). TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J. Biol. Chem. 281 (16), 11260–11270. 10.1074/jbc.M512885200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B287] Subramanyam M., Takahashi N., Hasegawa Y., Mohri T., Okada Y. (2010). Inhibition of protein kinase Akt1 by apoptosis signal-regulating kinase-1 (ASK1) is involved in apoptotic inhibition of regulatory volume increase. J. Biol. Chem. 285 (9), 6109–6117. 10.1074/jbc.M109.072785 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B288] Sumoza-Toledo A., Penner R. (2011). TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. 589 (7), 1515–1525. 10.1113/jphysiol.2010.201855 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B289] Sun H. S., Jackson M. F., Martin L. J., Jansen K., Teves L., Cui H., et al. (2009). Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat. Neurosci. 12 (10), 1300–1307. 10.1038/nn.2395 [DOI] [PubMed] [Google Scholar]

[B290] Sun L., Yau H. Y., Wong W. Y., Li R. A., Huang Y., Yao X. (2012). Role of TRPM2 in H₂O₂-induced cell apoptosis in endothelial cells. PLoS One 7 (8), e43186. 10.1371/journal.pone.0043186 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B291] Sun Y., Kamat A., Singh B. B. (2020a). Isoproterenol-dependent activation of TRPM7 protects against neurotoxin-induced loss of neuroblastoma cells. Front. Physiol. 11, 305. 10.3389/fphys.2020.00305 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B292] Sun Y., Sukumaran P., Selvaraj S., Cilz N. I., Schaar A., Lei S., et al. (2018). TRPM2 promotes neurotoxin MPP⁺/MPTP-induced cell death. Mol. Neurobiol. 55 (1), 409–420. 10.1007/s12035-016-0338-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B293] Sun Y., Sukumaran P., Singh B. B. (2020b). Magnesium-induced cell survival Is dependent on TRPM7 expression and function. Mol. Neurobiol. 57 (1), 528–538. 10.1007/s12035-019-01713-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B294] Szollosi A. (2021). Two decades of evolution of our understanding of the transient receptor potential melastatin 2 (TRPM2) cation channel. Life (Basel) 11 (5), 397. 10.3390/life11050397 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B295] Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., et al. (1993). Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol. Chem. 268 (35), 26052–26054. 10.1016/s0021-9258(19)74275-6 [DOI] [PubMed] [Google Scholar]

[B296] Tan C. H., McNaughton P. A. (2016). The TRPM2 ion channel is required for sensitivity to warmth. Nature 536 (7617), 460–463. 10.1038/nature19074 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B297] Thomas G. P., Karmazyn M., Zygmunt A. C., Antzelevitch C., Narayanan N. (1999). The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in Guinea-pig ventricular myocytes. Br. J. Pharmacol. 126 (7), 1531–1533. 10.1038/sj.bjp.0702475 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B298] Tian Y., Yang T., Yu S., Liu C., He M., Hu C. (2018). Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels. J. Cell Mol. Med. 22 (12), 6327–6337. 10.1111/jcmm.13931 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B299] Toda T., Yamamoto S., Yonezawa R., Mori Y., Shimizu S. (2016). Inhibitory effects of Tyrphostin AG-related compounds on oxidative stress-sensitive transient receptor potential channel activation. Eur. J. Pharmacol. 786, 19–28. 10.1016/j.ejphar.2016.05.033 [DOI] [PubMed] [Google Scholar]

[B300] Togashi K., Hara Y., Tominaga T., Higashi T., Konishi Y., Mori Y., et al. (2006). TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. Embo J. 25 (9), 1804–1815. 10.1038/sj.emboj.7601083 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B301] Togashi K., Inada H., Tominaga M. (2008). Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB). Br. J. Pharmacol. 153 (6), 1324–1330. 10.1038/sj.bjp.0707675 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B302] Tong L., Denu J. M. (2010). Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 1804 (8), 1617–1625. 10.1016/j.bbapap.2010.02.007 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B303] Tong Q., Zhang W., Conrad K., Mostoller K., Cheung J. Y., Peterson B. Z., et al. (2006). Regulation of the transient receptor potential channel TRPM2 by the Ca²⁺ sensor calmodulin. J. Biol. Chem. 281 (14), 9076–9085. 10.1074/jbc.M510422200 [DOI] [PubMed] [Google Scholar]

[B304] Tosteson D. C., Hoffman J. F. (1960). Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J. Gen. Physiol. 44 (1), 169–194. 10.1085/jgp.44.1.169 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B305] Tóth B., Csanády L. (2012). Pore collapse underlies irreversible inactivation of TRPM2 cation channel currents. Proc. Natl. Acad. Sci. U. S. A. 109 (33), 13440–13445. 10.1073/pnas.1204702109 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B306] Tóth B., Iordanov I., Csanády L. (2015). Ruling out pyridine dinucleotides as true TRPM2 channel activators reveals novel direct agonist ADP-ribose-2'-phosphate. J. Gen. Physiol. 145 (5), 419–430. 10.1085/jgp.201511377 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B307] Touyz R. M., He Y., Montezano A. C., Yao G., Chubanov V., Gudermann T., et al. (2006). Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (1), R73–R78. 10.1152/ajpregu.00515.2005 [DOI] [PubMed] [Google Scholar]

[B308] Tseng H. H., Vong C. T., Kwan Y. W., Lee S. M., Hoi M. P. (2016). TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells. Sci. Rep. 6, 35016. 10.1038/srep35016 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B309] Turlova E., Bae C. Y. J., Deurloo M., Chen W., Barszczyk A., Horgen F. D., et al. (2016). TRPM7 regulates axonal outgrowth and maturation of primary hippocampal neurons. Mol. Neurobiol. 53 (1), 595–610. 10.1007/s12035-014-9032-y [DOI] [PMC free article] [PubMed] [Google Scholar]

[B310] Turlova E., Feng Z. P., Sun H. S. (2018). The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia. Acta Pharmacol. Sin. 39 (5), 713–721. 10.1038/aps.2017.194 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B311] Turlova E., Wong R., Xu B., Li F., Du L., Habbous S., et al. (2021). TRPM7 mediates neuronal cell Death upstream of calcium/calmodulin-dependent protein kinase II and calcineurin mechanism in neonatal hypoxic-ischemic brain injury. Transl. Stroke Res. 12 (1), 164–184. 10.1007/s12975-020-00810-3 [DOI] [PubMed] [Google Scholar]

[B312] Tymianski M. (2011). Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat. Neurosci. 14 (11), 1369–1373. 10.1038/nn.2951 [DOI] [PubMed] [Google Scholar]

[B313] Varela D., Simon F., Riveros A., Jørgensen F., Stutzin A. (2004). NAD(P)H oxidase-derived H₂O₂ signals chloride channel activation in cell volume regulation and cell proliferation. J. Biol. Chem. 279 (14), 13301–13304. 10.1074/jbc.C400020200 [DOI] [PubMed] [Google Scholar]

[B314] Vennekens R., Mesuere M., Philippaert K. (2018). TRPM5 in the battle against diabetes and obesity. Acta Physiol. (Oxf) 222 (2), e12949. 10.1111/apha.12949 [DOI] [PubMed] [Google Scholar]

[B315] Verma S., Quillinan N., Yang Y. F., Nakayama S., Cheng J., Kelley M. H., et al. (2012). TRPM2 channel activation following in vitro ischemia contributes to male hippocampal cell death. Neurosci. Lett. 530 (1), 41–46. 10.1016/j.neulet.2012.09.044 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B316] Viana F., Van den Bosch L., Missiaen L., Vandenberghe W., Droogmans G., Nilius B., et al. (1997). Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 22 (4), 299–311. 10.1016/s0143-4160(97)90068-3 [DOI] [PubMed] [Google Scholar]

[B317] Volk T., Frömter E., Korbmacher C. (1995). Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells. Proc. Natl. Acad. Sci. U. S. A. 92 (18), 8478–8482. 10.1073/pnas.92.18.8478 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B318] Voss F. K., Ullrich F., Münch J., Lazarow K., Lutter D., Mah N., et al. (2014). Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science 344 (6184), 634–638. 10.1126/science.1252826 [DOI] [PubMed] [Google Scholar]

[B319] Vriens J., Voets T. (2019). Heat sensing involves a TRiPlet of ion channels. Br. J. Pharmacol. 176 (20), 3893–3898. 10.1111/bph.14812 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B320] Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M. (1997). A proton-gated cation channel involved in acid-sensing. Nature 386 (6621), 173–177. 10.1038/386173a0 [DOI] [PubMed] [Google Scholar]

[B321] Waldmann R., Champigny G., Lingueglia E., De Weille J. R., Heurteaux C., Lazdunski M. (1999). H⁺-gated cation channels. Ann. N. Y. Acad. Sci. 868, 67–76. 10.1111/j.1749-6632.1999.tb11274.x [DOI] [PubMed] [Google Scholar]

[B322] Wang C., Naruse K., Takahashi K. (2018). Role of the TRPM4 channel in cardiovascular physiology and pathophysiology. Cells 7 (6), 62. 10.3390/cells7060062 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B323] Wang H. Y., Shimizu T., Numata T., Okada Y. (2007). Role of acid-sensitive outwardly rectifying anion channels in acidosis-induced cell death in human epithelial cells. Pflugers Arch. 454 (2), 223–233. 10.1007/s00424-006-0193-z [DOI] [PubMed] [Google Scholar]

[B324] Wang J., Morishima S., Okada Y. (2003). Ik channels are involved in the regulatory volume decrease in human epithelial cells. Am. J. Physiol. Cell Physiol. 284 (1), C77–C84. 10.1152/ajpcell.00132.2002 [DOI] [PubMed] [Google Scholar]

[B325] Wang L., Fu T. M., Zhou Y., Xia S., Greka A., Wu H. (2018). Structures and gating mechanism of human TRPM2. Science 362 (6421), eaav4809. 10.1126/science.aav4809 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B326] Wang L., Negro R., Wu H. (2020). TRPM2, linking oxidative stress and Ca²⁺ permeation to NLRP3 inflammasome activation. Curr. Opin. Immunol. 62, 131–135. 10.1016/j.coi.2020.01.005 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B327] Wehage E., Eisfeld J., Heiner I., Jüngling E., Zitt C., Lückhoff A. (2002). Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose. J. Biol. Chem. 277 (26), 23150–23156. 10.1074/jbc.M112096200 [DOI] [PubMed] [Google Scholar]

[B328] Wehner F., Bondarava M., ter Veld F., Endl E., Nürnberger H. R., Li T. (2006). Hypertonicity-induced cation channels. Acta Physiol. (Oxf) 187 (1-2), 21–25. 10.1111/j.1748-1716.2006.01561.x [DOI] [PubMed] [Google Scholar]

[B329] Wehner F., Olsen H., Tinel H., Kinne-Saffran E., Kinne R. K. (2003a). Cell volume regulation: osmolytes, osmolyte transport, and signal transduction. Rev. Physiol. Biochem. Pharmacol. 148, 1–80. 10.1007/s10254-003-0009-x [DOI] [PubMed] [Google Scholar]

[B330] Wehner F., Sauer H., Kinne R. K. (1995). Hypertonic stress increases the Na⁺ conductance of rat hepatocytes in primary culture. J. Gen. Physiol. 105 (4), 507–535. 10.1085/jgp.105.4.507 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B331] Wehner F., Shimizu T., Sabirov R., Okada Y. (2003b). Hypertonic activation of a non-selective cation conductance in HeLa cells and its contribution to cell volume regulation. FEBS Lett. 551 (1-3), 20–24. 10.1016/s0014-5793(03)00868-8 [DOI] [PubMed] [Google Scholar]

[B332] Wei C., Wang X., Chen M., Ouyang K., Song L. S., Cheng H. (2009). Calcium flickers steer cell migration. Nature 457 (7231), 901–905. 10.1038/nature07577 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B333] Wilson C. S., Mongin A. A. (2018). Cell volume control in healthy brain and neuropathologies. Curr. Top. Membr. 81, 385–455. 10.1016/bs.ctm.2018.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B334] Won J., Vang H., Kim J. H., Lee P. R., Kang Y., Oh S. B. (2018). TRPM7 mediates mechanosensitivity in adult rat odontoblasts. J. Dent. Res. 97 (9), 1039–1046. 10.1177/0022034518759947 [DOI] [PubMed] [Google Scholar]

[B335] Wong K. K., Banham A. H., Yaacob N. S., Nur Husna S. M. (2019). The oncogenic roles of TRPM ion channels in cancer. J. Cell Physiol. 234, 14556–14573. 10.1002/jcp.28168 [DOI] [PubMed] [Google Scholar]

[B336] Wong S. M., Chase H. S., Jr. (1986). Role of intracellular calcium in cellular volume regulation. Am. J. Physiol. 250 (6), C841–C852. 10.1152/ajpcell.1986.250.6.C841 [DOI] [PubMed] [Google Scholar]

[B337] Wu D. C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., et al. (2003). NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (10), 6145–6150. 10.1073/pnas.0937239100 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B338] Wu H., Dai R., Wang M., Chen C. (2023). Uric acid promotes myocardial infarction injury via activating pyrin domain-containing 3 inflammasome and reactive oxygen species/transient receptor potential melastatin 2/Ca²⁺ pathway. BMC Cardiovasc Disord. 23 (1), 10. 10.1186/s12872-023-03040-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B339] Wuensch T., Thilo F., Krueger K., Scholze A., Ristow M., Tepel M. (2010). High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes 59 (4), 844–849. 10.2337/db09-1100 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B340] Xia R., Mei Z. Z., Mao H. J., Yang W., Dong L., Bradley H., et al. (2008). Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel 2. J. Biol. Chem. 283 (41), 27426–27432. 10.1074/jbc.M801049200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B341] Xia S., Wang L., Fu T. M., Wu H. (2019). Mechanism of TRPM2 channel gating revealed by cryo-EM. Febs J. 286 (17), 3333–3339. 10.1111/febs.14939 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B342] Xiao E., Yang H. Q., Gan Y. H., Duan D. H., He L. H., Guo Y., et al. (2015). Brief reports: TRPM7 senses mechanical stimulation inducing osteogenesis in human bone marrow mesenchymal stem cells. Stem Cells 33 (2), 615–621. 10.1002/stem.1858 [DOI] [PubMed] [Google Scholar]

[B343] Xie J., Sun B., Du J., Yang W., Chen H. C., Overton J. D., et al. (2011). Phosphatidylinositol 4,5-bisphosphate (PIP₂) controls magnesium gatekeeper TRPM6 activity. Sci. Rep. 1, 146. 10.1038/srep00146 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B344] Xu H. L., Liu M. D., Yuan X. H., Liu C. X. (2018). Suppression of cortical TRPM7 protein attenuates oxidative damage after traumatic brain injury via Akt/endothelial nitric oxide synthase pathway. Neurochem. Int. 112, 197–205. 10.1016/j.neuint.2017.07.010 [DOI] [PubMed] [Google Scholar]

[B345] Xu S. Z., Zeng F., Boulay G., Grimm C., Harteneck C., Beech D. J. (2005). Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 145 (4), 405–414. 10.1038/sj.bjp.0706197 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B346] Yamaguchi H., Matsushita M., Nairn A. C., Kuriyan J. (2001). Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol. Cell 7 (5), 1047–1057. 10.1016/s1097-2765(01)00256-8 [DOI] [PubMed] [Google Scholar]

[B347] Yang D., He Y., Muñoz-Planillo R., Liu Q., Núñez G. (2015). Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43 (5), 923–932. 10.1016/j.immuni.2015.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B348] Yang J., Chen J., Del Carmen Vitery M., Osei-Owusu J., Chu J., Yu H., et al. (2019). PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel. Science 364 (6438), 395–399. 10.1126/science.aav9739 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B349] Yang T., Zhang A., Honeggar M., Kohan D. E., Mizel D., Sanders K., et al. (2005). Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin. J. Biol. Chem. 280 (41), 34966–34973. 10.1074/jbc.M502430200 [DOI] [PubMed] [Google Scholar]

[B350] Yang W., Manna P. T., Zou J., Luo J., Beech D. J., Sivaprasadarao A., et al. (2011). Zinc inactivates melastatin transient receptor potential 2 channels via the outer pore. J. Biol. Chem. 286 (27), 23789–23798. 10.1074/jbc.M111.247478 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B351] Yang W., Zou J., Xia R., Vaal M. L., Seymour V. A., Luo J., et al. (2010). State-dependent inhibition of TRPM2 channel by acidic pH. J. Biol. Chem. 285 (40), 30411–30418. 10.1074/jbc.M110.139774 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B352] Yang X., Li C., Liao X., Liu S., Li X., Hou X., et al. (2023). Paclitaxel induces pyroptosis by inhibiting the volume-sensitive chloride channel leucine-rich repeat-containing 8a in ovarian cancer cells. Oncol. Rep. 49 (6), 115. 10.3892/or.2023.8552 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B353] Yazğan Y., Nazıroğlu M. (2021). Involvement of TRPM2 in the neurobiology of experimental migraine: focus on oxidative stress and apoptosis. Mol. Neurobiol. 58 (11), 5581–5601. 10.1007/s12035-021-02503-w [DOI] [PubMed] [Google Scholar]

[B354] Ye M., Yang W., Ainscough J. F., Hu X. P., Li X., Sedo A., et al. (2014). TRPM2 channel deficiency prevents delayed cytosolic Zn²⁺ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis. 5 (11), e1541. 10.1038/cddis.2014.494 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B355] Ye X., Liu X., Wei W., Yu H., Jin X., Yu J., et al. (2021). Volume-activated chloride channels contribute to lipopolysaccharide plus nigericin-induced pyroptosis in bone marrow-derived macrophages. Biochem. Pharmacol. 193, 114791. 10.1016/j.bcp.2021.114791 [DOI] [PubMed] [Google Scholar]

[B356] Yee N. S. (2017). Role of TRPM7 in cancer: potential as molecular biomarker and therapeutic target. Pharm. (Basel) 10 (2), 39. 10.3390/ph10020039 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B357] Yee N. S., Kazi A. A., Yee R. K. (2014). Cellular and developmental biology of TRPM7 channel-kinase: implicated roles in cancer. Cells 3 (3), 751–777. 10.3390/cells3030751 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B358] Yıldızhan K., Huyut Z., Altındağ F. (2023). Involvement of TRPM2 channel on doxorubicin-induced experimental cardiotoxicity model: protective role of selenium. Biol. Trace Elem. Res. 201 (5), 2458–2469. 10.1007/s12011-022-03377-2 [DOI] [PubMed] [Google Scholar]

[B359] Yin Y., Wu M., Hsu A. L., Borschel W. F., Borgnia M. J., Lander G. C., et al. (2019). Visualizing structural transitions of ligand-dependent gating of the TRPM2 channel. Nat. Commun. 10 (1), 3740. 10.1038/s41467-019-11733-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B360] Yu H., Zhang Z., Lis A., Penner R., Fleig A. (2013). TRPM7 is regulated by halides through its kinase domain. Cell Mol. Life Sci. 70 (15), 2757–2771. 10.1007/s00018-013-1284-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B361] Yu M., Huang C., Huang Y., Wu X., Li X., Li J. (2013). Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts. Inflamm. Res. 62 (11), 961–970. 10.1007/s00011-013-0653-9 [DOI] [PubMed] [Google Scholar]

[B362] Yu P., Liu Z., Yu X., Ye P., Liu H., Xue X., et al. (2019). Direct gating of the TRPM2 channel by cADPR via specific interactions with the ADPR binding pocket. Cell Rep. 27 (12), 3684–3695. e3684. 10.1016/j.celrep.2019.05.067 [DOI] [PubMed] [Google Scholar]

[B363] Yu W., Jiang L. H., Zheng Y., Hu X., Luo J., Yang W. (2014). Inactivation of TRPM2 channels by extracellular divalent copper. PLoS One 9 (11), e112071. 10.1371/journal.pone.0112071 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B364] Yu X., Xie Y., Zhang X., Ma C., Liu L., Zhen W., et al. (2021). Structural and functional basis of the selectivity filter as a gate in human TRPM2 channel. Cell Rep. 37 (7), 110025. 10.1016/j.celrep.2021.110025 [DOI] [PubMed] [Google Scholar]

[B365] Yürüker V., Nazıroğlu M., Şenol N. (2015). Reduction in traumatic brain injury-induced oxidative stress, apoptosis, and calcium entry in rat hippocampus by melatonin: possible involvement of TRPM2 channels. Metab. Brain Dis. 30 (1), 223–231. 10.1007/s11011-014-9623-3 [DOI] [PubMed] [Google Scholar]

[B366] Zeng B., Chen G. L., Xu S. Z. (2012). Divalent copper is a potent extracellular blocker for TRPM2 channel. Biochem. Biophys. Res. Commun. 424 (2), 279–284. 10.1016/j.bbrc.2012.06.107 [DOI] [PubMed] [Google Scholar]

[B367] Zhan H. Q., Li P. F., Li S. Y., Yan F. L., Yang J., Liu R. L., et al. (2014). Influence of lactuside B on the expression of AQP4 and TRPM7 mRNAs in the cerebral cortex after cerebral ischemia injury. Eur. Rev. Med. Pharmacol. Sci. 18 (8), 1151–1157. [PubMed] [Google Scholar]

[B368] Zhang H., Yu P., Lin H., Jin Z., Zhao S., Zhang Y., et al. (2021). The discovery of novel ACA derivatives as specific TRPM2 inhibitors that reduce ischemic injury both in vitro and in vivo . J. Med. Chem. 64 (7), 3976–3996. 10.1021/acs.jmedchem.0c02129 [DOI] [PubMed] [Google Scholar]

[B369] Zhang W., Chu X., Tong Q., Cheung J. Y., Conrad K., Masker K., et al. (2003). A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J. Biol. Chem. 278 (18), 16222–16229. 10.1074/jbc.M300298200 [DOI] [PubMed] [Google Scholar]

[B370] Zhang W., Hirschler-Laszkiewicz I., Tong Q., Conrad K., Sun S. C., Penn L., et al. (2006). TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage. Am. J. Physiol. Cell Physiol. 290 (4), C1146–C1159. 10.1152/ajpcell.00205.2005 [DOI] [PubMed] [Google Scholar]

[B371] Zhang W., Tong Q., Conrad K., Wozney J., Cheung J. Y., Miller B. A. (2007). Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1. Am. J. Physiol. Cell Physiol. 292 (5), C1746–C1758. 10.1152/ajpcell.00569.2006 [DOI] [PubMed] [Google Scholar]

[B372] Zhang X., Chen Q., Wang Y., Peng W., Cai H. (2014). Effects of curcumin on ion channels and transporters. Front. Physiol. 5, 94. 10.3389/fphys.2014.00094 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B373] Zhang Y., Zhou L., Zhang X., Bai J., Shi M., Zhao G. (2012). Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia. Neurol. Sci. 33 (5), 1125–1131. 10.1007/s10072-011-0916-6 [DOI] [PubMed] [Google Scholar]

[B374] Zhang Z., Tóth B., Szollosi A., Chen J., Csanády L. (2018). Structure of a TRPM2 channel in complex with Ca²⁺ explains unique gating regulation. Elife 7, e36409. 10.7554/eLife.36409 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B375] Zhao R., Afthinos A., Zhu T., Mistriotis P., Li Y., Serra S. A., et al. (2019). Cell sensing and decision-making in confinement: the role of TRPM7 in a tug of war between hydraulic pressure and cross-sectional area. Sci. Adv. 5 (7), eaaw7243. 10.1126/sciadv.aaw7243 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B376] Zhao Y. J., Lam C. M., Lee H. C. (2012). The membrane-bound enzyme CD38 exists in two opposing orientations. Sci. Signal 5 (241), ra67. 10.1126/scisignal.2002700 [DOI] [PubMed] [Google Scholar]

[B377] Zhao Y., Wang J., Jiang H., Yu Z., Li X., Shi J. (2015). Following OGD/R, annexin 1 nuclear translocation and subsequent induction of apoptosis in neurons are assisted by myosin IIA in a TRPM7 kinase-dependent manner. Mol. Neurobiol. 51 (2), 729–742. 10.1007/s12035-014-8781-y [DOI] [PubMed] [Google Scholar]

[B378] Zhelay T., Wieczerzak K. B., Beesetty P., Alter G. M., Matsushita M., Kozak J. A. (2018). Depletion of plasma membrane-associated phosphoinositides mimics inhibition of TRPM7 channels by cytosolic Mg²⁺, spermine, and pH. J. Biol. Chem. 293 (47), 18151–18167. 10.1074/jbc.RA118.004066 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B379] Zheng Q., Zhu T., Hu H., Zhao Y., Ying Y., Luo X., et al. (2020). TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice. Brain Res. Bull. 155, 48–60. 10.1016/j.brainresbull.2019.11.018 [DOI] [PubMed] [Google Scholar]

[B380] Zhong Z., Zhai Y., Liang S., Mori Y., Han R., Sutterwala F. S., et al. (2013). TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun. 4, 1611. 10.1038/ncomms2608 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B381] Zierler S., Yao G., Zhang Z., Kuo W. C., Pörzgen P., Penner R., et al. (2011). Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J. Biol. Chem. 286 (45), 39328–39335. 10.1074/jbc.M111.264341 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B382] Zocchi E., Franco L., Guida L., Benatti U., Bargellesi A., Malavasi F., et al. (1993). A single protein immunologically identified as CD38 displays NAD⁺ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem. Biophys. Res. Commun. 196 (3), 1459–1465. 10.1006/bbrc.1993.2416 [DOI] [PubMed] [Google Scholar]

[B383] Zong P., Feng J., Yue Z., Li Y., Wu G., Sun B., et al. (2022a). Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury. Neuron 110 (12), 1944–1958.e8. e1948. 10.1016/j.neuron.2022.03.021 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B384] Zong P., Feng J., Yue Z., Yu A. S., Vacher J., Jellison E. R., et al. (2022b). TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages. Nat. Cardiovasc Res. 1 (4), 344–360. 10.1038/s44161-022-00027-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B385] Zou J., Ainscough J. F., Yang W., Sedo A., Yu S. P., Mei Z. Z., et al. (2013). A differential role of macrophage TRPM2 channels in Ca²⁺ signaling and cell death in early responses to H₂O₂. Am. J. Physiol. Cell Physiol. 305 (1), C61–C69. 10.1152/ajpcell.00390.2012 [DOI] [PubMed] [Google Scholar]

[B386] Zubcevic L. (2020). TRP channels, conformational flexibility, and the lipid membrane. J. Membr. Biol. 253 (4), 299–308. 10.1007/s00232-020-00127-0 [DOI] [PubMed] [Google Scholar]

PERMALINK

Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7

Yasunobu Okada

Tomohiro Numata

Ravshan Z Sabirov

Makiko Kashio

Peter G Merzlyak

Kaori Sato-Numata

Abstract

Introduction

Phenotypic properties and molecular structures of TRPM2 and TRPM7

Chanzymes TRPM2 and TRPM7 as the members of sensor TRP channels

Physiological roles of TRPM2 and TRPM7

TRPM2

TRPM7

Biophysical properties of TRPM2 and TRPM7

TRPM2

FIGURE 1.

TRPM7

FIGURE 2.

Activation and inactivation signals for TRPM2 and TRPM7

TRPM2

TRPM7

Pharmacological properties of TRPM2 and TRPM7

TRPM2

TRPM7

Three-dimensional structures of TRPM2 and TRPM7

TRPM2

FIGURE 3.

TRPM7

FIGURE 4.

Roles of TRPM2 and TRPM7 in cell volume regulation and cell death induction/protection

Roles of TRPM2 and TRPM7 in cell volume regulation

RVI and TRPM2

FIGURE 5.

RVD and TRPM7

Roles of TRPM2 and TRPM7 in cell death

Inductive/protective roles of TRPM2 in cell death and tissue injury

Inductive roles of TRPM2 in apoptotic cell death

Inductive roles of TRPM2 in non-apoptotic cell death

Inductive roles of TRPM7 in cell death

Inductive/protective roles of TRPM7 in apoptotic cell death

Inductive roles of TRPM7 in non-apoptotic cell death

Ionic mechanisms of cell death induction/protection involving TRPM2 and TRPM7

Roles of TRPM2 and TRPM7 in ionic mechanisms leading to apoptotic cell death

FIGURE 6.

Roles of TRPM2 and TRPM7 in ionic mechanisms leading to necrotic cell death

FIGURE 7.

Conclusion and perspective

Author contributions

Conflict of interest

Publisher’s note

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases